Genetic regulation of bovine milk fatty acid composition: Improving the healthfulness of milk through selection by Nafikov, Rafael
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2010
Genetic regulation of bovine milk fatty acid
composition: Improving the healthfulness of milk
through selection
Rafael Nafikov
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biochemistry, Biophysics, and Structural Biology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Nafikov, Rafael, "Genetic regulation of bovine milk fatty acid composition: Improving the healthfulness of milk through selection"
(2010). Graduate Theses and Dissertations. 11674.
https://lib.dr.iastate.edu/etd/11674
 
Genetic regulation of bovine milk fatty acid composition: Improving the 
healthfulness of milk through selection 
 
by 
 
Rafael Albertovich Nafikov 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
 
Co-majors: Biochemistry;  
Nutritional Sciences (Molecular and Cellular Nutrition) 
 
Program of Study Committee: 
Donald C. Beitz, Major Professor 
Lloyd L. Anderson 
Dorian J. Garrick 
Ted W. Huiatt 
Kenneth J. Koehler 
Diane E. Spurlock 
 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2010 
 
Copyright © Rafael Albertovich Nafikov, 2010. All rights reserved.  
 ii
TABLE OF CONTENTS 
 
ABSTRACT                                                                                                             v 
CHAPTER 1. GENERAL INTRODUCTION                                                                 1 
Dissertation Organization                                                                                       1 
Literature Review                                                                                                   2 
Cardiovascular disease occurrence             2 
Fatty acids and human plasma cholesterol concentrations       3                             
Environmental factors affecting milk fatty acid composition in dairy 
cattle                                                                              7 
Genetic regulation of milk fatty acid composition in dairy cattle        12 
Heritability of milk fatty acids                                                       12 
QTL affecting milk lipids                                                           13 
Single nucleotide polymorphisms associated with milk 
fatty acid composition                                                                    14 
Milk lipid biosynthesis in the lactating mammary gland            17 
References                                                                                                 30 
Figures                                                                               52 
CHAPTER 2. EFFECTS OF POLYMORPHISMS IN GPAT1, GPAT4, AGPAT1, 
AND LPIN1 GENES FROM THE TRIACYLGLYCEROL BIOSYNTHETIC  
PATHWAY ON MILK FATTY ACID COMPOSITION IN DAIRY CATTLE           54 
Abstract                                                                                                                 54 
Introduction                                                                                                        55 
 iii
Materials and Methods                                                                                      59 
Results                                                                                                                 65 
Discussion                                                                                                             72 
Conclusions                                                                                                       78 
References                                                                                                          78 
Tables                                                                                                                  84 
CHAPTER 3. EFFECTS OF POLYMORPHISMS IN FABP3, FABP4, AND 
SLC27A6 GENES ON BOVINE MILK FATTY ACID COMPOSITION                    97 
Abstract                                                                                                                97 
Introduction                                                                                                        98 
Materials and Methods                                                                                        101 
Results                                                                                                                 108 
Discussion                                                                                                            111 
Conclusions                                                                                                        115 
References                                                                                                          116 
Tables                                                                                                                 125 
CHAPTER 4. EFFECTS OF GENETIC POLYMORHPISMS IN THE SREBP 
PATHWAY ON MILK FATTY ACID COMPOSITION IN DAIRY CATTLE           134 
Abstract                                                                                                               134 
Introduction                                                                                                        135 
Materials and Methods                                                                                        138 
Results                                                                                                                 145 
Discussion                                                                                                           147 
 iv
Conclusions                                                                                                         151 
References                                                                                                           152 
Tables                                                                                                                 160 
CHAPTER 5. GENERAL CONCLUSIONS                                                               168 
General Discussion                                                                                            168 
Future Research                                                                                                 171 
References                                                                           173 
APPENDIX A. SUPPLEMENTARY INFORMATION FOR CHAPTER 2   175 
APPENDIX B. SUPPLEMENTARY INFORMATION FOR CHAPTER 3   188 
APPENDIX C. SUPPLEMENTARY INFORMATION FOR CHAPTER 4   195 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v
ABSTRACT 
 
The current study was designed to identity polymorphisms in the genes involved in milk lipid 
biosynthesis to provide animal breeders with tools that allow selection of animals producing 
milk with healthier fatty acid composition. High concentrations of saturated fatty acids (SFA) 
in human diets are known to increase plasma cholesterol concentrations and, as a result, 
increase the risk of developing cardiovascular diseases (CVD), the number one cause of 
death worldwide. Because bovine milk is one of the primary sources of SFA and individual 
atherogenic fatty acids such as palmitic (16:0) and myristic (14:0) in human diets the 
improvement of the healthfulness of milk through selection becomes one of the primary 
measures that has been taken with the intention of decreasing the incidence of CVD among 
humans.  
The candidate gene approach was used to address the objectives of the study. Genes 
involved in milk triacylglycerol (TAG) biosynthesis, fatty acid uptake into mammary gland 
and fatty acid transport inside the mammary epithelial cells, and transcriptional regulation of 
some lipogenic genes were investigated. DNA sequencing was used to discover single 
nucleotide polymorphisms (SNPs) in the genes of interest. After genotyping animals on the 
study for the discovered SNPs, the intragenic haplotypes were reconstructed and tested for 
the association with milk fatty acid composition.  
 The glycerol-3-phosphate acyltransferases-1 and -4 (GPAT1 and GPAT4), 1-
acylglycerol-3-phosphate acyltransferase-1 (AGPAT1), and phosphatidate phosphatase 
(LPIN1) genes from the TAG biosynthetic pathway were studied in the first set of 
experiments to test the associations of the polymorphisms in those genes with milk fatty acid 
 vi
composition. The polymorphisms in GPAT4 were associated with large differences in  
atherogenic index (AI), concentrations of SFA, unsaturated fatty acids (UFA), 
monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), SFA/UFA, 
concentrations of capric (10:0), lauric (12:0), palmitic (16:0), and oleic (18:1c9) acids, CLA 
(18:2c9, t11), C16 and C18 desaturation indices in milk. The size of the effects of GPAT4 
polymorphisms for some of the traits was numerically at least the same or larger compared 
with the effect of DGAT1 A232K mutation, making the polymorphisms in GPAAT4 to be a 
very valuable tool for the improvement of the healthfulness of milk. Other polymorphisms 
significantly associated with the studied traits in the first set of experiments were in GPAT1 
for milk fat percentage, concentrations of short- and medium-chain SFA, and myristoleic 
(14:1c9) acid concentration, and in AGPAT1 for the concentrations of linoleic (18:2c9, c12) 
acid and other UFA. The polymorphisms in GPAT1 can be used to select for animals 
producing milk with higher percentage of fat and desirable concentrations of short- and 
medium-chain SFA. The polymorphisms in AGPAT1 can be used to select for animals 
producing milk with higher concentration of UFA and linoleic (18:2c9, c12) acid, in particular. 
 In the second set of experiments, the polymorphisms in the solute carrier family 27 
(SLC27A6), isoform A6 and fatty acid binding proteins-3 and -4 (FABP3 and FABP4) genes 
involved in fatty acid uptake into mammary gland and fatty acid transport inside the 
mammary epithelial cells were tested for the association with milk fatty acid composition. 
The haplotype effects of SLC27A6 were associated significantly with milk fat percentage, AI, 
the concentrations of SFA, UFA, MUFA, SFA/UFA, the concentrations of capric (10:0), 
lauric (12:0), myristic (14:0), and palmitic (16:0) acids. The size of the haplotype effects of 
SLC27A6 on the studied traits was large and numerically similar to the size of allelic effects 
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of DGAT1 A232K mutation that makes the polymorphisms in SLC27A6 as valuable as the 
of DGAT1 A232K mutation to select for animals producing milk with higher fat percentage 
and healthier fatty acid composition. The haplotype effects of FABP4 were associated 
significantly with the concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, the 
concentrations of linoleic (18:2c9, c12) acid, CLA (18:2c9, t11), and C18 desaturation index. 
The sterol regulatory element binding protein-1c (SREBP-1c) is involved in the 
transcriptional regulation of lipogenesis and its proteolytic activation is controlled by SREBP 
cleavage-activating protein (SCAP) and insulin-induced genes (Insig) that are all part of the 
SREBP pathway. In the third set of experiments, the significant association of the overall 
haplotype effect of SREBP1 with the concentrations of myristic (14:0), myristoleic (14:1c9) 
acids, and C14 desaturation index were detected. The overall haplotype effect of Insig1 was 
associated with the concentrations of PUFA and linoleic (18:2c9, c12) acid. There were no 
significant associations with milk fatty acid composition determined for SCAP. 
In conclusion, we were able to identify polymorphisms in a number of genes that 
were associated significantly with milk fat percentage and fatty acid composition. The 
information about those polymorphisms can be used to select for animals producing healthier 
milk. 
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GENERAL INTRODUCTION 
 
Dissertation Organization 
The research described here is presented in the form of three publications prepared for the 
submission to scientific journals as a partial fulfillment of the requirements for the Doctor of 
Philosophy degree. Each paper is complete in itself and includes an abstract, introduction, 
materials and methods, results, discussion, conclusions, and references. The title of the first 
paper, prepared for the submission to BMC Genomics, is “Effects of the polymorphisms in 
GPAT1, GPAT4, AGPAT1, and LPIN1 genes from the triacylglycerol biosynthetic pathway 
on milk fatty acid composition in dairy cattle”. The second paper, prepared for the 
submission to Physiological Genomics, entitled “Effects of the polymorphisms in FABP3, 
FABP4, and SLC27A6 genes on bovine milk fatty acid composition”. The third paper, 
entitled “Effects of genetic polymorphisms in the SREBP pathway on milk fatty acid 
composition in dairy cattle”, is prepared for the submission to Animal Genetics. The 
manuscripts are formatted according to the requirements of each journal. The three papers are 
preceded by a literature review and followed by general conclusions containing a general 
discussion, future research, and references sections. The appendix with results not included 
into the publications concludes the dissertation.  
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Literature Review 
 
Cardiovascular disease occurrence 
Cardiovascular diseases (CVD) are a group of diseases (International Classification of 
Diseases 10, 100-199; Q20-Q28) that includes high blood pressure, coronary heart disease, 
heart failure, and stroke. The importance of studying the etiology of CVD and developing the 
preventatives and treatments for CVD comes from the fact that, according to the World 
Health Organization, CVD are the number one cause of death globally with an estimated 17.1 
million deaths from CVD in 2004, representing 29% of all global deaths from diseases. Low- 
and middle-income countries are affected the most, with 82% of total CVD deaths occurring 
in those countries. It is projected that in 2030 almost 23.6 million people worldwide will die 
from CVD.   
As of the year of 2009, 81,100,000 American adults (more than 1 in 3) have at least 
one type of CVD. More precisely, 74,500,000 suffer from high blood pressure (hypertension), 
17,600,000 have coronary heart disease, 5,800,000 had heart failure, and 6,400,000 suffered 
from stroke [1]. Mortality data show that CVD, as the underlying cause of death, accounted 
for 34.3% (831,272) of all deaths in the United States in 2006, with 33% of all CVD deaths 
occurring before the age of 75 years [1].  Nearly 2,300 Americans die of CVD each day, an 
average of one death every 38 seconds. The CVD claims more lives each year than cancer, 
chronic lower respiratory diseases, and accidents combined. The probability at birth of 
eventually dying of major CVD is 47%, whereas the chance of dying of cancer is 22%. Other 
probabilities are 3% for accidents, 2% for diabetes mellitus, and 0.7% for HIV.  
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In countries other than the United States, the death rates per 100,000 people per year 
from CVD calculated separately for men and women in the age group between 35 and 74 
years were the following: Russian Federation (2002) 3,186.9 and 1,192.4; Germany (2006) 
788.5 and 402.4; Mexico (2001) 1,055.8 and 713.2; Canada (2004) 705.3 and 432.7; and 
France (2006) 793.6 and 358.4 [1].  
 
Fatty acids and human plasma cholesterol concentrations 
Dietary SFA as a class can raise plasma cholesterol, LDL-cholesterol, and HDL-cholesterol 
concentrations of humans. According to a meta-analysis based prediction model that 
explained 74% of the variability related to the changes in plasma cholesterol concentrations, 
a 1% increase in dietary total energy from SFA will result in 1.9 mg/dL increase in plasma 
total cholesterol concentration [2]. A similar prediction model that explained 65% of the 
variability in plasma LDL-cholesterol concentrations indicated a 1.8 mg/dL rise in plasma 
LDL-cholesterol concentration for every 1% increase in dietary total energy from SFA [2]. A 
weaker prediction model that explained only 41% of the variability in HDL-cholesterol 
concentrations indicated a 0.3 mg/dL increase in plasma HDL-cholesterol concentration for 
every 1% increase in dietary total energy from SFA [2]. Similar results about the effects of 
SFA on plasma cholesterol concentrations were obtained in other studies [3-9]. 
 Separate SFA, however, do not have the same effects on plasma cholesterol 
concentrations. Specifically, palmitic (16:0) and myristic (14:0) acids raise plasma total and 
LDL-cholesterol concentrations much higher compared with other SFA [4]. Palmitic acid 
(16:0) is the major SFA in human diets. It is predominantly found in milk and other dairy 
products, beef tallow and lard, and some vegetable oils. Myristic acid (14:0) in human diets 
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comes mainly from milk and other dairy products and some vegetable oils. The ability of 
myristic acid (14:0) to raise plasma cholesterol concentrations is at least the same as palmitic 
acid (16:0) or even higher [4]. The percentage of myristic acid (14:0) in human diets is 
relatively low and therefore its hypercholesterogenic effects are not considered to be as 
severe as those caused by the presence of palmitic acid in the diet [3].  
 Lauric acid (12:0) is another SFA considered to be hypercholesterolemic [10]. Some 
data, however, show that lauric acid (12:0) is only mildly hypercholesterolemic [11]. A meta-
analysis based summary of recent studies shows that lauric acid indeed can increase plasma 
total cholesterol and LDL-cholesterol concentrations, but it decreased total cholesterol to 
HDL-cholesterol ratio [12].    
 Stearic (18:0) acid and short- and medium-chain SFA have little or no effect on blood 
total and LDL-cholesterol concentrations [7, 12-17]. The fact that short- and medium-chain 
fatty acids are absorbed directly into portal circulation and not into the blood stream via 
chylomicrons in the lymphatic system might explain their neutral effects on blood cholesterol 
concentrations [3]. The hypocholesterolemic effect of stearic acid (18:0) can be explained by 
its rapid desaturation to oleic acid (18:1c9) as compared with palmitic acid (16:0) in which 
desaturation to oleic acid (18:1c9) first will require an elongation step [18].  
 In major foods, the MUFA are represented mainly by oleic acid (18:1c9). The effects 
of MUFA on plasma cholesterol concentrations are considered to be neutral or mildly 
hypocholesterolemic [4, 5, 19]. Nevertheless, a high intake of MUFA may increase risk of 
developing CVD [20]. The effects of PUFA on plasma cholesterol concentrations, however, 
are hypocholesterolemic. According to a meta-analysis based prediction model that explains 
74% of variability associated with differences in plasma cholesterol concentrations, a 1% 
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increase in dietary total energy coming from PUFA will result in 0.99 mg/dL decrease in 
plasma total cholesterol concentration [2].  
The PUFA are classified into n-3 and n-6 fatty acids found primarily in fish and 
different vegetable oils, respectively [8]. Linoleic acid (18:2c9, c12, n-6) that is the major n-6 
fatty acid in human diets was shown to decrease CVD risks by promoting a desirable profile 
of lipoprotein fractions and TAG concentration in blood [12, 21, 22]. Prospective 
epidemiological studies confirm cardioprotective role of linoleic acid (18:2c9, c12, n-6) by 
showing that its consumption decreases CVD risks [23]. A negative view about dietary 
linoleic acid (18:2c9, c12, n-6), however, was developed because it can be metabolized through 
a few elongation and desaturation steps to form arachidonic acid (20:4c5, c8, c11, c14, n-6), which 
can be metabolized further to prostaglandins and leukotrienes known to be prothrombotic, 
proinflammatory, and vasoconstricting [24]. Discovery of a possible competition of n-6 with 
n-3 PUFA for cyclooxygenase that can lead to a decreased production of antiinflammatory 
prostaglandins from n-3 PUFA added more support to a negative view about n-6 PUFA and 
linoleic acid (18:2c9, c12, n-6) in particular. The importance of considering the n-6 PUFA to n-
3 PUFA ratio of 6:1 was suggested, then, to maintain increased production of 
antiinflammatory prostaglandins [22, 25]. Nevertheless, linoleic acid (18:2c9, c12, n-6) is still 
the most effective PUFA for lowering blood cholesterol concentrations and decreasing risk of 
CVD [26].     
The contributions of individual fatty acids to atherogenic potential for a lipid source 
or a diet are summarized by an atherogenic index (AI) that was developed by Ulbricht and 
Southgate in 1991 [27].  The AI, described by these authors, ranks mixtures of fatty acids 
according to their propensity to cause atherogenesis, as predicted from concentrations of 
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individual fatty acids in the dietary lipid.  The AI is calculated as: (12:0 + 4 × (14:0) + 16:0) 
÷ (ΣMUFA + ΣPUFA). 
 Trans fatty acids from partially hydrogenated vegetable oils are well known to 
increase the risk of CVD in humans [28]. The effects of trans fatty acids of animal origin, 
however, are quite opposite [29, 30]. The predominant trans fatty acid in milk is vaccenic 
acid (18:1t11) that can be converted by delta-9 desaturase to conjugated linoleic acid (CLA; 
18:2c9, t11) known to have several potential health benefits. Feeding CLA to rabbits decreased 
plasma total and LDL-cholesterol, the LDL-cholesterol to HDL-cholesterol ratio, and TAG  
concentration [31]. Similar effects of CLA on plasma cholesterol metabolites were observed 
in a hamster study [32]. Another hamster study showed that butter naturally enriched with 
vaccenic acid and CLA decreased plasma total cholesterol and LDL-cholesterol 
concentrations in treated animals compared with the control [33]. It was also shown that not 
all CLA isomers have the same effect with respect to plasma cholesterol concentrations. For 
example, trans-10, cis-12 CLA (18:2t10, c12) was shown to modify HDL particles in a way that 
makes them more atherosclerosis-promoting [34]. 
 In humans, intake of dairy products naturally enriched in CLA was shown to increase 
CLA concentration in plasma and cellular lipids [35]. The health-promoting effects of CLA 
on blood lipid profiles in humans are quite inconsistent, though. For example, some 
researchers observed improvement in cholesterol-containing lipoprotein profile in blood [36] 
whereas others did not [37, 38]. The one clear observation is that different CLA isomers have 
different effects on plasma lipid concentrations, with trans-10, cis-12 CLA being detrimental 
in terms of plasma cholesterol concentrations [36]. A possible role for CLA as a health-
promoting compound awaits future discovery.  
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 Fatty acids also are known to affect insulin secretion. Studies in rats showed that 
different dietary fatty acids influenced insulin secretion to a different extent, with caprylic 
(8:0), linoleic (18:2c9, c12), oleic (18:1c9), palmitic (16:0), and stearic (18:0) acids causing an 
increase in insulin secretion by 3.4, 5.3, 9.4, 16.2, and 21.0 fold, respectively [39]. All 
together, the results of these studies suggest that fatty acid composition of a diet can affect 
insulin secretion. High-fat diets, however, are known to induce insulin resistance 
accompanied by increased TAG deposition in liver and skeletal muscle. The developmental 
mechanism of insulin resistance is still unknown, but certain fatty acids acting through the 
novel protein kinase C family members are thought to be responsible for the effect [40, 41]. 
Palmitic acid (16:0), in particular, was responsible for developing insulin resistance in 
hypothalamus and skeletal muscle [42, 43]. Fatty acids also are thought to increase the risk of 
some diseases other than CVD, but the absence of good biomarkers for those diseases makes 
it difficult to study the effects of fatty acids on them.  
     
Environmental factors affecting milk fatty acid composition in dairy cattle 
The major environmental factors that are known to affect milk fatty acid composition are diet, 
stage of lactation, and season of the year. Nutrition can affect lipid concentration and fatty 
acid composition in milk, but the extent to which the change can occur differs among species 
and between different stages of lactation for the same species [44]. In nonruminants, for 
example, milk fatty acid composition reflects fatty acid composition of their diets. In 
ruminants, however, the majority of dietary unsaturated fatty acids are reduced by 
biohydrogenation in the rumen and many new fatty acids of bacterial origin are introduced 
into the milk, which makes it difficult to control fatty acid composition of milk by dietary 
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means. At the same time, diet can affect the microbial population of the rumen and as a 
consequence alter milk fatty acid composition.    
 It is important to know the contribution of de novo lipogenesis in the mammary gland 
to milk lipid biosynthesis to better understand the effects of a diet on milk fatty acid 
composition. In animals such as elephants who derive more than 90% of their fatty acids in 
milk from de novo lipogenesis, milk contains mainly short-chain and medium-chain fatty 
acids [44]. In seals, however, who rely exclusively on their adipose tissue depots to provide 
fatty acids for milk TAG biosynthesis, the majority of milk fatty acids are long-chain fatty 
acids. In ruminants, when they are not in a negative energy balance state, de novo lipogenesis 
contributes only 50% of all fatty acids in milk and as a consequence milk from ruminants 
contains many groups of fatty acids [45]. Nonruminants utilize glucose as a major carbon 
source for de novo lipogenesis, whereas ruminants utilize acetate produced from 
carbohydrate fermentation in the rumen along with β-hydroxybutyrate, another product of 
fermentation, providing about one half of the first four carbons of de novo synthesized fatty 
acids [46].   
 In dairy cattle, fatty acids taken up from blood by the mammary gland are derived 
from NEFA and very-low density lipoproteins of intestinal origin [47]. The blood NEFA 
comes mainly from lipolysis in adipose tissue that accounts for less than 10% of fatty acids 
used for milk lipid biosynthesis unless cows are in negative energy balance when lipolysis in 
adipose tissue provides the majority of fatty acids for milk lipid biosynthesis [48, 49]. Other 
fatty acids are derived from the diet.  
 Earlier attempts to study the effect of a diet on milk fat yield and fatty acid 
composition were directed towards addressing the milk fat depression (MFD) problem. It 
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was discovered that diets containing large proportion of readily digestible carbohydrates and 
low concentration of effective digestible fiber can cause MFD [49, 50]. Another major 
contributor to MFD is the addition of dietary supplements containing plant and fish oils rich 
in PUFA [51]. A number of theories were proposed to explain MFD, with one of the first 
theories linking changes in the concentrations of volatile fatty acids (VFA) in the rumen to 
the decrease in milk fat yield for a variety of diets [49]. It was proposed, first, that a decrease 
in the production of acetate and butyrate in the rumen is responsible for limiting milk lipid 
biosynthesis in the mammary gland [50]. A variation in milk lipid concentration estimated to 
be up to 80% was associated with changes in molar proportions of VFA in the rumen [44]. 
Other researchers, however, do not fully support the MFD theory based on the differences in 
acetate and butyrate production in the rumen, because there is some evidence showing that a 
decrease in ruminal acetate molar proportion is a result of increased propionate production 
rather than an actual decrease in acetate production [44].   
 Another theory on MFD related an increase in plasma insulin concentrations in 
response to low fiber high carbohydrate diets with the repartitioning of nutrients from lipid 
biosynthesis in mammary gland towards lipid biosynthesis in adipose tissue [52]. The 
weakness of this theory comes from the fact that a number of studies looking at the effects of 
insulin on nutrient repartitioning were conducted on cows in a negative energy balance state 
when lipolysis in adipose tissue, liable to be inhibited by increased plasma insulin 
concentration, was the main source of fatty acids for lipid biosynthesis in mammary gland 
[44]. Under conditions of positive energy balance, infusions of insulin in dairy cows were not 
able to cause repartitioning of nutrients towards lipid biosynthesis in adipose tissue [49]. 
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 The final theory about MFD called “trans fatty acid theory” was proposed to indicate 
the effect of diet on PUFA biohydrogenation in the rumen [49]. It was proven that feeding 
dairy cows low-fiber high-carbohydrate diet leads to the production of trans-10 octadecenoic 
acid (18:1t10) rather than trans-11 octadecenoic acid (18:1t11) as an intermediate of ruminal 
biohydrogenation of dietary PUFA [51]. Then, it was hypothesized that trans-10 
octadecenoic acid (18:1t10) was responsible for the inhibition of milk lipid biosynthesis. The 
increased concentration of trans-10 octadecenoic acid (18:1t10) in milk from cows fed diets 
that typically cause MFD was another indication of potential involvement of the trans isomer 
in MFD [53].   
 Later studies that focused on developing ways to increase CLA concentration in milk 
serendipitously discovered that CLA (18:2t10, c12) is a more potent inhibitor of milk lipid 
biosynthesis than is trans-10 octadecenoic acid (18:1t10) [54]. That discovery prompted the 
introduction of a new MFD theory called “biohydrogenation theory”  that was a modification 
of the earlier proposed “trans fatty acid theory” [44]. The knowledge gap about the 
mechanism of MFD was closed when it was shown that CLA (18:2t10, c12) not only inhibits 
milk lipid synthesis in mammary gland but also repartitions nutrients towards lipid 
biosynthesis in adipose tissue [55]. 
Lipid supplementation of dairy cow rations in the form of oilseeds and oils rich in 
linoleic (18:2c9, c12) and linolenic (18:3c9, c12, c15) acids decreased concentrations of palmitic 
acid (16:0) and short- and medium-chain fatty acids (C6 to C14) in milk at the expense of 
increasing stearic (18:0) acid  concentration [56]. Such a change in milk fatty acid 
concentrations can be explained by increased uptake of dietary fatty acids, mainly stearic 
(18:0) acid, by the mammary gland that causes an inhibition of de novo lipogenesis [57]. The 
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concentrations of odd-chain fatty acids in milk also were decreased with the dietary lipid 
supplementation, supporting the argument about their origin in favor of de novo biosynthesis 
in the mammary gland rather than in the rumen [56].     
In addition to increased concentration of stearic acid (18:0) in milk, dietary 
supplementation with linoleic (18:2c9, c12) and linolenic (18:3c9, c12, c15) acids also increased 
the concentration of vaccenic acid (18:1t11) and other cis- and trans-18:1 isomers [56]. The 
recovery of linoleic (18:2c9, c12) and linolenic (18:3c9, c12, c15) acids in milk after their dietary 
supplementation was minimal because of a high percentage of their biohydrogenation in the 
rumen unless those fatty acids were protected  from the reducing environment of the rumen 
[56, 58, 59].  
 Stage of lactation affects milk fatty acid composition, because it determines whether 
cows use adipose tissue or both adipose tissue and de novo lipogenesis in the mammary 
gland to provide fatty acids for milk TAG biosynthesis. At the beginning of lactation, cows 
usually are in negative energy balance, relying more extensively on lipolysis in adipose tissue 
to provide fatty acids for milk lipid biosynthesis [57]. This situation results in the 
concentration of short- and medium-chain fatty acids (C6 to C14) in milk being low at the 
beginning of the lactation because of the inhibitory effects of mobilized long-chain fatty 
acids on de novo lipogenesis in mammary tissue. With the progression of lactation, the 
concentration of short- and medium-chain fatty acids in milk gradually increases. There were 
no obvious seasonal effects on milk fatty acid composition, but the trend was to have lower 
concentration of short- and medium-chain fatty acids during warm months of the year 
probably because of the higher dietary fat intake at that time [57]. 
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Genetic regulation of milk fatty acid composition in dairy cattle 
Heritability of milk fatty acids 
The heritability values for individual milk fatty acids range from 0.00 to 0.50 and higher [60-
65]. Such a variation in heritability values can be explained by differences in units used to 
express milk fatty acid concentrations, methods used to measure milk fatty acid 
concentrations, models used to analyze the data, and number of samples available for the 
analysis. When milk fatty acid concentrations were expressed as g/100 g of milk total lipids, 
the heritability values for the major milk fatty acids were the following: 0.07-0.19 for 
myristic acid (14:0), 0.03-0.20 for palmitic acid (16:0), 0.08-0.28 for stearic acid (18:0), 
0.06-0.17 for oleic acid (18:1c9), 0.14 for SFA, and 0.14-0.24 for MUFA [60-62, 64]. The 
heritability values for milk fatty acids were 0-0.49 for myristic acid (14:0), 0.09-0.31 for 
palmitic acid (16:0), 0.19-0.24 for stearic acid (18:0), 0.06-0.18 for oleic acid (18:1c9), 0.05 
for SFA, and 0.08 for MUFA when fatty acid concentrations were expressed as weights as a 
proportion of total fat fatty acid weight [63, 65]. The heritability values of milk fatty acids 
are generally higher than above values when fatty acid concentrations are expressed per 
volume of milk [64].  
 The genetic correlation between palmitic acid (16:0) and the percentage of milk fat 
was high and positive (0.65-0.74) [62, 65], implying that selection for high milk fat 
percentage will result in increased concentration of palmitic acid (16:0) in milk. The 
concentration of MUFA with 18 carbon atoms, however, had a negative genetic correlation 
with the percentage of milk fat (from -0.55 to -.074) [62, 65]. Other fatty acids that had a 
positive genetic correlation with milk fat percentages were lauric (12:0) and stearic (18:0) 
acids with values for the correlation coefficients as 0.55 and 0.84, respectively [60].   
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QTL affecting milk lipids 
One of the earlier studies that mapped quantitative trait loci (QTL) controlling milk 
production in dairy cattle using a granddaughter design identified QTL on bovine 
chromosomes 1, 9, and 10 that were associated with milk fat yield and QTL on bovine 
chromosomes 6 and 20 that were associated with milk fat percentage  [66]. Another study 
mapped QTL for milk fat percentage to bovine chromosomes 6, 14, 20, and 26 and QTL for 
milk fat yield to bovine chromosomes 9 and 14, confirming some results from earlier studies 
and identifying new QTL that were not reported before [67]. Further studies mapped QTL for 
milk fat percentage to bovine chromosomes 3, 6, and 14 [68], QTL for milk fat yield to 
bovine chromosomes 19 and 26, and milk fat content to bovine chromosome 19 [69], QTL 
for milk fat percentage to bovine chromosome 3, and QTL for milk fat yield to bovine 
chromosome 26 [70]. The findings from numerous studies looking at QTL effects on milk 
production traits in dairy cattle were summarized in the form of QTL maps [71, 72]. 
Discoveries of numerous QTL for milk production traits in dairy cattle prompted 
researchers to identify causal genes for the QTL of interest. The QTL for milk fat percentage 
and yield located on bovine chromosome 14 was mapped more precisely [73-75] because of 
the highly significant effects, leading to the discovery of a nonconservative substitution of 
lysine by alanine at 232 position in the DGAT1 protein [76]. Since then, numerous 
publications characterized the K232A mutation in DGAT1 gene in relation to milk fat yield, 
percentage, and milk fatty acid composition [77-84]. Recent studies, however, pointed out 
that the DGAT1 K232A mutation is not solely responsible for the milk production QTL on 
bovine chromosome 14 [85]. Moreover, alleles of the DGAT1 promoter derived from the 
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variable number of tandem repeat polymorphisms were associated with milk fat percentage 
in animals that were homozygous for the allele 232A in DGAT1 [86]. The presence of 
additional genetic polymorphisms in DGAT1 and elsewhere on bovine chromosome 14 
indicates that the DGAT1 K232A polymorphism cannot completely explain the variability in 
milk production traits attributed to the QTL on the same chromosome, and thus new 
polymorphisms are awaiting their discoveries.  
The discovery of significant QTL for milk production traits [66] and the presence of 
casein genes on bovine chromosome 6 drew attention of many researchers to try to fine-map 
the QTL and identify the candidate genes. Earlier studies identified QTL for milk fat yield 
mapped near casein genes on bovine chromosome 6 [66, 87]. Another study identified a 
second QTL for milk fat yield on bovine chromosome 6 [88] that was fine-mapped [89, 90], 
and peroxisome proliferator-activated receptor-γ coactivator-1α (PPARGC1A) was identified 
as a functional candidate gene for the discovered QTL [91]. A significant association 
between a SNP in intron 9 of PPARGC1A gene and milk fat yield was found [91], but it was 
not confirmed in a later study [92].        
 
Single nucleotide polymorphisms associated with milk fatty acid composition 
Following studies designed to identify QTL in dairy cattle in relation to milk production and 
quality, a discovery of a polymorphism in DGAT1 gene that is associated with milk fat yield 
was the first example showing an association between genetic polymorphism in the form of 
single nucleotide mutations and milk fat yield [76, 93]. Since then, it was shown that DGAT1 
polymorphism affects not only milk fat yield but also milk fatty acid composition [82, 84, 
94]. The DGAT1 gene is located on bovine chromosome 14 and encodes an enzyme that 
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catalyzes the rate-limiting step in TAG biosynthesis by adding acyl-CoA to sn-3 position on 
the glycerol backbone. Following the discovery of DGAT1 gene location [95], it was 
demonstrated that a knock-out mice for DGAT1 gene had impaired lactation [2], prompting 
researchers to look at the effects of mutations in DGAT1 gene on milk fat synthesis.   A 
nonconservative substitution of lysine by alanine (K232A) in DGAT1 was identified to be 
responsible for the effects of that enzyme on milk fat yield, with the lysine-encoding allele 
being associated with higher milk fat yield [76, 93].  A functional conformation of the 
K232A mutation in DGAT1 was made later by showing that the K allele was characterized 
by higher Vmax for the DGAT1-catalyzed reaction compared with the A allele, which 
explained why animals with the K allele had higher milk fat yield [96]. 
 The DGAT1 232K polymorphism is associated with a higher percentage of palmitic 
acid (16:0), smaller percentages of myristic (14:0) acid, MUFA with 18 carbon atoms, and 
CLA (18:2c9, t11), and higher SFA/ unsaturated fatty acid (UFA) ratio [82]. Fatty acid 
desaturation indices defined as the ratio of the percentage of MUFA to the sum of the 
percentages of MUFA and SFA with the same number of carbon atoms expressed on a 
percentage bases were studied for milk fatty acids with respect to DGAT1 K232A 
polymorphism [84]. The DGAT1 allele was associated with smaller desaturation indices for 
capric (10:0), lauric (12:0), myristic (14:0), and palmitic (16:0) acids with higher 
desaturation indices for stearic (18:0) and vaccenic (18:1t11) acids, and with higher total 
desaturation index. The observed differences in milk fatty acid composition for DGAT1 
K232A polymorphism also can be attributed to the fact that DGAT1 has a preference for 
adding short-chain and UFA to the sn-3 position of TAGs [97]. 
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 After the discovery of SNPs in stearoyl-CoA desaturase 1 (SCD1) gene that were 
associated with beef fatty acid composition in Japanese Black cattle [98], there were a few 
studies describing the effects of the same SNPs on milk fatty acid composition in dairy cattle, 
but the results of those studies were slightly inconsistent [84, 99, 100]. The SCD1 gene 
located on bovine chromosome 26 encodes an enzyme that catalyzes the desaturation of 
long-chain SFA, primarily palmitic (16:0) and stearic (18:0) acids, to corresponding MUFA 
at delta-9 carbon atom. A nonconservative substitution of valine by alanine (T878C) in exon 
5 of the SCD1 gene was associated with greater concentration of MUFA in beef from 
Japanese Black cattle [98]. The T878C SNP in dairy cattle in one study was associated with 
higher concentrations of caproleic (10:1c4) and myristoleic (14:1c9) acids for C allele 
(alanine) [99], and in another study was associated with higher concentrations of MUFA, 
myristoleic (14:1c9), and oleic (18:1c9) acids for the same C allele [100]. Yet another study 
reported that the C allele (alanine) was associated with lower concentrations of capric (10:0), 
lauric (12:0), myristic (14:0), and palmitoleic (16:1c9) acids and of CLA (18:2c9, t11) and 
higher concentrations of caproleic (10:1c4), lauroleic (12:1c4), myristoleic (14:1c9), stearic 
(18:0), and vaccenic (18:1t11) acids [84].  
 The fatty acid synthase (FAS) gene located on bovine chromosome 19 was the focus 
of recent studies designed to identify SNPs associated with differences in milk fatty acid 
composition and milk fat yield [92, 101, 102]. Earlier studies showed the presence of QTLs 
associated with milk fat percentage and yield on bovine chromosome 19 [72]. The QTL 
mapping identified FAS as a candidate gene responsible for some of the variation in milk fat 
percentage and yield [103]. The association study determined two SNPs located in exons 1 (g. 
763 G>C) and 34 (g. 16009 A>G) that were associated with milk fat yield in dairy cattle 
 
17
[102]. The SNP g. 16009 A>G caused a nonconservative substitution of threonine by alanine. 
Further studies showed association of SNPs in FAS gene with differences in milk fatty acid 
composition. For example, SNPs located in the FAS gene at positions 15531 (C>A) and 
15603 (G>A) (accession AF285607) were associated with increased percentage of myristic 
acid (14:0) in milk for alleles A, respectively [101]. Another study looked at earlier 
discovered SNPs g. 16009 A>G [102] and g. 17924 A>G [101] in FAS gene that caused 
nonconservative substitutions of threonine by alanine in both cases and were associated with 
the concentration of myristic (14:0) acid in milk [92]. In addition, g. 16009 A>G and g. 
17924 A>G were associated with the concentrations of linoleic (18:2c9, c12) and oleic (18:1c9) 
acids, respectively. 
 
Milk lipid biosynthesis in the lactating mammary gland    
The uptake of long-chain fatty acids from plasma into mammary epithelial cells is likely 
mediated by fatty acid transport proteins (FATPs, gene name: solute carrier family 27, 
SLC27) and fatty acid translocase (FAT/ CD36) [104-108]. There are six members of SLC27 
family of FATPs. The FATP1, also known as SLC27A1, is highly expressed in adipose 
tissue and skeletal and heart muscles, and it translocates from inside a cell to the plasma 
membrane in response to insulin stimulation [104]. The FATP2 is expressed predominantly 
in liver and kidney, and FATP5 is mainly abundant in liver and plays a major role in fatty 
acid uptake by that organ. The only FATP protein found in small intestine is FATP4.  There 
is not much information about the role of different FATPs in fatty acid uptake in mammary 
tissue. Regarding FAT/ CD36, it was shown that this fatty acid translocase is a key protein 
for long-chain fatty acid uptake in metabolically active tissues [105]. Thus, the absence of 
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murine FAT/ CD36 decreased uptake of fatty acid analogs in vivo in heart (50-80%), skeletal 
muscle (40-75%), and adipose tissue (60-70%). 
 After fatty acids enter a cell, they are either esterified to coenzyme A with a 
subsequent binding to acyl-CoA binding proteins (ACBP) or bound to fatty acid binding 
proteins (FABP) as NEFA. The FABPs are 14-15 kDa proteins that reversibly bind non-
esterified saturated and unsaturated long-chain fatty acids, eicosanoids, and other lipids with 
the purpose of transporting or storing them inside a cell [109]. There are nine members of the 
FABP protein family that are expressed differentially in multiple tissues. The most abundant 
isoforms of FABPs expressed in the lactating bovine mammary gland are FABP3, FABP4, 
and FABP5 [107]. The FABP3 protein, also known as heart FABP, is expressed in tissues 
such as heart, skeletal muscle, mammary gland, brown adipose tissue, and others [109]. The 
main function of FABP3 in heart and skeletal muscles is to channel fatty acids inside a cell 
towards mitochondrial β-oxidation. The discovery of FABP3 protein in mammary gland was 
related to the identification of a mammary-derived growth inhibitor (MDGI) that turned out 
to be a mixture of FABP3 and FABP4 proteins [110, 111]. The MDGI inhibited the growth 
of human breast cancer cells [112]. The FABP3 protein is highly expressed in mammary 
gland during cell differentiation and formation of ductal structures at the onset of lactation 
[113], but the requirement of FABP3 for mammary tissue development and function was not 
well established [5, 114]. 
 The FABP4, also known as adipocyte FABP, is highly expressed in mature and 
differentiating adipose tissues, and its expression is tightly regulated by fatty acids, 
peroxisome proliferator-activated receptor-γ agonists, and insulin [109]. There is not much 
information about FABP4 function in the mammary gland. The FABP5, also known as 
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epidermal FABP, is highly abundant in epidermis and also is expressed in adipose tissue, 
mammary gland, liver, and other tissues. The function of FABP5 in the mammary gland is 
not well known, but it was shown that the overexpression of FABP5 in benign rat mammary 
epithelial cell lines may induce metastasis [115].   
 Before fatty acids can be used in any of the metabolic pathways inside a cell, they 
have to be activated by esterification to the coenzyme A moiety [116]. Enzymes that catalyze 
this reaction are called acyl-CoA synthetases (ACS). There are different sub-families of ACS 
that are defined on the bases of the chain length of the acyl groups used as a substrate by 
those enzymes. In this review, I will only focus on long-chain acyl-CoA synthetases (ACSL), 
a sub-family that includes five members annotated as ACSL1, 3, 4, 5, and 6 with each 
member having multiple isoforms produced by alternative splicing [116]. There is not much 
information known about specific function and subcellular localization of each ACSL protein. 
The ACSL1, ACSL4, and ACSL5 are present in liver and adipose tissue, ACSL3 and ACSL6 
are expressed in brain, ACSL4 is abundant in steroidogenic tissues, and ACSL5 is abundant 
in intestine [117]. The ACSLs are localized in a number of intracellular membranes including 
the plasma, microsomal, and mitochondrial outer membranes. One of the most studied ACSL 
is ACSL1, which, when overexpressed in the liver of rodents, increase TAG biosynthesis 
[117]. The other interesting function of ACSL1 is that it can interact with FATP1 in adipose 
tissue to channel fatty acids towards TAG biosynthesis, demonstrating a first example of 
vectorial acylation  [118].     
The glycerol phosphate pathway is the major pathway utilized by most cells for TAG 
biosynthesis [119]. The pathway consists of stepwise addition of activated fatty acyl groups 
to glycerol 3-phosphate (figure 2.1). The first and rate-limiting step in the TAG biosynthetic 
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pathway is catalyzed by a class of enzymes called glycerol-3-phosphate acyltransferases 
(GPAT) that add fatty acyl groups to the sn-1 position of glycerol 3-phosphate. In mammals, 
there are four known GPAT isoforms (GPAT1-4) that are localized to the mitochondrion 
(GPAT1-2) and endoplasmic reticulum (GPAT3-4) [120]. The mitochondrial GPAT isoforms 
account for about 50% of the total GPAT activity in rat liver whereas the microsomal GPAT 
isoforms account for 80-90% of the total GPAT activity in brown and white adipose tissues.  
The GPAT1 is a 94 kDa protein that is embedded into the outer mitochondrial 
membrane and is resistant to N-ethylmaleimide (NEM). The GPAT1 catalyzes the 
esterification of SFA with a high preference for palmitic acid (16:0). The physiological 
significance of GPAT1 presence in the outer mitochondrial membrane is thought to be 
related to its involvement in channeling fatty acids  away from β-oxidation and into 
glycerophospholipid biosynthesis by competing for fatty acids with carnitine 
palmitoyltransferase I [119]. The GPAT2 is another mitochondrial acyltransferase that is 
sensitive to NEM and is mostly abundant in testis but is also detectable in other tissues.    
The GPAT4 is a 52 kDa NEM-sensitive protein that resides in the ER and catalyzes 
the acylation of lauric (12:0), palmitic (16:0), stearic (18:0), oleic (18:1c9), linoleic (18:2c9, 
c12), and arachidonic (20:4c5, c8, c11, c14) acids to the sn-1 position of glycerol 3-phosphate [119]. 
The expression of GPAT4 is detected in most of the tissues but is highly abundant in brown 
and white adipose tissues, liver, testis, and different parts of the brain [120]. The GPAT4 was 
classified initially as 1-acylglycerol-3-phosphate acyltransferase-6 (AGPAT6) on the basis of 
its high amino acid similarity to AGPAT1 and AGPAT2 [121, 122]; later it was recognized 
as another microsomal GPAT and renamed as GPAT4 [123, 124]. The AGPAT6 knock-out 
mice had no subcutaneous adipose tissue and altered fatty acid composition of 
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glycerophospholipids, with an increased percentage of PUFA at the expense of MUFA  [122]. 
During lactation, AGPAT6-/- mice had undeveloped mammary glands with a decreased 
number of lipid droplets [121]. The concentration of diacyglycerols (DAG) and TAG in milk 
of AGPAT6-/- mice was decreased by more than 90% compared with the milk from normal 
mice. Surprisingly, overexpression of GPAT4 did not increase TAG formation but rather 
increased biosynthesis of certain phospholipids [123, 124]. This observation might suggest 
the importance of GPAT4 in synthesizing phospholipids for the lipid droplet monolayer.  
The second step in the glycerophospholipid biosynthetic pathway is catalyzed by 
AGPAT enzymes that add activated fatty acyl groups to the sn-2 position on the glycerol 
backbone, leading to the conversion of lysophosphatidic acid into phosphatidic acid (figure 
2.1). There are 10 known isoforms of AGPAT enzymes (AGPAT1-10), but only AGPAT1 
and AGPAT2 are well studied and considered to contribute significantly to the functionality 
of TAG biosynthetic pathway. The AGPAT6 and AGPAT10 were discovered to have GPAT 
activity and subsequently renamed GPAT4 and GPAT3, respectively [119]. The AGPAT1 is 
a 32 kDa microsomal protein that has a preference for lauric (12:0), myristic (14:0), palmitic 
(16:0), palmitoleic (16:1c9), linoleic (18:2c9, c12), and α-linolenic (18:3c9, c12, c15) acids, 
followed by stearic (18:0), oleic (18:1c9), and arachidonic (20:4c5, c8, c11, c14) acids and poor 
affinity for arachidic (20:0) and lignoceric (24:0) acids as substrates [125, 126].  
Mouse AGPAT1 is expressed in most tissues including muscle, white and brown 
adipose tissues, liver, and heart [119]. Overexpression of AGPAT1 in 3T3-L1 adipocytes 
promotes non-insulin-stimulated exogenous oleate (18:1c9) uptake and incorporation into 
phosphatidic acid and glucose uptake and conversion into fatty acids [127]. The AGPAT1 
overexpression suppresses NEFA release during stimulated lipolysis without affecting 
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glycerol release, suggesting a role for AGPAAT1 in stimulating NEFA reesterification. In 
C2C12 myotubes, AGPAT1 overexpression increases insulin-stimulated oleate (18:1c9) uptake 
and glucose partitioning towards fatty acids [127].  
The AGPAT2 enzyme is also a microsomal 31 kDa protein that catalyzes the 
acylation of myristic (14:0), palmitic (16:0), oleic (18:1c9), and linoleic (18:2c9, c12) acids and, 
to a lesser extent, the acylation of stearic (18:0) and arachidonic (20:4c5, c8, c11, c14) acids to 1-
oleoyl-lysophosphatitidc acid [126]. The fatty acid preference of AGPAT2 suggests that it 
might be involved mainly with de novo glycerophospholipid biosynthesis because only those 
compounds have the sn-2 position occupied by oleic (18:1c9) or linoleic (18:2c9, c12) acid and 
not by arachidonic acid (20:4c5, c8, c11, c14) as is the case with membrane phospholipids. The 
AGPAT2 is expressed at high levels in visceral white and brown adipose tissues, liver, heart, 
and pancreas, at moderate levels in muscle, lung, and small intestine, and at low levels in 
brain, placenta, and subcutaneous adipose tissue [119]. The deficiency of AGPAT2 is linked 
to congenital generalized lipodystrophy that occurs in humans and was studied in mouse 
using transgenic models [128, 129]. The disease is characterized by lack of adipose tissue at 
birth, severe insulin resistance, hypertriglyceridemia, hepatic steatosis, and earlier onset of 
diabetes.         
The phosphatidate produced through the action of AGPAT enzymes has to be 
dephosphorylated to produce DAG before advancing to the final steps of TAG and 
phospholipid biosynthesis. The enzyme catalyzing the removal of a phosphate group from 
phosphatidic acid is called phosphatidate phosphatase (PAP) or lipin [130], (figure 2.1). 
There are four known lipin isoforms (lipin1A, lipin1B, and lipin2-3) encoded by three 
different genes. Lipin-1A and -1B are produced from the same gene by differential splicing. 
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In addition to being a PAP, lipin-1 also acts as a transcriptional coactivator. The lipins are 
localized in the cytosol and translocate to the ER in response to elevated intracellular 
concentrations of fatty acids [131]. The main sites of lipin-1 expression are adipose tissue, 
muscles, and liver, with lipin-2 being expressed at high levels in liver, brain, and kidney and 
lipin-3 being detected in small intestine and liver [132]. 
The gene encoding lipin-1 was discovered by studying a spontaneous mouse mutation 
known as fatty liver dystrophy (fld) [133]. During the neonatal period, the fld mouse was 
characterized by a complex phenotype that included fatty liver, hypertriglyceridemia, and 
lipodystrophy affecting white adipose tissue and interscapular brown adipose tissue [133, 
134]. On the other hand, a transgenic mice with enhanced expression of lipin-1 in adipose 
tissue developed obesity [135].           
The final step in TAG biosynthesis is catalyzed by diacylglycerol acyltransferases 
(DGAT) that add activated fatty acyl groups to the sn-3 position on the glycerol backbone 
(figure 2.1). There are two known isoforms of the enzyme: DGAT1 and  DGAT2 [136]. Both 
DGAT isoforms reside in the ER, and a deficiency in either of the isoforms was associated 
with decreased TAG concentration in affected tissues. The substrate specificity of DGAT 
isoforms was tested in competition assays that revealed DGAT1 preference for oleic acid 
(18:1c9) over palmitic acid (16:0), with DGAT2 not showing any specific preferences at all 
[95]. In another study, DGAT2 purified from a fungus showed substrate specificity towards 
medium-chain fatty acids as compared with long-chain fatty acids and catalyzed the addition 
of activated fatty acyl groups to DAG containing short- and medium-chain fatty acyl groups 
more readily than to DAG containing longer fatty acyl groups [137].   
 
24
Over the past few decades, a group of sterol regulatory element binding proteins 
(SREBPs), consisting of three transcription factors (SREBP-1a, SREBP-1c, and SREBP-2) 
that bind to sterol response element (SRE) on the promoters of different genes, was studied 
extensively because of  the ability of SREBPs to transcriptionally regulate genes from fatty 
acid and cholesterol biosynthetic pathways [138]. The process of converting SREBP proteins 
from an inactive to a transcriptionally active form called the SREBP pathway will be the next 
focus of this review (figure 2.2). 
The SREBP proteins (SREBP-1a, SREBP-1c, and SREBP-2) are encoded by two 
different genes (SREBP1 and SREBP2) with SREBP-1a and SREBP-1c being produced from 
SREBP1 gene by alternate transcription [41]. The SREBP proteins are embedded into the ER 
membrane, with their N-terminal transcriptionally active and C-terminal regulatory domains 
projecting into the cytosol. Another protein named as SREBP cleavage activating protein 
(SCAP) also resides in the ER membrane and interacts through its C-terminal domain 
containing multiple WD40 sequences with the C-terminal regulatory domain of SREBP 
proteins on the cytosolic site of the ER [41].        
 In sterol-depleted cells, SCAP transports SREBP proteins in coated vesicles from ER 
to Golgi, where the N-terminal domain of SREBP proteins is released into cytosol after a 
sequence of proteolytic cleavages catalyzed by S1P and S2P proteases (figure 2.2). The 
cleaved SREBP proteins then enter the nucleus where they activate transcription of genes for 
fatty acid and cholesterol biosynthetic pathways. When ER cholesterol concentration rises 
above 5%, SCAP binds cholesterol and undergoes a conformational change that prevents 
SCAP-SREBP transport via coated vesicles to Golgi. As a result, N-terminal domain of 
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SREBP proteins cannot be released and no transcriptional activation of SRE-containing 
genes can occur.  
 Yet another protein, named as insulin-induced gene (Insig) was found to reside in the 
ER membrane and to bind to SCAP in the presence of oxysterols, leading to the inhibition of 
SCAP-SREBP transport to Golgi, even in sterol-depleted cells (figure 2.2). There are two 
known genes (Insig-1 and Insig-2) that code for three different forms of Insig proteins (Insig-
1, Insig-2a, and Insig-2b). In the presence of oxysterols, Insig-1 not only prevents SCAP-
SREBP transport to Golgi but also binds hydroxymethylglutaryl-CoA on the cytosolic side of 
ER to facilitate its proteolytic degradation. The Insig-1 gene also is activated 
transcriptionally with SREBPs, thus providing a feed-back mechanism by which nuclear 
SREBP trigger buildup of their own inhibitor. 
 Whereas SREBP-2 protein participates in the regulation of cholesterol biosynthesis 
and SREBP-1a participates in the regulation of both cholesterol and fatty acid biosynthesis, 
the SREBP-1c is involved mainly with the regulation of lipogenic genes. The SREBP-1c is 
expressed in most of the tissues in mice and humans, with high levels of expression in the 
liver, white and brown adipose tissues, adrenal gland, and brain [139]. In contrast to SREBP-
1a and SREBP-2, expression and nuclear abundance of SREBP-1c does not depend on 
cellular cholesterol concentration [140]. Moreover, overexpression of the nuclear form of 
SREBP-1c in the liver of transgenic mice caused TAG accumulation without any change in 
cholesterol concentration [141].  
The activity of SREBP-1c is controlled by transcriptional regulation of its gene 
expression and by proteolytic cleavage of SREBP-1c in Golgi. It was shown that in the liver 
insulin can increase SREBP-1c proteolytic activation by decreasing the mRNA abundance of 
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Insig-2a that otherwise would be able to block SCAP-SREBP-1c transport from ER to Golgi 
and subsequently inhibit SREBP-1c activation [142]. Insulin did not change the transcription 
of Insig-1, suggesting that Insig-1 is not involved in the regulation of fatty acid biosynthesis 
through SREBPs.         
Transcriptional regulation of SREBP-1c is accomplished by liver X-activated 
receptors (LXR), insulin, and glucagon [143]. The main role of LXRs is to activate oleate 
(18:1c9) production for the synthesis of cholesteryl esters. This activation could be potentially 
achieved by up-regulating fatty acid elongase and the stearoyl-CoA desaturase activities as it 
was observed in transgenic mice overexpressing the nuclear form of SREBP-1a in their livers 
[144, 145]. LXRs are also a part of the regulatory mechanism by which UFA can suppress 
fatty acid biosynthesis [143]. Insulin also up-regulates SREBP-1c expression, leading to an 
increase in the rates of fatty acid biosynthesis as demonstrated in rodents using cultures of 
isolated hepatocytes and adipocytes [146]. The effects of insulin on SREBP-1c expression 
are thought to be mediated through PI3-kinase pathway, with potential downstream effectors 
being protein kinase B and protein kinase C-λ. Glucagon is known to oppose the effects of 
insulin on SREBP-1c expression via cAMP.     
The information regarding the regulation of fatty acid and cholesterol biosynthesis by 
SREBPs in the lactating mammary gland is limited. In mice, it was shown that SREBP-1a 
and SREBP-1c are expressed in mammary tissue and their expression is increased during 
lactation [147]. In addition to earlier described regulatory mechanisms for lipid biosynthesis 
involving SREBP-1c that are assumed to be true in the lactating mammary gland, some 
studies suggested a potential role for insulin in the regulation of lipid biosynthesis via PI3 
kinase  pathway, with protein kinase B (Akt1) being a possible downstream effector (figure 
 
27
2.2). Overexpression of a constitutively active form of Akt1 in mice during lactation results 
in precocious lipid droplet formation in mammary epithelial cells, with a significant increase 
in milk lipid concentration that reaches 60-70% on a wet weight basis as compared with only 
25-30% in wild type mice [148]. On the basis of recent discoveries of the Akt  role in the 
regulation of SREBP activation [149-151], it was proposed [147] that the insulin-mediated 
up-regulation of lipid biosynthesis via Akt is achieved by either Akt-stimulated proteolytic 
activation of SREBP-1c or an Akt-stimulated decrease in the degradation of a nuclear form 
of SREBP-1c in the nucleus or both (figure 2.2).      
A study on a diet-induced MFD in dairy cows highlighted a potential role of SREBP-
1 in the regulation of lipid biosynthesis in lactating mammary gland by showing a reduction 
in SREBP-1, SCAP, Insig-1, and Insig-2 gene expressions after feeding a diet rich in 
vegetable oil [55]. On the basis of the results of this study, it is difficult to determine, 
however, whether Insig-1 or Insig-2 played any role in the regulation of SREBP-1 activation, 
because, if it were the case, the expression of either Insig-1 or Insig-2 or both isoforms 
should have been increased. It also could be possible that the low expression levels for Insig-
1 and Insig-2 were as a result of decreased SCAP expression. In another study, there was an 
up-regulation in the expression of SREBP-1, SREBP-2, SCAP, Insig-1, and Insig-2 during 
lactation, but the information is still too incomplete to make any conclusions about potential 
involvement of any of the above proteins from the SREBP pathway in the regulation of lipid 
biosynthesis [108].    
One of the first studies looking at the global changes in lipid metabolism in the 
mammary gland during lactation was performed in mice by using a combination of 
microarray analysis and metabolic profiling [106]. Later, a similar study was conducted in 
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dairy cows [108]. The first set of genes that was evaluated in both studies was related to the 
regulation of fatty acid uptake by the mammary gland. Fatty acids in blood are present as 
NEFA bound to albumin and as a part of very-low density lipoproteins (VLDL) where they 
are esterified into TAG. Lipoprotein lipase (LPL) is an enzyme that is highly expressed in 
mammary gland [152, 153] and responsible for the hydrolysis of TAG from VLDL with the 
release of NEFA and glycerol. The LPL gene expression was up-regulated in both murine 
and bovine mammary glands during lactation, and, for the bovine mammary gland, the 
change in activity for LPL over time resembled a lactation curve, pointing to the importance 
of LPL and VLDL in supplying fatty acids to the mammary gland during lactation in dairy 
cows [106, 108]. Recent evidence indicates the importance of a VLDL receptor in facilitating 
the interaction between LPL and VLDL [154] and the requirement of  this interaction for 
efficient TAG hydrolysis. The expression of the VLDL receptor in mammary gland was up-
regulated during lactation in dairy cows [108].  
  In mice, three genes from the SLC27 family of fatty acid transporters (SLC27A1, 
SLC27A3, and SLC27A4) were expressed in mammary tissue and their expression was up-
regulated with the onset of lactation [106]. The SLC27A6 transporter was the only one from 
the SLC27 family to be significantly up-regulated in bovine mammary gland during lactation 
[107, 108]. The fatty acid translocase (CD36) gene thought to be involved in fatty acid 
transport [155] was up-regulated during lactation in both mouse and cow mammary glands. 
Even though the definite role for CD36 involvement in fatty acid transport has not been 
established, the fact that CD36 co-localizes with SLC27A6, ACSL, and FABP proteins [156] 
makes CD36 a good candidate for the regulation of lipid biosynthesis in the mammary gland.      
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The next set of genes involved in lipid biosynthesis in a lactating mammary gland is 
associated with fatty acid activation and channeling inside a lipogenic cell. The ACSL1 that 
catalyzes the activation of long-chain fatty acids is highly expressed in bovine mammary 
tissue [107], and its expression increases more than four-fold  at the onset of lactation [108]. 
Among a group of ACSS enzymes that catalyze the activation of medium-chain fatty acids, 
ACSS1 and ACSS2 are the most abundant in bovine mammary tissue and their expression is 
increased during lactation [108]. The activated fatty acids in the form of acyl-CoA are 
transported by acyl binding proteins (ACBP) to their final destination within a cell, but in the 
mammary gland the role of ACBP proteins in lipid metabolism is considered to be minor and 
some of the ACBP protein functions are considered  to be fulfilled by FABPs [106, 108].  
Non-activated fatty acids are bound and transported inside a cell by FABPs. The 
FABP3 is the most abundant isoform in both murine and bovine mammary tissues, but other 
FABP isoforms such as FABP4 and FABP5 are present as well [106, 108]. The FABP3 was 
the second most abundant transcript in bovine mammary gland, and its expression was up-
regulated tremendously during lactation [107, 108]. The expression of FABP4 and FABP5 
also was up-regulated with the onset of lactation but to a lesser extend compared with 
FABP3. It was speculated that FABP3 provides substrates for SCD, and FABP4 binds oleic 
(18:1c9) acid, the major product of the SCD-catalyzed reaction and then transports the oleate 
(18:1c9) to other enzymes for TAG biosynthesis [108]. In the bovine mammary gland, 
FABP3 also buffers the cells from negative effects of activated fatty acyl groups that might 
otherwise inhibit the activity of SCD and ACACA enzymes, playing the role that was 
traditionally attributed to acyl fatty acid binding proteins [157].   
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Figure 2.1 TAG biosynthetic pathway. ACSL, long-chain acyl-CoA synthetase; AGPAT, 
1-acylglycerol-3-phosphate acyltransferase; DAG, diacylglycerol; DGAT, diacylglycerol 
acyltransferase; ER, endoplasmic reticulum; FA, fatty acid; FABP3 and FABP4, fatty acid 
binding proteins 3 and 4; GPAT-1 and GPAT-4, glycerol-3-phosphate acyltransferases 1 and 
4; LPIN, phosphatidate phosphatase; SLC27, solute carrier protein family 27; TAG, 
triacylglycerol.  
 
 53
 
 
Figure 2.2 Regulation of lipogenesis in mammary epithelial cells by the SREBP 
pathway and insulin. Akt1, protein kinase B; ER, endoplasmic reticulum; Insig, insulin-
induced gene; PI3K, phosphoinositide-3-kinase; SRE, sterol response element; SREBP1, 
sterol regulatory element binding protein 1; SCAP, SREBP cleavage-activating protein.  
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Abstract 
Developing tools to improve the healthfulness of milk through genetic selection is the 
goal of our study. High concentrations of saturated fatty acids (SFA) in milk including 
the atherogenic fatty acids such as palmitic (16:0) and myristic (14:0) are detrimental to 
human health and as such are not desirable. Increasing the concentration of unsaturated 
fatty acids (UFA) in milk at the expense of SFA, however, is beneficial to human health. 
The objectives of our study were to discover genetic polymorphisms in glycerol-3-
phosphate acyltransferases-1 and -4 (GPAT1 and GPAT4), 1-acylglycerol-3-phosphate 
acyltransferase-1 (AGPAT1) and a phosphatidate phosphatase (LPIN1) and to test the 
associations of those polymorphisms with bovine milk fat percentage and fatty acid 
composition. We hypothesized that because of the selectivity in fatty acid acylation by 
different acyltransferases and the importance of LPIN1 for the triacylglycerol 
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biosynthesis in adipose tissue, polymorphisms in GPAT1, GPAT4, AGPAT1, and LPIN1 
genes will be associated with differences in bovine milk fat percentage and fatty acid 
composition. The results of our study showed that the overall haplotype effect of GPAT4 
was associated significantly with the concentrations of capric (10:0), lauric (12:0), 
palmitic (16:0), and oleic (18:1c9) acids and as a consequence with the concentrations of 
SFA, UFA, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), 
SFA/UFA, C16 and C18 desaturation indices, and an atherogenic index (AI). The overall 
haplotype effect of GPAT1 was significantly associated with milk fat percentage, the 
concentrations of caproic (6:0), caprylic (8:0), capric (10:0), tridecylic (13:0), margaric 
(17:0), myristoleic (14:1c9) acids, and C14 desaturation index. The overall haplotype 
effect of AGPAT1 showed significant associations with the concentrations of PUFA, 
caproic (6:0), margaric (17:0), linoleic (18:2c9, c12) acids, conjugated linoleic acid (CLA, 
18:2c9, t11), and myristoleic (14:1c9) acid. The overall haplotype effect of LPIN1 was 
associated significantly only with myristoleic (14:1c9) acid concentration and C14 
desaturation index. In conclusion, the identified polymorphisms in GPAT1, GPAT4, 
AGPAT1, and LPIN1 can be used as genetic markers by animal breeders to select for 
animals producing milk with healthier fatty acid composition and with higher fat 
percentage.  
 
Introduction 
The regulation of bovine milk fatty acid composition by dietary and genetic means 
received much attention in recent years because of the adverse effects of certain dietary 
fatty acids on human health [1-6]. The total cholesterol (TC), low-density lipoprotein 
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cholesterol (LDL-C), and high-density lipoprotein cholesterol concentrations in plasma 
are predictors of cardiovascular disease risk [7], and those concentrations are influenced 
by a number of factors including dietary fatty acids. Saturated fatty acids (SFA) as a class 
and individual SFA such as palmitic (16:0), myristic (14:0), and lauric (12:0) acids raise 
plasma TC and LDL-C concentrations much higher than other fatty acids, and their 
presence at high concentrations in human diets is undesirable  [8]. Monounsaturated fatty 
acids (MUFA), however, are considered to be neutral with respect to plasma cholesterol 
concentrations, and their concentrations in milk can be increased at the expense of SFA 
to make milk healthier. Improving fatty acid composition of bovine milk by dietary 
means has limitations because of ruminal biohydrogenation of unsaturated fatty acids 
(UFA) [9], but the genetic regulation of bovine milk fatty acid composition is plausible 
because of the moderate to high heritabilities of milk fatty acids [3, 10-13]. Thus, the 
objective of our study was to develop genetic markers that will allow selection for 
animals producing milk with healthier fatty acid profile. 
The biosynthesis of milk triacylglycerols (TAG) occurs in mammary epithelial 
cells through a stepwise addition of activated fatty acyl groups to glycerol 3-phosphate by 
different acyltransferases [14]. The first and rate limiting step in the TAG biosynthetic 
pathway is catalyzed by glycerol-3-phosphate acyltransferases (GPAT) that add fatty acyl 
groups to the sn-1 position of glycerol 3-phosphate. The major GPAT isoforms known to 
be expressed in bovine mammary gland are GPAT1 (mitochondrial) and GPAT4 
(microsomal) [15]. The GPAT1 catalyzes the acylation of saturated fatty acids with a 
high preference for palmitic acid (16:0) whereas GPAT4 catalyzes the acylation of lauric 
(12:0), palmitic (16:0), stearic (18:0), oleic (18:1c9), linoleic (18:2c9, c12), and arachidonic 
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(20:4c5, c8, c11, c14) acids [14]. The GPAT4 was initially classified as 1-acylglycerol-3-
phosphate acyltransferase-6 (AGPAT6) based on high amino acid similarity to AGPAT1 
and AGPAT2 [16, 17], but later was recognized as another microsomal GPAT and 
renamed as GPAT4 [18, 19] . The AGPAT6 knock-out mice had no subcutaneous 
adipose tissue and altered fatty acid composition of glycerophospholipids with increased 
percentage of polyunsaturated fatty acids (PUFA) at the expense of MUFA [17]. During 
lactation, AGPAT6-/- mice had underdeveloped mammary glands with reduced number of 
lipid droplets [16]. The concentration of diacyglycerols (DAG) and TAG in milk of 
AGPAT6-/- mice was decreased by more than 90% compared with the milk from normal 
mice. Surprisingly, overexpression of GPAT4 did not increase TAG formation but rather 
increased biosynthesis of certain phospholipids [18, 19].  
The second step in the TAG biosynthetic pathway is catalyzed by AGPAT that 
add fatty acyl groups to the sn-2 position on the glycerol backbone, leading to the 
conversion of lysophosphatidic acid into phosphatidic acid. The AGPAT1 has a 
preference for lauric (12:0), myristic (14:0), palmitic (16:0), palmitoleic (16:1c9), linoleic 
(18:2c9, c12), and α-linolenic (18:3c9, c12, c15) acids followed by stearic (18:0), oleic (18:1c9), 
and arachidonic (20:4c5, c8, c11, c14) acids and poor affinity for arachidic (20:0) and 
lignoceric (24:0) acids as substrates [20, 21]. The phosphatidate produced through the 
action of AGPAT has to be dephosphorylated to produce DAG before advancing to the 
final steps of the TAG biosynthesis. The enzyme catalyzing the removal of a phosphate 
group from phosphatidic acid is called phosphatidate phosphatase (PAP) or lipin (LPIN) 
[22]. The LPIN are localized in the cytosol and translocate to ER in response to elevated 
intracellular concentrations of fatty acids [23]. The major isoform of PAP expressed in 
 58
bovine mammary gland is LPIN1 [15]. In addition to being a PAP, LPIN1 also acts as a 
transcriptional coactivator.  
The positional distribution of fatty acids in milk TAG is not random, and it 
depends on the specificity of different acyltransferases for a particular fatty acid. The sn-
1 position of bovine milk TAG, for example, is occupied predominantly by palmitic 
(16:0; 34.0 mol %) and oleic (18:1c9; 30.0 mol %) acids followed by stearic (18:0; 10.5 
mol %), myristic (14:0; 9.7 mol %), and lauric (12:0; 4.9 mol %) acids [24]. The major 
fatty acids at the sn-2 position are palmitic (16:0; 32.3 mol %) and oleic (18:1c9; 18.9 
mol %) acids followed by myristic (14:0; 17.5 mol %), stearic (18:0; 9.5 mol %), and 
lauric (12:0; 6.2 mol %) acids. Butyric (4:0; 35.4 mol %), oleic (18:1c9; 23.1 mol %), and 
caproic (12.9 mol %) acids are the major fatty acids at the sn-3 position. 
Considering the positional distribution of fatty acids in milk TAG and preferential 
acylation of different fatty acids by acyltransferases, we hypothesize that genetic 
polymorphisms in GPAT1, GPAT4, AGPAT1, and LPIN1 genes will be associated with 
differences in milk fatty acid composition. To test the hypothesis, single nucleotide 
polymorphisms (SNPs) in GPAT1, GPAT4, AGPAT1, and LPIN1 genes were identified 
by sequencing. After genotyping animals for the discovered SNPs, intragenic haplotypes 
were reconstructed and the associations between the haplotypes within the same gene and 
milk fatty acid composition were tested. The results of the association tests are reported 
in this paper. 
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Materials and methods 
Milk fatty acid analysis 
Milk samples were collected during morning milking once a month throughout a 305-d 
lactation period and stored at -20 °C until further analysis. The extraction of milk fatty 
acids with subsequent esterification into methyl esters for the analysis by gas 
chromatography (GC) was performed according to the procedure published by Chouinard 
et al. [25] with minor modifications. The procedure is based on the original milk lipid 
extraction method with hexane and isopropanol developed by Hara and Radin [26] and 
fatty acid methyl ester production method developed by Christie [24]. After thawing, 
milk samples were vortexed for 10 s and 25 mL aliquots were transferred to 50 mL teflon 
centrifuge tubes pre-rinsed with chloroform/methanol (2/1 vol.vol). Following 
centrifugation at 17,800 × g for 30 min at 4 °C, the liquid phase of the milk samples was 
removed and 18 mL of hexane/isopropanol (3/2 vol/vol) were added for every gram of 
lipids with subsequent vortexing for 1 min. To achieve a better separation of hexane 
phase containing lipids from water phase containing proteins, 12 mL of 6.7 % sodium 
sulfate (Na2SO4) solution were added for every gram of lipids and samples were vortexed 
for 1 min. After centrifugation at 2,500 × g for 5 min at 4 °C, the hexane fraction 
containing lipids was removed into a scintillation vial pre-rinsed with 
chloroform/methanol (2/1 vol/vol) and an aliquot containing 40 mg of lipids (400 μL) 
was transferred into an esterification vial . After the evaporation of hexane under nitrogen 
gas, 2 mL of hexane were added to the esterification vial followed by 40 μL of methyl 
acetate and vortexing for 30 s. The methylation step was initiated by the addition of 40 
μL of sodium methoxide (0.4 mL of 5.4 M sodium methoxide in 1.75 mL of methanol) 
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solution. The mixture was vortexed for 30 s and allowed to react for 10 min at room 
temperature. The reaction was terminated by the addition of 60 μL of oxalic acid (1 gram 
of oxalic acid/30 mL of diethyl ether) solution. The samples were centrifuged at 2,400 × 
g for 5 min at 4 °C, and a clear hexane fraction, which contained fatty acid methyl esters, 
was placed into GC vials, purged with nitrogen gas for 3 s, capped, and used for 
chromatographic analysis. In the above steps, capping of the vials that contained hexane 
lipid extract was preceded by purging with nitrogen gas for 3 s.    
A Varian 3900 gas chromatograph (Varian Analytical Instruments, Walnut Creek, 
CA) equipped with CP-8400 auto-sampler, CP-8410 auto-injector, CP-1177 split/splitless 
injector, and flame ionization (FID) detector was used to analyze fatty acid methyl esters 
with helium as a carrier gas. One μL of fatty acid methyl esters in hexane was injected 
(split ratio 50:1) into a fused silica capillary column (SupelcoTM-2560 Capillary Column, 
100m x 0.25 mm i.d., with 0.2 μm film thickness) with the initial column temperature set 
at 70 °C and held for 4 min. Then, the column temperature was increased to 175 °C at the 
rate of 13 °C/min and held for 27 min with subsequent increase to 215 °C at the rate of 
4 °C/min where it was held for 28 min [27]. The injector and detector temperatures were 
set constant at 220 °C. Peak area was measured by integration using Star 
Chromatography Workstation Version 6, and peaks were identified by comparing the 
retention times with separately run fatty acid methyl ester standards (Matreya LLC, 
Pleasant Gap, PA).  
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DNA extraction 
Genomic DNA was extracted from 20 mL of blood obtained from the coccygeal vein of 
every dairy cow. The blood was collected into 10 mL EDTA Vacutainer tubes and kept at 
4 °C. After transferring 20 mL of blood into 50 mL centrifuge tubes, the ice-cold 1X red 
blood cell (RBC) lysis buffer was added to fill in the tubes that were inverted and 
incubated on ice for 30 min. The samples were centrifuged at 300 × g for 5 min at 4 °C. 
Supernatant was aspirated and 20 mL of ice-cold 1X RBC lysis buffer were added again 
followed by a light vortexing and 30 min incubation on ice. After centrifugation and 
aspiration steps performed as mentioned earlier, 20 mL of room temperature PBS buffer 
were added to wash the pellet and the centrifugation step was repeated again. Then, 
supernatant was discarded and pellet was resuspended in PBS, transferred to cryovial, 
and stored at -70 °C until further analysis. The DNA purification from the white blood 
cells was performed with DNeasy® Blood and Tissue Kit (Qiagen Inc., Valencia, CA) 
according to the instructions. The DNA concentration was measured using NanoDrop® 
ND1000, and dilutions were made with DNase-free water to desired concentration.  
 
SNP discovery and genotyping 
The GPAT4, GPAT1, AGPAT1, and LPIN1 genes from the TAG biosynthetic pathway 
(table 2.1), were sequenced in exonic and some intronic regions to discover SNPs. A set 
of 12 DNA samples from cows that were daughters of 12 different sires was used for the 
SNP discovery. The PCR primers were designed with Primer3 (version 0.4.0) software 
[28]. Regular or “Hot-start” PCR was performed to amplify the DNA regions of interest. 
For the regular PCR, the reaction mixture contained 50 ng of genomic DNA, 13.6 μL of 
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DNA grade water, 2 μL of dimethyl sulfoxide (DMSO), 1.5 μL of MgCl2 (25 mM), 0.1 
μL of forward and reverse primers (100 ng/μL), 0.5 μL of dNTP mix (40 mM), 5 μL of 
5X buffer, and 0.2 μL of Tag DNA polymerase (5 U/μL) with the total volume of the 
reaction mixture equal to 25 μL. For the “Hot-start” PCR, the reaction mixture was 
almost the same as for the regular PCR with the only difference that 5 μL of 10X buffer 
was used instead of 5X buffer and 0.2 μL of “ Hot-start” Tag DNA polymerase (5 U/μL) 
was used instead of Tag DNA polymerase. The PCR were performed in a DNA Engine 
thermal cycler (Bio-Rad) with the separate temperature cycle programs for the regular 
and “Hot-start” PCR. The regular PCR was performed with the following program: 94 °C 
for 2 min followed by 35 cycles of 94 °C for 15 s, an optimal annealing temperature for a 
particular primer set (table 2.2 ) for 30 s, and 72 °C for 30 s with a final extension step at 
72 °C for 10 min. The “Hot-start” PCR was performed with the following program: 
95 °C for 15 min followed by 30 cycles of 94 °C for 1 min, an optimal annealing 
temperature for a particular primer set (table 2.2) for 1 min, and 72 °C for 1 min with a 
final extension step at 72 °C for 10 min. The optimal annealing temperature for a 
particular primer set was determined by a PCR temperature gradient. Before sequencing, 
the PCR product was cleaned up from unused primers and dNTPs with ExoSAP-IT® 
(USB Corporation, Cleveland, OH) that contained exonuclease 1 and shrimp alkaline 
phosphatase [29]. Reverse and forward sequences representing 12 different samples were 
aligned using Vector NTI AdvanceTM 10 to identify SNPs. Genotyping of discovered 
SNPs was performed with the Sequenom MassARRAY platform using 10 ng of genomic 
DNA dissolved in DNase-free water [30]. Haplotypes and their frequencies were 
estimated using PHASE (version 2.1) program [31, 32]. Only samples with the 
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probability ≥0.9 for the best haplotype pair were used in the analysis. The restriction 
fragment length polymorphism technique was used to genotype animals for DGAT1 
A232K mutation. A set of primers (table 2.2), was used to amplify a 405-bp region of 
DNA containing the mutation site by using the “Hot start” PCR. The resulting PCR 
product then was digested with EaeI restriction enzyme and run on a 2% agarose gel. 
There were 230-bp and 175-bp DNA fragments on a gel when an animal had DGAT1 
232K genotype and a 405-bp DNA fragment on a gel when an animal had DGAT1 232A 
genotype.    
 
Statistical analysis 
A linear mixed model for longitudinal data was used to analyze the data with PROC 
MIXED procedure of SAS 9.1 (2002). The haplotype substitution model [33] used to test 
the association between intragenic haplotypes and milk fatty acid composition was the 
following: 
Y = µ + dim + dim2 + dim3 + cg + dim*cg + dim2*cg + dim3*cg + ∑bk Hk + sire + ε    
where y is the response variable; µ is the mean response at 0 dim for a cow with no 
copies of the haplotypes; dim, dim2, and dim3 are covariates describing the effects of days 
in milk on milk fatty acid composition; cg is a fixed effect of the contemporary group 
(cg=8 classes); Hk is a haplotype effect fitted as a covariate and coded as 0, 1, or 2 for 0, 
1, or 2 copies of each haplotype present in an animal; bk is the partial regression 
coefficient which corresponds to the haplotype substitution effect for the kth haplotype as 
a deviation from the effect of the most frequent haplotype that is set to zero to have a full 
rank model; sire is a sire random effect; and ε is a residual error. The higher order terms 
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for days in milk were introduced to account for a non-linear trend of the response 
variables over time. The cubic term of days in milk allows the response variable to have 
different slopes whenever the direction of its trend changes over time. When the higher 
order terms for days in milk were not significant, they were dropped from the model. 
Contemporary groups were created by combining herd (two herds) and season of calving 
(four seasons: December to February, March to May, June to August, and September to 
November) effects. The year of sampling was not included in the model to avoid 
redundancy because the season of calving is already containing some information about 
the year when a particular sample was collected.  Haplotypes with a population frequency 
more than 0.05 were used in the analysis, and those with frequency less than 0.05 were 
pooled in the “other” category. The CONTRAST statement in PROC MIXED was used 
to construct the F-tests of the overall haplotype effects, and, when the test was significant 
after applying the Bonferroni adjustment to account for multiple testing, the pairwise 
comparisons between all haplotypes within each gene were performed using the 
ESTIMATE statement and the estimates of the differences between haplotype effects, 
their standard errors, and p-values were reported. The REPEATED statement was used to 
indicate that milk samples were collected repeatedly for the same animal throughout the 
305-d lactation period. Correlations between repeated measures taken on the same animal 
were modeled using a first order autoregressive covariance structure that assumes equal 
variances and correlations that decline exponentially with an increase in the distance 
between time points [34]. The covariance structure was selected on the basis of the 
biology of the experiment and using Akaike’s and Bayesian Information Criteria and 
residual log likelihood [35]. 
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A Bonferroni adjustment was used to control type I error rate during multiple 
comparisons between intragenic haplotypes. Bonferroni-adjusted significance levels were 
determined by dividing desired experiment-wide significance level (0.05) by the number 
of pairwise comparisons. The numbers of pairwise comparisons for GPAT4, GPAT1, 
AGPAT1, and LPIN1 genes were 15, 15, 10, and 21, respectively that resulted in the 
Bonferroni-adjusted significance levels of 0.0033, 0.0033, 0.0050, and 0.0024, 
respectively. We compared haplotype sequences within each gene on the basis of their 
effects on milk fatty acid composition to determine “tag” SNPs that can be used as 
genetic markers. 
In recent years, a number of studies evaluated the effects of SNPs from different 
genes on milk fatty acid composition [1, 6, 36, 37]. It is difficult, however, to compare 
the size of the effects of different polymorphisms on any particular fatty acid 
concentration in milk because of the different approaches used to analyze the data. To 
compare the results of our study with earlier published data, we genotyped our animals 
for diacylglycerol acyltransferase-1 (DGAT1) K232A and fatty acid synthase g. 
17924A>G polymorphisms and analyzed the data the same way as earlier, with the only 
difference that allele effects of the SNPs were tested instead of the haplotype effects. All 
animals on the study were treated in accordance with guidelines established by the Iowa 
State University Committee on Animal Care. 
 
Results 
Mean values, their standard deviations, and 5% and 95% quantiles for milk production, 
milk fat percentage, concentrations of different fatty acids and fatty acid groups, and fatty 
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acid indices are reported in table 2.3. There were 39 different milk fatty acids measured 
by GC. All fatty acid data were used to calculate the concentrations of individual fatty 
acids that were expressed as wt %, but the data reported are only for fatty acids present in 
milk at relatively high concentrations. The mean values for the major milk fatty acids in 
our study were similar to those reported by others [2, 13]. The major fatty acid in milk 
was palmitic (16:0; 29.33 wt %) followed, in decreasing concentrations, by oleic (18:1c9; 
23.55 wt %), stearic (18:0; 11.92 wt %), and myristic (14:0; 10.15 wt %) acids.  
We were able to identify 6, 8, 12, and 20 SNPs in GPAT4, AGPAT1, GPAT1, 
and LPIN1 genes, respectively (table 2.4) and to validate those SNPs using the Sequenom 
MassARRAY system. The majority of SNPs were intronic with a few synonymous and 
nonsynonymous mutations. The interesting finding was a relatively large number of 
nonsynonymous mutations (6 SNPs) discovered in the LPIN1 gene. After genotyping 
animals for the discovered SNPs, the PHASE program was used to reconstruct intragenic 
haplotypes. There were 6, 6, 5, and 7 haplotypes determined for GPAT4, GPAT1, 
AGPAT1, and LPIN1 genes, respectively, and their population frequencies were above 
5 % (table 2.5).  
F-tests were used to determine the overall haplotype effects on milk fatty acid 
composition for each gene separately (table 2.6). Results with p-value ≤ 0.0125 were 
considered to be significant, as determined by applying the Bonferroni adjustment to 
account for testing the association of genetic polymorphisms with milk fatty acid 
composition in each of four different genes. The overall haplotype effect of GPAT4 was 
associated significantly with  atherogenic index (AI), SFA, UFA, MUFA, PUFA, 
SFA/UFA, caprylic (8:0), capric (10:0), lauric (12:0), myristic (14:0), palmitic (16:0), 
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oleic (18:1c9) acids, CLA (18:2c9, t11), C16 and C18 desaturation indices (table 2.6). There 
was a tendency for the association between the overall haplotype effect of GPAT4 and 
linoleic (18:2c9, c12) acid concentration (p-value = 0.0126). The overall haplotype effect of 
GPAT1 was significantly associated with milk fat percentage, caproic (6:0), caprylic 
(8:0), capric (10:0), tridecylic (13:0), margaric (17:0), and myristoleic (14:1c9) acid 
concentrations, and C14 desaturation index. The AGPAT1 gene showed significant 
associations of its haplotypes with PUFA, caproic (6:0), pentadecylic (15:0), margaric 
(17:0), myristoleic (14:1c9), linoleic (18:2c9, c12) acids, and CLA (18:2c9, t11). The 
haplotypes from the LPIN1 gene affected only myristoleic (14:1c9) acid concentration and 
C14 desaturation index.  
 Pairwise comparisons of the haplotype effects on milk fatty acid composition 
within GPAT4 (table 2.7) revealed that the haplotype h8 was the most desirable to select 
for animals producing milk with lower AI, lower concentrations of SFA and atherogenic 
fatty acids such as palmitic (16:0) and lauric (12:0) acids, lower concentration of capric 
(10:0) acid, lower SFA/UFA, and higher concentrations of UFA, MUFA, PUFA, and 
oleic (18:1c9) acid (table 2.7). Thus, the haplotype h8 of GPAT4 was associated with 0.13 
lower AI, 1.48 wt % lower SFA, 1.48 wt % higher UFA, 1.34 wt % higher MUFA, 0.12 
lower SFA/UFA, 0.66 wt % lower palmitic (16:0) acid, and 0.80 wt % higher oleic 
(18:1c9) acid concentrations compared with the effects of haplotype h6 of GPAT4. The 
haplotype h8 of GPAT4 also was associated with 0.21 wt % lower capric (10:0) acid and 
0.23 wt % lower lauric (12:0) acid concentrations compared with the effects of haplotype 
h2 of GPAT4. Moreover, the haplotype h8 of GPAT4 was associated with 0.23 wt % 
higher PUFA concentration compared with the effects of haplotype h1 of GPAT4.  
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The second most desirable haplotypes of GPAT4 to select for animals producing 
healthier milk were haplotypes h10 and h3 that had similar effects on milk fatty acid 
composition in relation to each other, but the size of the their effects was smaller 
compared with the effects of haplotype h8 of GPAT4 (table 2.7). The haplotype h10 of 
GPAT4 was associated with 0.90 wt % lower SFA, 0.90 wt % higher UFA, 0.86 wt % 
higher MUFA concentrations, 0.061 lower SFA/UFA, and 0.048 higher C16 and 0.01 
higher C18 desaturation indices compared with the effects of haplotype h6 of GPAT4. 
The haplotype h10 of GPAT4 also was associated with 0.18 wt % lower lauric (12:0) acid 
and 0.15 wt % higher PUFA concentrations compared with the effects of haplotypes h2 
and h1 of GPAT4, respectively. The haplotype h3 of GPAT4 was associated with 0.90 
wt % lower SFA, 0.90 wt % higher UFA, 0.86 higher MUFA concentrations, 0.069 wt % 
lower SFA/UFA, 0.54 wt % lower palmitic (16:0) acid, 0.63 wt % higher oleic (18:2c9) 
acid concentrations, 0.043 higher C16 and 0.01 higher C18 desaturation indices 
compared with the effects of haplotype h6 of GPAT4. The haplotype h3 of GPAT4 also 
was associated 0.15 wt % higher PUFA concentration compare with the effects of 
haplotype h1 of GPAT4. 
 The haplotype h6 of GPAT4 was the most undesirable to select for animals 
producing healthier milk because, in addition to earlier mentioned negative effects of 
haplotype h6 compared with the effects of haplotypes h8, h10, and h3 of GPAT4, 
haplotype h6 of GPAT4 also was associated with 0.74 wt % lower MUFA, 0.61 wt % 
lower oleic (18:1c9) acid concentrations, and 0.009 lower C18 index compared with the 
effects of haplotype h1 of GPAT4. The haplotype h6 of GPAT4 also was associated with 
0.013 lower C18 desaturation index compared with the effects of haplotype h2 of GPAT4.     
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 The haplotype h2 of GPAT1 was associated with lower percentage of milk fat, 
lower concentrations of short- and medium-chain SFA, and lower myristoleic (14:1) acid 
concentration compared with the effects of other haplotypes of GPAT1 (table 2.8). In 
particular, haplotype h2 of GPAT1 was associated with 0.086 wt % lower caproic (6:0) 
and 0.057 wt % lower caprylic (8:0) acid concentrations compared with the effects of the 
haplotype h8 of GPAT1. The haplotype h2 of GPAT1 also was associated with 0.056 
wt % lower caprylic (8:0), 0.016 wt % lower tridecylic (13:0), and 0.066 wt % lower 
myristoleic (14:1c9) acid concentrations compared with the effects of haplotype h12 of 
GPAT1 and 0.015 wt % lower tridecylic (13:0) acid concentration compared with the 
effects of haplotype h1 of GPAT1. Finally, haplotype h2 was associated with 0.15 % 
lower milk fat, 0.051 wt % lower caprylic (8:0), and 0.15 wt % lower capric (10:0) acid 
concentrations compared with the effects of haplotype h9 of GPAT1.     
 The haplotype h9 of GPAT1 was associated with higher percentage of milk fat, 
higher concentration of caprylic (8:0) and capric (10:0) acids, lower concentrations of 
myristoleic (14:1c9) and margaric (17:0) acids, and lower C14 desaturation index 
compared with the effects of other haplotypes of GPAT1 (table 2.8). Thus, haplotype h9 
of GPAT1 was associated with 0.11 % higher milk fat, 0.073 wt % lower myristoleic 
(14:1c9), 0.013 wt % lower margaric (17:0) acid concentrations, and 0.0071 lower C14 
desaturation index compared with the effects of haplotype h7 of GPAT1. The haplotype 
h9 also was associated with 0.065 and 0.10 wt % lower myristoleic (14:1c9) acid 
concentration and 0.0058 and 0.0082 lower C14 desaturation index compared with the 
effects of the haplotypes h8 and h12 of GPAT1, respectively. The haplotype h9 of 
GPAT1 also was associated with 0.016 wt % lower margaric (17:0) acid concentration 
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compared with the effects of haplotype h12 of GPAT1. The haplotype h9 of GPAT1 was 
associated with 0.15 % higher milk fat, 0.051 wt % higher caprylic (8:0) and 0.15 wt % 
higher capric (10:0)) acid concentrations compared with the effects of haplotype h2 of 
GPAT1. The haplotype h12 of GPAT1 was associated with 0.072 wt % higher 
myristoleic (14:1) acid concentration and 0.0057 higher C14 desaturation index 
compared with the effects of haplotype h1 of GPAT1.  
   The haplotype h9 of AGPAT1 was associated with the lowest myristoleic 
(14:1c9) acid concentration compared with the effects of the rest of the haplotypes of 
AGPAT1, and haplotype h10 of AGPAT1 was associated with the lowest PUFA, linoleic 
(18:2c9, c12) acid and CLA (18:2c9, t11) concentrations compared with the effects of the rest 
of the haplotypes of AGPAT1 (table 2.9). In particular, haplotype h9 of AGPAT1 was 
associated with 0.067, 0.084, 0.073, and 0.086 wt % lower myristoleic (14:1c9) acid 
concentration compared with the effects of h2, h4, h6, and h10 haplotypes of AGPAT1, 
respectively. The haplotype h10 of AGPAT1 was associated with 0.16 wt % lower PUFA 
and 0.12 wt % lower linoleic (18:2c9, c12) acid concentrations compared with the effects of 
the haplotype h6 of AGPAT1. The haplotype h10 also was associated with 0.12 wt % 
lower PUFA, 0.082 wt % lower linoleic (18:2 c9, c12) acid, 0.035 wt % lower CLA (18:2c9, 
t11), and 0.045 wt % higher caproic (6:0) acid concentrations compared with the effects of 
haplotype h2 of AGPAT1. The haplotype h10 of AGPAT1 also was associated with 
0.016 wt % lower margaric (17:0) acid concentration compared with the effects of 
haplotype h4 of AGPAT1. The haplotype h22 of LPIN1 was associated with the lowest 
concentration of myristoleic (14:1) acid and the lowest C14 desaturation index (table 2.9). 
Thus, the haplotype h22 of LPIN1 was associated with 0.085, 0.081, and 0.078 wt % 
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lower myristoleic (14:1c9) acid concentration and 0.0073, 0.073, and 0.0067 lower C14 
desaturation index compared with the effects of the h1, h24, and h26 haplotypes of 
LPIN1. 
 The allele substitution effect of DGAT1 A232K mutation (table 2.10) was 
associated with milk fat percentage, AI, concentrations of SFA, UFA, MUFA, PUFA, 
SFA/UFA, concentrations of palmitic (16:0), stearic (18:0) and other fatty acids. The 
significance was declared when p≤0.05. In particular, DGAT1 232K mutation was 
associated with 0.22 % higher milk fat, 0.10 higher AI, 1.05 wt % higher SFA, 1.05 wt % 
lower UFA, 0.88 wt % lower MUFA, 0.16 wt % lower PUFA concentrations, 0.086 
higher SFA/UFA, 0.070 wt % higher lauric (12:0), 0.066 wt % higher myristoleic (14:1c9), 
0.87 wt % higher palmitic (16:0), 0.23 wt % lower stearic (18:0), 0.037 wt % lower oleic 
(18:1c9), 0.038 wt % lower linoleic (18:2c9, c12), 0.042 wt % lower CLA  (18:2c9, t11), 0.041 
wt % higher caproic (6:0), 0.042 wt % higher caprylic (8:0), 0.086 wt % higher capric 
(10:0), 0.013 wt % higher tridecylic (13:0), 0.050 wt % higher pentadecylic (15:0) acid 
concentrations, 0.048 higher C14 desaturation index, and 0.015 lower elongation index 
compared with the effects of DGAT1 232A mutation. In addition, we tested FAS g. 
17924G>A polymorphism for the association with milk fatty acid composition and the 
significance was declared when p≤0.05. Thus, the FAS g. 17924A allele was associated 
with 0.11 wt % higher myristic (14:0) and 0.17 wt % higher palmitic (16:0) acid 
concentrations.    
   
 
 
 72
Discussion 
The overall effect of the GPAT4 haplotypes on milk fatty acid composition identified 
herein is in agreement with GPAT4 substrate specificities reported earlier [14]. The 
concentrations of GPAT4 substrates such as lauric (12:0), palmitic (16:0), oleic (18:1c9), 
and linoleic (18:2c9, c12) acids were affected by the GPAT4 haplotypes (table 2.6). In 
addition, AI, concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, C16 and C18 
desaturation indices were affected by GPAT4 haplotypes as a result of the changes in the 
concentrations of the earlier mentioned fatty acids. The concentrations of fatty acids that 
are not typical GPAT4 substrates were affected by the GPAT4 haplotypes as well 
probably because of the alterations in the pool of fatty acids for TAG biosynthesis caused 
by the changes in the concentrations of the GPAT4 fatty acid substrates. The pairwise 
comparison of the GPAT4 haplotype effects on milk fatty acid composition showed that 
the haplotype h8 was the most desirable in terms of milk healthfulness followed by the 
haplotypes h10 and h3. The haplotype h6 of GPAT4 was the most undesirable to select 
for animals producing healthier milk. The effects of the haplotypes h1 and h2 of GPAT4 
on milk healthfulness were in between the effects of the haplotype h6 and the haplotypes 
h3 and h10 of GPAT4, and thus those effects were not very desirable for improving milk 
healthfulness. The haplotype sequence comparison revealed a “tag” SNP that will allow 
distinguishing animals with the haplotype h8 of GPAT4 from the animals with any other 
GPAT4 haplotype. The “tag” SNP is intronic SNP6 located between exons 7 and 8 of 
GPAT4 and allele A is present in the haplotype h8 of GPAT4 (tables 2.4 and 2.5). There 
was no significant overall haplotype effect of GPAT4 on the percentage of milk fat (table 
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2.6), suggesting that it is possible to select for animals with the desirable fatty acid profile 
without affecting milk fat percentage. 
 The overall effect of GPAT1 haplotypes was associated with milk fat percentage, 
myristoleic (14:1c9) acid concentration, and the concentrations of different SFA (table 
2.6). Apart from milk fat and myristoleic (14:1c9) acid, the affected SFA are the usual 
substrates of GPAT1 [14]. The importance of GPAT1 haplotype effects is related to their 
association with milk fat percentage. Even though the concentrations of different SFA 
were affected by GPAT1 haplotypes, none of the affected SFA is considered to be 
atherogenic and the total SFA concentration was not affected by GPAT1 haplotypes 
either. The pairwise comparison of the GPAT1 haplotype effects on milk fat percentage 
and milk fatty acid composition showed that the haplotype h9 of GPAAT1 always was 
associated with the higher milk fat percentage compared with the effects of the 
haplotypes h2 and h7 of GPAT1. We, however, were not able to identify a “tag” SNP for 
the haplotype h9 of GPAT1. The haplotype h2 of GPAT1 was associated with lower milk 
fat percentage compared with the effects of the haplotype h9 of GPAT1. A “tag” SNP for 
the haplotype h2 of GPAT1 was identified as SNP12, a nonsynonymous mutation located 
in exon 1 of GPAT1 that causes a substitution of argenine (Arg) by tryptophan (Trp) at 
26 amino acid residue in GPAT1 polypeptide chain. The allele T of SNP12 was present 
in the haplotype h2 of GPAT1. In addition to the association with milk fat percentage, the 
haplotype h2 of GPAT1 was associated with low concentrations of mainly short- and 
medium-chain SFA. It is likely that the presence of Trp instead of Arg at position 26 in 
GPAT1 protein alters its substrate specificity, leading to decreased esterification of 
caproic (6:0), caprylic (8:0), capric (10:0), tridecylic (13:0) acids to sn-1 position of 
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glycerol-3-phsophate. The haplotype h7 of GPAT1 also was associated with lower milk 
fat percentage compared with the effect of haplotype h9 of GPAT1. We, however, were 
not able to identify any “tag” SNPs for the haplotype h7 of GPAT1.    
 The effects of AGPAT1 haplotypes on milk fatty acid composition were 
associated mainly with PUFA, linoleic (18:2c9, c12) acid, CLA (18:2c9, t11), and myristoleic 
(14:1c9) acid concentrations (tables 2.6 and 2.9). The haplotype h10 of AGPAT1 was 
undesirable in terms of milk healthfulness because it always was associated with lower 
concentrations of PUFA, linoleic (18:2c9, c12) acid and CLA (18:2c9, t11) compared with the 
effects of haplotypes h2 and h6 of AGPAT1. The haplotype h9 of AGPAT1 always was 
associated with lower concentrations of myristoleic (14:1c9) acid compared with the 
effects of haplotypes h2, h4, h6, and h10 of AGPAT1. The presence of the haplotype h9 
of AGPAT1 could be considered undesirable when animals are selected for higher 
concentration of UFA in milk but, because of the small size of the haplotype effect on 
myristoleic (14:1c9) acid concentration, the selection against the haplotype h9 of 
AGPAT1 might not produce the desirable results. The haplotype h6 of AGPAT1 is the 
most desirable to select for animals producing milk with higher concentrations of PUFA 
and linoleic (18:2c9, c12) acid because the size of the effect of haplotype h6 of AGPAT1 on 
the concentrations of those fatty acids was very large (table 2.9). Another haplotype of 
AGPAT1 that can be used to select for animals producing milk with high concentrations 
of PUFA, linoleic (18:2c9, c12) acid, and CLA (18:2c9, t11) is haplotype h2. The sequence 
comparison among different AGPAT1 haplotypes revealed “tag” SNPs for the haplotypes 
h6, h9, and h10 of AGPAT1 (table 2.5). The “tag” SNPs for the haplotype h6 of 
AGPAT1 were intronic SNPs 37 and 38 located between exons 5 and 6. The “tag” SNPs 
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for the haplotype h9 of AGPAT1 were a synonymous SNP33 located in exon 3 and an 
intronic SNP34 located between exons 4 and 5. The “tag” SNPs for the haplotype h10 of 
AGPAT1 were intronic SNPs 32 and 35 located between exons 2 and 3 and exons 5 and 
6, respectively.   
 The effects of LPIN1 haplotypes on milk fatty acid composition were associated 
with myristoleic (14:1c9) acid concentration and C14 desaturation index (tables 2.6 and 
2.9). The haplotype h22 of LPIN1 always was associated with lower concentration of 
myristoleic (14:1c9) acid and lower C14 desaturation index compared with the effects of 
the haplotypes h1, h24, and h26 of LPIN1. The “tag” SNP for the haplotype h22 of 
LPIN1 was identified as SNP361, a nonsynonymous mutation that causes the substitution 
of asparagine by aspartic acid at 740 amino acid residue in a polypeptide chain of LPIN1. 
The allele A of SNP361 was present in the haplotype h22 of LPIN1. The selection against 
animals with the haplotype h22 of LPIN1 is desirable to increase the concentration of 
UFA in milk, but, because of the small size of the haplotype effect on myristoleic (14:1c9) 
acid concentration, the selection goal might not be achieved.            
We compared the results from our association study with the published data on a 
genome-wide association study that used 1,341 SNPs as genetic markers to genotype 849 
Holstein dairy cows to identify quantitative trait loci (QTL) for milk fatty acids [38, 39]. 
The significant QTL for a number of medium- and long-chain fatty acids were reported to 
be between 27 and 31 cM on BTA26. Those QTL were attributed to the effects of 
polymorphisms in stearoyl-CoA desaturase-1 gene located around 16 cM on BTA26. The 
GPAT1 gene is located around 41 cM on BTA26, and the associations of the 
polymorphisms in GPAT1 gene with myristoleic (14:1) acid and C14 desaturation index 
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might be attributed to the QTL effects observed on BTA26 in the genome-wide study 
[39]. Even though the GPAT1 gene is not located in the exact area of observed QTL, the 
relatively low power to position those QTL correctly because of the limited number of 
genetic markers (34 markers on BTA26) and not large enough size of the phenotypic data 
can explain very wide confidence intervals for QTL and might not exclude the possibility 
that the observed effects either attributed to GPAT1 effects alone or to the combined 
effects of GPAT1 and SCD-1.  
 The QTL on BTA27 were associated only with butyric (4:0) and vaccenic 
(18:1t11) acid concentrations, milk fat percentage, and total desaturation index, and those 
QTL were positioned around 34 cM, 44, 33, and 44 cM regions of the chromosome, 
respectively [38, 39]. The GPAT4 gene is located on BTA27 at 40 cM region, and, even 
though we did not calculate the total desaturation index, the haplotype effects of GPAT4 
on C16 and C18 desaturation indices might be attributed to the QTL on BTA27 at 44 cM 
associated with the total desaturation index. Other haplotype effects of GPAT4 
discovered in our study were not detected in the genome-wide association study because 
of the limited number of markers used (22 markers on BTA27) and not large enough 
phenotypic data and consequently, the low power to detect such effects.      
The FAS g. 17924A>G polymorphism was associated with milk myristic (14:0) 
and palmitic (16:0) acid concentrations. In particular, the A allele was associated with 
higher concentration of myristic (14:0) acid and lower concentration of palmitic (16:0) 
acid. The same results were reported earlier only for milk myristic (14:0) acid and the 
SNPs that were associated with myristic (14:0) acid concentration in FAS were at 
positions 15531 and 15603, but not 17924 [36]. In a different study, the A allele of the 
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SNP at position 17924 was associated with higher concentration of myristic (14:0) acid 
[1] as it was in our study.  
We performed a numerical comparison of the size of haplotype effects of GPAT4, 
GPAT1, AGPAT1, LPIN1 and the size of allelic effects of DGAT1 A232K and FAS g. 
17924A>G on milk fat percentage and fatty acid composition to determine which genetic 
polymorphisms had the largest effect (table 2.11). The haplotype effect of GPAT4 was 
associated with at least the same or larger differences in AI (0.13), concentrations of SFA 
(1.48 wt %), UFA (1.48 wt %), MUFA (1.34 wt %), PUFA (0.23 wt %), SFA/UFA (0.12), 
and lauric (12:0; 0.23 wt %) acid concentration compared with the effects of DGAT1 
A232K mutation. The haplotype effect of GPAT4 also was associated with at least the 
same or larger difference in capric (10:0; 0.21 wt %) acid concentration compared with 
the GPAT1 haplotype effects. The DGAT1 A232K mutation was associated with at least 
the same or larger difference in milk fat percentage (0.22 %) compared with the 
haplotype effect of GPAT1. The size of the effect of DGAT1 A232K mutation on the 
concentrations of palmitic (16:0; 0.87 wt %) and oleic (18:1c9; 0.23 wt %) acids were at 
least the same or larger compared with the haplotype effect of GPAT4. The size of the 
effect of DGAT1 A232K mutation on the concentration of linoleic (18:2c9, c12) acid was 
0.12 wt % that was numerically similar to the AGPAT1 haplotype effect. The effects of 
GPAT1 haplotypes were associated with at least the same or larger concentrations of 
caproic (6:0), caprylic (8:0), tridecylic (13:0), myristoleic (14:1c9) acid, and C14 
desaturation index compare with the effects of DGAT1 A232K mutation.   
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Conclusions 
The results of our study show that the polymorphisms in GPAT4 were associated with 
large differences in milk fatty acid composition. In particular, AI, concentrations of SFA, 
UFA, MUFA, PUFA, SFA/UFA, concentrations of capric (10:0), lauric (12:0), palmitic 
(16:0), oleic (18:1c9) acids, CLA (18:2c9, t11), C16 and C18 desaturation indices were 
affected the most by GPAT4 polymorphisms. The polymorphisms in GPAT4 provide a 
very valuable tool to improve milk healthfulness. Other polymorphisms discovered in our 
study were for milk fat percentage, concentrations of short- and medium-chain SFA, and 
myristoleic (14:1c9) acid concentration in GPAT1, and for the concentrations of linoleic 
(18:2c9, c12) acid and other UFA in AGPAT1. The polymorphisms in GPAT1 can be used 
to select for animals producing milk with higher percentage of fat and desirable 
concentrations of short- and medium-chain SFA. The polymorphisms in AGPAT1 can be 
used to select for animals producing milk with higher concentration of UFA and linoleic 
(18:2c9, c12) acid, in particular.  
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Table 2.1 Gene information 
Gene BTA Chromosomal position, cM 
Gene 
length, bp 
Transcript 
length, bp 
Protein 
length, aa 
Number 
of exons 
Strand 
direction 
GPAT4 27 40 16752 2295 457 12 Forward 
GPAT1 26 41 39943 6129 825 20 Reverse 
AGPAT1 23 31 7481 2233 287 7 Forward 
LPIN1 11 97 79574 3131 931 22 Reverse 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; BTA, Bos taurus autosome; GPAT1 and GPAT4, 
glycerol-3-phosphate acyltransferases-1 and -4; LPIN1, lipin-1 
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Table 2.2 Primer sequences and annealing temperatures for PCR 
Gene SNP Forward primer Reverse primer PCR type1 Tm, °C 
GPAT4 3 GCAGCAGGCAGGGAGTATG GACAAGCACCCTTCCGAGAG Regular 56 
GPAT4 4 TGTCTTGGGACAGTGAGTGG ATCTAAGAGCCTGTGGTTTGG Regular 56 
GPAT4 5, 6 GGGACTTTGTGTGAGGATGG CGTAGGCTGCTATGACAATGG Regular 56 
GPAT4 7 CTCTCTCCAGCGTGTGTTCC GTGGAGTGTCTTCCGAGCTG Regular 56 
GPAT4 8 GACACACGCACACAAGCAG GTGTGGACGGAGTGAGCTG Regular 56 
AGPAT1 32, 33 GTGTGCAGGAGACACTGAGC CTCCTGAGGGCAGCAGAG Regular 60 
AGPAT1 34 CCCAGTCTACCTCTTCCCTTATC GGAAGACACACATGGAGCAG Regular 56 
AGPAT1 35, 37, 38 CAGAAGTCCCATGACAGCATC AGGTGGACATCTCACCGTTC Regular 56 
AGPAT1 40, 41 TGTGCAAAGTCAGAGCATCC TCCAAAGAGGAGAACAAGTGG Regular 56 
GPAT1 25 GTCTTTGTAAGGAACTCTTCTGTGAC AGGCACTTGTCTTCCAGGAG Regular 56 
GPAT1 23, 24 CCTCCTACACTCTCTTCCTGTG TTGAAACACATGGACACCTTC Regular 56 
GPAT1 21, 22 AACCTCAAATACCACGAAAGTCAC CCATGGAGTGAGAGGTCAGG Regular 58 
GPAT1 18 CGTCGGAAATCTTAGTGCTTG TCATCTTGGACATGACTCTCTCTC Regular 56 
GPAT1 17 TGCAGGCAGAATCTTCACC CCTCTCAGCATGATCTTCCTTC Regular 56 
GPAT1 16 CATTCTATGAGTCATTCTGCACTTC GGCACAGTCAGTTCCCAGTC "Hot start" 59 
GPAT1 15 CACCTTGAATTCTTGATTGCTC CTCATCCTCCTCTCGCTCTC "Hot start" 54 
GPAT1 14 TTGCAAGATGCTGAGGAGTAG AGAATAGTAATAGGTCTCTCAGGTTCC "Hot start" 59 
GPAT1 12, 13 GAAGTCCTCCTTAGTTCATTTGAC AACTAACCTTCAAACAGCTGGAG Regular 56 
LPIN1 369 CACTTCTGCTCTGTCCTTCG CTCCTCGGTCCTCTATGCTC Regular 56 
LPIN1 364, 367 CAGCAAAGTCACTGCTCCAG GCTGTCCTTGCCTTCAGATG Regular 56 
LPIN1 361, 362, 363 CCATTGTGGTTTGTCACAGG ACAAACCTGCTTGGAATTGG "Hot start" 59 
LPIN1 360 GGAAAGAACCATCCTCATCG CCCAGAAACTGAACTACATGAGC Regular 56 
LPIN1 359 GCTCGATTGTAGACGACAGC TGAGTAAATGACAGAGCACCAG Regular 56 
LPIN1 355 GAACGGTGCTCTGACCTGAC GCTGCAACACCACCTTGG Regular 56 
LPIN1 353, 354 TTGACTCGACTCTTCTCTGACC GAAGCGTTGGCTTTCTCAC Regular 56 
LPIN1 352 ATGTGGTCCTCTGCCATTG TTTCACTTCCAAGAATCTATACGG Regular 56 
1“Hot start” PCR is a procedure that decreases non specific DNA amplification during the initial PCR cycles. 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; GPAT1 and GPAT4, glycerol-3-phosphate acyltransferases-1 and -4; LPIN1, lipin-1 
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Table 2.2 (continued) 
Gene SNP Forward primer Reverse primer PCR type Tm, °C
LPIN1 350 AGATAAGGAGAAATGGAAACTTGC TGTGTTTAATCCTGATCTGTACCTTC Regular 56 
LPIN1 346, 347, 348, 349 ACCTGTGCTTGGACCTCTG AACAGGACCATCTGAAACACTG Regular 56 
LPIN1 340, 341 CGTCTGAGCCACCTCTGG CGGTGAACCAGAGCATCC "Hot start" 59 
LPIN1 339 TGGACAAGGAGAGAACATGG CAGAGCAAACCACAGAAGGTC Regular 56 
DGAT1 A232K TGGGCTCCGTGCTGGCCCTGATGGTCTA TTGAGCTCGTAGCACAGGGTGGGGGCGA "Hot start" 63 
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Table 2.3 Summary of milk fatty acid composition1, 2 
Trait Mean Standard deviation 5% Quantile 95% Quantile 
Milk production, kg/d 40.24 10.02 24.52 57.43 
Milk fat, % 3.65 0.70 2.50 4.80 
AI 2.07 0.46 1.27 2.80 
SFA, wt % 63.93 4.47 55.57 70.29 
UFA, wt % 36.07 4.47 29.71 44.43 
MUFA, wt % 31.26 4.04 25.66 38.91 
PUFA, wt % 4.81 0.92 3.46 6.42 
SFA/UFA 1.81 0.34 1.25 2.37 
4:0, wt % 2.47 0.76 1.29 3.80 
6:0, wt % 1.55 0.35 0.90 2.05 
8:0, wt % 1.00 0.23 0.57 1.35 
10:0, wt % 2.47 0.63 1.35 3.47 
12:0, wt % 2.94 0.73 1.61 4.10 
13:0, wt % 0.18 0.08 0.07 0.33 
14:0, wt % 10.15 1.60 6.80 12.26 
14:1c9, wt % 0.79 0.30 0.39 1.34 
15:0, wt % 1.08 0.28 0.71 1.63 
16:0, wt % 29.33 2.83 24.91 34.14 
16:1c9, wt % 1.75 0.41 1.16 2.47 
17:0, wt % 0.63 0.09 0.50 0.77 
18:0, wt % 11.92 2.37 8.44 16.14 
18:2c9, c12, wt % 3.24 0.70 2.23 4.47 
18:1c9, wt % 23.55 3.45 18.83 30.05 
18:2c9,t11 (CLA), wt % 0.70 0.24 0.43 1.19 
C14 Index3 0.07 0.02 0.04 0.11 
C16 Index4 0.06 0.01 0.04 0.08 
C18 Index5 0.66 0.05 0.59 0.74 
Elongation index6 0.53 0.05 0.46 0.62 
1Summary statistics were computed from 4397 milk samples collected from 551 cows. 
2The data presented here are for only 16 fatty acids out of 39 fatty acids analyzed because the concentrations of 
the rest of fatty acids in milk were low. 
3C14 Desaturation index = 14:1/ (14:0 + 14:1) 
4C16 Desaturation index = 16:1/ (16:0 + 16:1) 
5C18 Desaturation index = 18:1/ (18:0 + 18:1) 
6Elongation index = (18:0 + 18:1)/ (16:0 + 16:1 + 18:0 + 18:1) 
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Table 2.4 SNPs used for the reconstruction of haplotypes in GPAT4, GPAT1, AGPAT1, 
and LPIN1 genes 
SNP Gene 
Order in 
haplotype 
sequence 
Nucleotide 
position, 
bp 
Gene area Alleles Mutation type 
A.A. 
Residue 
change 
3 GPAT4 1 8435 Exon 3 T/C Synonymous None 
4 GPAT4 2 9205 Intron 3-4 G/A Intronic None 
5 GPAT4 3 11238 Intron 7-8 C/T Intronic None 
6 GPAT4 4 11381 Intron 7-8 T/A Intronic None 
7 GPAT4 5 12288 Intron 8-9 G/C Intronic None 
8 GPAT4 6 15625 Intron 9-10 G/A Intronic None 
32 AGPAT1 1 4660 Intron 2-3 T/G Intronic None 
33 AGPAT1 2 4858 Exon 3 C/T Synonymous None 
34 AGPAT1 3 5334 Intron 4-5 G/A Intronic None 
35 AGPAT1 4 5567 Intron 5-6 G/A Intronic None 
37 AGPAT1 5 5612 Intron 5-6 C/G Intronic None 
38 AGPAT1 6 5662 Intron 5-6 C/T Intronic None 
40 AGPAT1 7 6180 Intron 6-7 C/G Intronic None 
41 AGPAT1 8 6354 Exon 7 A/G Nonsynonymous T267A 
25 GPAT1 1 35991 Intron 19-20 A/G Intronic None 
24 GPAT1 2 35680 Intron 19-20 G/A Intronic None 
23 GPAT1 3 35483 Exon 19 T/C Synonymous None 
21 GPAT1 4 34124 Exon 18 A/G Synonymous None 
22 GPAT1 5 33921 Intron 17-18 A/G Intronic None 
18 GPAT1 6 31956 Intron 16-17 C/T Intronic None 
17 GPAT1 7 26680 Intron 12-13 C/T Intronic None 
16 GPAT1 8 22884 Intron 10-11 G/A Intronic None 
15 GPAT1 9 16972 Intron 7-8 A/G Intronic None 
14 GPAT1 10 4694 Exon 3 G/A Synonymous None 
12 GPAT1 11 105 Exon 1 C/T Nonsynonymous R26W 
13 GPAT1 12 11 Exon 1 G/A Synonymous None 
369 LPIN1 1 79397 Intron 21-22 C/T Intronic None 
367 LPIN1 2 73986 Intron 20-21 G/A Intronic None 
364 LPIN1 3 66001 Intron 18-19 G/A Intronic None 
363 LPIN1 4 65969 Intron 18-19 G/A Intronic None 
362 LPIN1 5 65917 Exon 18 C/T Synonymous None 
361 LPIN1 6 65897 Exon 18 G/A Nonsynonymous D740N 
360 LPIN1 7 65349 Intron 17-18 A/G Intronic None 
359 LPIN1 8 58196 Intron 15-16 G/A Intronic None 
355 LPIN1 9 48610 Intron 10-11 C/T Intronic None 
354 LPIN1 10 46162 Exon 9 A/C Nonsynonymous H407P 
353 LPIN1 11 46128 Exon 9 C/T Nonsynonymous P396S 
352 LPIN1 12 40751 Intron 7-8 T/G Intronic None 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; GPAT1 and GPAT4, glycerol-3-phosphate 
acyltransferases-1 and -4; LPIN1, lipin-1 
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Table 2.4 (continued) 
SNP Gene 
Order in 
haplotype 
sequence 
Nucleotide 
position, 
bp 
Gene area Alleles Mutation type 
A.A. 
Residue 
change 
350 LPIN1 13 38382 Exon 6 G/A Nonsynonymous R217H 
349 LPIN1 14 34758 Exon 5 C/T Synonymous None 
348 LPIN1 15 34714 Exon 5 A/G Nonsynonymous T125A 
347 LPIN1 16 34643 Exon 5 T/C Nonsynonymous M101T 
346 LPIN1 17 34607 Intron 4-5 C/T Intronic None 
341 LPIN1 18 31071 Intron 3-4 G/C Intronic None 
340 LPIN1 19 30751 Exon 3 G/A Synonymous None 
339 LPIN1 20 -23 5' UTR C/T 5’ UTR None 
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Table 2.5 Intragenic haplotypes and their frequencies   
Gene Haplotype Sequence1, 2 Frequency3 
GPAT4 h1 C1G2C3T4G5G6 0.22 
GPAT4 h2 C1G2C3T4G5A6 0.06 
GPAT4 h3 C1G2C3T4C5G6 0.32 
GPAT4 h6 C1G2T3T4G5G6 0.12 
GPAT4 h8 C1G2T3A4G5G6 0.05 
GPAT4 h10 T1G2C3T4G5G6 0.18 
GPAT1 h1 A1G2T3A4A5C6C7G8A9G10C11G12 0.09 
GPAT1 h2 A1G2T3A4A5C6C7G8A9G10T11G12 0.08 
GPAT1 h7 A1A2C3G4G5T6C7G8G9G10C11G12 0.19 
GPAT1 h8 A1A2C3G4G5T6C7G8G9A10C11G12 0.15 
GPAT1 h9 A1A2C3G4G5C6C7G8A9G10C11G12 0.30 
GPAT1 h12 A1A2C3G4G5C6T7G8A9G10C11G12 0.13 
AGPAT1 h2 G1C2G3G4C5C6C7A8 0.54 
AGPAT1 h4 G1C2G3G4C5C6G7G8 0.05 
AGPAT1 h6 G1C2G3G4G5T6C7A8 0.13 
AGPAT1 h9 G1T2A3G4C5C6C7A8 0.07 
AGPAT1 h10 T1C2G3A4C5C6C7A8 0.18 
LPIN1 h1 C1G2A3A4T5G6A7G8C9A10C11T12G13C14A15T16C17G18G19C20 0.14 
LPIN1 h4 C1G2A3A4T5G6A7G8C9C10C11T12G13T14G15C16C17G18G19T20 0.13 
LPIN1 h13 C1G2A3A4C5G6G7G8C9C10C11T12G13T14G15C16T17G18G19C20 0.09 
LPIN1 h18 C1G2G3G4C5G6A7G8C9A10C11T12G13C14A15T16C17G18G19C20 0.12 
LPIN1 h22 C1G2G3G4C5A6A7G8T9C10T11G12A13T14G15C16T17C18G19C20 0.07 
LPIN1 h24 C1A2G3G4C5G6A7G8T9C10T11G12A13T14G15C16T17C18G19C20 0.10 
LPIN1 h26 T1G2G3G4C5G6A7G8T9C10T11G12A13T14G15C16T17C18G19C20 0.15 
1Subsripts indicate the order of SNPs in a particular haplotype for a particular gene  
2The “tag” SNPs in the haplotypes of interest are highlighted in bold and underlined 
3Only haplotypes with the population frequencies ≥ 5% were considered in the analysis 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; GPAT1 and GPAT4, glycerol-3-phosphate 
acyltransferases-1 and -4; LPIN1, lipin-1 
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Table 2.6 Results of the F-tests for the overall haplotype effect on milk fatty acid composition 
GPAT4 GPAT1 AGPAT1 LPIN1 Trait 
 F-value p-value F-value p-value F-value p-value F-value p-value 
Milk fat 0.40 0.88 3.49 0.0021* 2.14 0.059 2.60 0.11 
AI 3.32 0.0031* 1.33 0.24 1.70 0.13 0.91 0.50 
SFA 3.65 0.0014* 1.26 0.27 1.70 0.13 0.97 0.45 
UFA 3.65 0.0014* 1.26 0.27 1.70 0.13 0.97 0.45 
MUFA 3.89 0.0008* 1.57 0.15 1.10 0.36 1.10 0.36 
PUFA 3.99 0.0006* 1.08 0.38 3.74 0.0023* 2.18 0.033 
SFA/UFA 3.68 0.0013* 1.16 0.33 2.17 0.056 0.95 0.47 
4:0 0.59 0.74 1.19 0.31 1.11 0.35 0.72 0.65 
6:0 2.27 0.035 3.01 0.0065* 3.67 0.0027* 1.02 0.41 
8:0 3.70 0.0012* 3.00 0.0067* 2.61 0.024 1.30 0.25 
10:0 5.14 <.0001* 2.93 0.0078* 1.15 0.33 1.30 0.25 
12:0 4.57 0.0001* 2.04 0.059 0.44 0.82 1.11 0.35 
13:0 1.46 0.19 2.79 0.011* 1.76 0.12 0.65 0.71 
14:0 3.18 0.0043* 2.04 0.059 0.50 0.77 0.61 0.74 
14:1c9 1.24 0.28 11.16 <.0001* 3.04 0.01* 3.66 0.0007* 
15:0 0.67 0.68 0.76 0.60 3.01 0.011* 0.95 0.47 
16:0 3.99 0.0006* 1.39 0.21 2.09 0.064 1.42 0.19 
16:1c9 2.07 0.054 2.43 0.025 2.57 0.026 0.22 0.98 
17:0 0.64 0.70 4.96 <.0001* 5.50 <.0001* 1.88 0.070 
18:0 1.75 0.11 1.68 0.12 1.38 0.23 0.43 0.88 
18:1c9 3.52 0.0019* 1.99 0.065 0.66 0.65 1.08 0.37 
18:2c9, c12 2.73 0.0126 1.18 0.31 3.05 0.0098* 2.53 0.014 
18:2c9, t11 (CLA) 2.89 0.0086* 1.23 0.29 3.51 0.0038* 0.72 0.66 
Index 14 2.30 0.033 11.79 <.0001* 2.45 0.033 4.20 0.0001* 
Index 16 3.07 0.0056* 2.49 0.022 1.48 0.19 0.26 0.97 
Index 18 3.03 0.0062* 1.36 0.23 1.22 0.30 0.86 0.54 
Elongation index 1.81 0.095 1.48 0.18 1.79 0.11 0.82 0.57 
*The Bonferroni adjustment was used to account for multiple testing on four different genes. The significance of haplotype effects was declared if p≤0.0125 
(0.05 divided by the number of genes that was 4) 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; GPAT1 and GPAT4, glycerol-3-phosphate acyltransferases-1 and -4; LPIN1, lipin-1 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected were the following: 3768 and 469; 3715 and 
462; 3653 and 454; and 3986 and 501 for AGPAT1, GPAT1, GPAT4, and LPIN1, respectively. 
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Table 2.7 Pairwise comparisons of GPAT4 haplotype effects on milk fatty acid 
composition1 
H-Hb PUFA H-Hb 10:0 12:0 
H3-H1 0.15 H8-H2 -0.21 -0.23 
 (0.039)  (0.062) (0.07) 
 0.0002  0.0009 0.0013 
H8-H1 0.23 H10-H2  -0.18 
 (0.063)  NS (0.055) 
 0.0003   0.0017 
H10-H1 0.15    
 (0.046)    
 0.0014    
H-Hb AI SFA UFA MUFA 
SFA/ 
UFA 16:0 18:1
c9 C16 Index 
C18 
Index 
H1-H6    0.74   0.61  0.009 
 NS NS NS (0.24) NS NS (0.19) NS (0.003) 
    0.0023   0.0014  0.0022 
H2-H6         0.013 
 NS NS NS NS NS NS NS NS (0.004) 
         0.0007 
H3-H6  -0.90 0.90 0.86 -0.069 -0.54 0.63 0.0026 0.01 
 NS (0.25) (0.25) (0.23) (0.019) (0.15) (0.18) (0.0008) (0.003) 
  0.0004 0.0004 0.0002 0.0003 0.0003 0.0006 0.0019 0.0004 
H8-H6 -0.13 -1.48 1.48 1.34 -0.12 -0.66 0.80   
 (0.036) (0.38) (0.38) (0.34) (0.028) (0.22) (0.27) NS NS 
 0.0002 <.0001 <.0001 <.0001 <.0001 0.0031 0.0029   
H10-H6  -0.90 0.90 0.86 -0.061   0.0032 0.01 
 NS (0.27) (0.27) (0.25) (0.02) NS NS (0.0009) (0.003) 
  0.0009 0.0009 0.0005 0.0027   0.0003 0.0012 
1The first number out of three numbers in a cell is an estimate of the haplotype substitution effect expressed in 
wt % for all individual fatty acids and fatty acid groups excluding indices. The second number in the 
parenthesis is a standard error of an estimate of the haplotype substitution effect expressed in the same units as 
the estimate. The third number is a p-value.  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0033 (0.05 divided by the number of comparisons that was 15.  
H-Hb, indicates a pair of haplotypes for which the haplotype effects on milk fatty acid composition were 
compared with Hb, indicating the position of a haplotype used as a baseline.  
GPAT4, glycerol-3-phosphate acyltransferases-4; NS, not significant 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were 3653 and 454.
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Table 2.8 Pairwise comparisons of GPAT1 haplotype effects on milk fatty acid 
composition1 
H-Hb 13:0 14:1c9 
C14 
Index H-Hb 6:0 8:0 13:0 14:1
c9 
H2-H1 -0.015   H8-H2 0.086 0.057   
 (0.005) NS NS  (0.025) (0.018) NS NS 
 0.0024    0.0007 0.0014   
H12-H1  0.072 0.0057 H12-H2  0.056 0.016 0.066 
 NS (0.020) (0.0017)  NS (0.018) (0.004) (0.023) 
  0.0004 0.0009   0.0017 0.0004 0.0033 
H-Hb Milk fat 8:0 10:0 14:1c9 17:0 C14 Index 
H2-H9 -0.15 -0.051 -0.15    
 (0.047) (0.016) (0.044) NS NS NS 
 0.0019 0.0014 0.0008    
H7-H9 -0.11   0.073 0.013 0.0071 
 (0.033) NS NS (0.014) (0.0032) (0.0012) 
 0.0015   <.0001 <.0001 <.0001 
H8-H9    0.065  0.0058 
 NS NS NS (0.016) NS (0.0013) 
    <.0001  <.0001 
H12-H9    0.10 0.016 0.0082 
 NS NS NS (0.016) (0.0036) (0.0013) 
    <.0001 <.0001 <.0001 
1The first number out of three numbers in a cell is an estimate of the haplotype substitution effect expressed in 
percentages for milk fat, wt % for all individual fatty acids and fatty acid groups excluding indices. The second 
number in the parenthesis is a standard error of an estimate of the haplotype substitution effect expressed in the 
same units as the estimate. The third number is a p-value.  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0033 (0.05 divided by the number of comparisons that was 15.  
H-Hb, indicates a pair of haplotypes for which the haplotype effects on milk fatty acid composition were 
compared with Hb, indicating the position of a haplotype used as a baseline.  
GPAT1, glycerol-3-phosphate acyltransferases-1; NS, not significant 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were 3715 and 462.
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Table 2.9 Pairwise comparisons of AGPAT1 and LPIN1 haplotype effects on milk fatty 
acid composition1 
AGPAT1 LPIN1 
H-Hb 14:1c9 H-Hb 14:1c9 C14 Index 
H2-H9 0.067 H1-H22 0.085 0.0073 
 (0.020)  (0.023) (0.0020) 
 0.0007  0.0002 0.0002 
H4-H9 0.084 H24-H22 0.081 0.0073 
 (0.028)  (0.024) (0.0021) 
 0.0029  0.001 0.0005 
H6-H9 0.073 H26-H22 0.078 0.0067 
 (0.023)  (0.022) (0.0018) 
 0.002  0.0003 0.0003 
H10-H9 0.086    
 (0.023)    
 0.0002    
AGPAT1 
H-Hb PUFA 18:2c9, c12 18:2c9, t11 (CLA) 6:0 17:0 
H2-H10 0.12 0.082 0.035 -0.045  
 (0.036) (0.026) (0.012) (0.015) NS 
 0.0008 0.0017 0.0044 0.0023  
H4-H10     0.016 
 NS NS NS NS (0.0053) 
     0.0023 
H6-H10 0.16 0.12    
 (0.049) (0.035) NS NS NS 
 0.0013 0.0008    
1The first number out of three numbers in a cell is an estimate of the haplotype substitution effect expressed in 
wt % for all individual fatty acids and fatty acid groups excluding indices. The second number in the 
parenthesis is a standard error of an estimate of the haplotype substitution effect expressed in the same units as 
the estimate. The third number is a p-value.  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value were 
≤ 0.005 and 0.0024 for AGPAT1 and LPIN1, respectively (0.05 divided by the number of comparisons that 
were 10 and 21 for AGPAT1 and LPIN1, respectively).  
H-Hb, indicates a pair of haplotypes for which the haplotype effects on milk fatty acid composition were 
compared with Hb, indicating the position of a haplotype used as a baseline.  
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; LPIN1, lipin-1; NS, not significant 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 3768 and 469; and 3986 and 501 for AGPAT1 and LPIN1, respectively.
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Table 2.10 Allele substitution effects of DGAT1 A2232K and FAS g. 17924G>A 
polymorphisms on milk fatty acid composition 
DGAT1 (A232K) FAS (g. 17924G>A) 
Trait 
Estimate Standard error p-value Estimate 
Standard 
error p-value 
Milk fat, % 0.22 0.030 <.0001 0.0080 0.023 0.72 
AI 0.10 0.019 <.0001 0.008 0.014 0.58 
SFA, wt % 1.05 0.20 <.0001 -0.099 0.14 0.50 
UFA, wt % -1.05 0.20 <.0001 0.099 0.14 0.50 
MUFA, wt % -0.88 0.19 <.0001 0.11 0.13 0.41 
PUFA, wt % -0.16 0.037 <.0001 -0.011 0.028 0.70 
SFA/ UFA 0.086 0.015 <.0001 -0.004 0.011 0.69 
4:0, wt % 0.0046 0.025 0.86 -0.024 0.020 0.22 
6:0, wt % 0.060 0.015 0.0001 -0.015 0.011 0.17 
8:0, wt % 0.042 0.011 <.0001 -0.009 0.008 0.25 
10:0, wt % 0.086 0.030 0.0042 -0.013 0.022 0.57 
12:0, wt % 0.070 0.033 0.035 -0.003 0.024 0.90 
13:0, wt % 0.013 0.003 <.0001 0.000 0.002 0.85 
14:0, wt % 0.11 0.061 0.081 0.11 0.047 0.018 
14:1c9, wt % 0.042 0.015 0.0037 0.0012 0.0098 0.90 
15:0, wt % 0.056 0.012 <.0001 -0.0042 0.0086 0.63 
16:0, wt % 0.87 0.11 <.0001 -0.17 0.085 0.042 
16:1c9, wt % 0.087 0.022 <.0001 -0.0038 0.016 0.81 
17:0, wt % -0.0035 0.0032 0.27 0.0016 0.0023 0.49 
18:0, wt % -0.23 0.11 0.032 0.040 0.078 0.61 
18:1c9, wt % -0.88 0.14 <.0001 0.036 0.10 0.73 
18:2c9, c12, wt % -0.12 0.026 <.0001 -0.0077 0.020 0.70 
18:2c9, t11 (CLA), wt % -0.028 0.013 0.028 0.0061 0.0093 0.51 
C14 Index 0.0030 0.0013 0.016 -0.00022 0.00083 0.79 
C16 Index 0.00099 0.00068 0.14 0.00024 0.00049 0.63 
C18 Index -0.004 0.002 0.062 0.000 0.002 0.83 
Elongation index -0.015 0.002 <.0001 0.002 0.001 0.23 
DGAT1, diacylglycerol acyltransferase-1; FAS, fatty acid synthase 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 2587 and 325; and 4003 and 500 for DGAT1 and FAS, respectively.
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Table 2.11 Summary of the largest effects of polymorphisms in GPAT4, GPAT1, 
AGPAT1, LPIN1, DGAT1, and FAS genes on milk fat percentage and milk fatty acid 
composition 
Gene Trait 
GPAT4 GPAT1 AGPAT1 LPIN1 DGAT1 FAS 
Milk fat, % NS 0.15 NS NS 0.22 NS 
AI 0.13 NS NS NS 0.10 NS 
SFA, wt % 1.48 NS NS NS 1.05 NS 
UFA, wt % 1.48 NS NS NS 1.05 NS 
MUFA, wt % 1.34 NS NS NS 0.88 NS 
PUFA, wt % 0.23 NS NS NS 0.16 NS 
SFA/ UFA 0.12 NS NS NS 0.086 NS 
4:0, wt % NS NS NS NS NS NS 
6:0, wt % NS 0.086 0.045 NS 0.060 NS 
8:0, wt % NS 0.057 NS NS 0.042 NS 
10:0, wt % 0.21 0.15 NS NS 0.086 NS 
12:0, wt % 0.23 NS NS NS 0.070 NS 
13:0, wt % NS 0.016 NS NS 0.013 NS 
14:0, wt % NS NS NS NS NS 0.11 
14:1c9, wt % NS 0.10 0.086 0.085 0.042 NS 
15:0, wt % NS NS NS NS 0.056 NS 
16:0, wt % 0.66 NS NS NS 0.87 0.17 
16:1c9, wt % NS NS NS NS 0.087 NS 
17:0, wt % NS 0.016 0.016 NS NS NS 
18:0, wt % NS NS NS NS 0.23 NS 
18:1c9, wt % 0.80 NS NS NS 0.88 NS 
18:2c9, c12, wt % NS NS 0.12 NS 0.12 NS 
18:2c9, t11 (CLA), wt % NS NS 0.035 NS 0.028 NS 
C14 Index NS 0.0082 NS 0.0073 0.0030 NS 
C16 Index 0.0032 NS NS NS NS NS 
C18 Index 0.013 NS NS NS NS NS 
Elongation index NS NS NS NS 0.015 NS 
AGPAT1, 1-acylglycerol-3-phosphate acyltransferase-1; FAS, fatty acid synthase; DGAT1, diacylglycerol 
acyltransferase-1; GPAT1 and GPAT4, glycerol-3-phosphate acyltransferases-1 and -4; LPIN1, lipin-1; NS not 
significant  
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CHAPTER 3. EFFECTS OF POLYMORPHISMS IN FABP3, FABP4, 
AND SLC27A6 GENES ON BOVINE MILK FATTY ACID 
COMPOSITION 
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Rafael A. Nafikov, Jon P. Schoonmaker, Kathleen T. Korn, Kristin Noack, Dorian J. 
Garrick, Kenneth J. Koehler, Jennifer Minick-Bormann, James M. Reecy, Diane E. 
Spurlock, and Donald C. Beitz 
 
Abstract 
The main goal of our study was to develop tools for the genetic selection of animals 
producing milk with lower concentration of saturated fatty acids (SFA) as a class and 
lower concentrations of individual atherogenic SFA, such as palmitic (16:0) and myristic 
(14:0), with the purpose of improving the healthfulness of bovine milk. We hypothesized 
that genetic polymorphisms in solute carrier family 27, isoform A6 (SLC27A6) fatty acid 
transport protein and fatty acid binding proteins-3 and -4 (FABP3 and FABP4) will affect 
the selectivity of fatty acid uptake into and fatty acid redistribution inside mammary 
epithelial cells, resulting in altered fatty acid composition of bovine milk. The objectives 
of our study were to discover genetic polymorphisms in SLC27A6, FABP3, and FABP4 
and to test those polymorphisms for the association with milk fat percentage and fatty 
acid composition. The results of our study showed that the overall haplotype effect of 
SLC27A6 was associated significantly with the percentage of milk fat, the concentrations 
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of SFA, unsaturated fatty acids (UFA), monounsaturated fatty acids (MUFA), SFA/UFA, 
and the concentrations of capric (10:0), lauric (12:0), myristic (14:0), and palmitic (16:0) 
acids in milk. The overall haplotype effect of FABP4 was associated significantly with 
the concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, the concentrations of 
linoleic (18:2c9, c12) acid, conjugated linoleic acid (18:2c9, t11), and C18 desaturation index. 
The overall haplotype effect of FABP3 was associated significantly with the 
concentrations of only pentadecylic (15:0) acid and elongation index. In conclusion, the 
results of our study show that the information about polymorphisms in SCL27A6, 
FABP3, and FABP4 can be used to select for cattle producing milk with healthier fatty 
acid composition and with higher percentage of milk fat. 
 
Introduction 
Dietary saturated fatty acids (SFA) are known for their adverse effects on plasma 
cholesterol concentrations in humans (32). For example, a 1% increase in dietary total 
energy from SFA will result in a 1.9 mg/dL increase in plasma total cholesterol (TC) and 
a 1.8 mg/dL increase in plasma low-density lipoprotein-cholesterol (LDL-C) 
concentrations (28). Particular attention also should be paid to the concentrations of 
palmitic (16:0) and myristic (14:0) acids in human diets because those fatty acids raise 
plasma TC and LDL-C concentrations much higher compared with other individual SFA 
(32). Bovine milk contains a relatively high percentage of SFA, with palmitic (16:0) acid 
being the most abundant among all fatty acids. The main objective of our study was to 
develop genetic markers allowing the selection of animals producing healthier milk with 
high concentration of UFA and low concentrations of SFA and palmitic (16:0) and 
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myristic (14:0) acids. The animal genetic approach to improve the healthfulness of milk 
was chosen over the nutritional regulation because of the moderate to high heritabilities 
of milk fatty acids (2, 8, 37, 47, 52) and the low conversion rate of dietary UFA into milk 
UFA as a consequence of ruminal biohydrogenation of UFA (18). 
The uptake of long-chain fatty acids from plasma into a cell is mediated by fatty 
acid transport proteins that also are called solute carrier family 27 (SLC27) proteins (11, 
17, 49). There are six members of SLC27 protein family (SLC27A1-6).  The SLC27A1 is 
highly expressed in adipose tissue and skeletal and heart muscles, and its translocation 
from inside a cell to plasma membrane is stimulated by insulin. The SLC27A3 expression 
is not well established, but SLC27A4 is predominantly expressed in small intestine, 
adipose tissue, liver, heart, and skin. The SLC27A5 is abundant in liver and plays the 
major role in fatty acid uptake by that organ, SLC27A2 is expressed in liver and kidney, 
and SLC27A6 is mainly expressed in heart tissue. The information regarding the function 
of SLC27 protein family members in the mammary gland is limited. The expression of 
three members of SLC27 family, however, was detected in the mouse mammary gland. 
Those proteins were SLC27A1, SLC27A3, and SLC27A4, with SLC27A3 being the most 
abundant (41). In bovine mammary epithelial cells, the SLC27A6 was the major isoform 
to be expressed, followed by SLC27A1 and SLC27A5 (6, 7). The expression of all three 
SLC27 isoforms was highly up-regulated with the onset of lactation.    
 After entering a cell, fatty acids have to be either esterified to coenzyme A with a 
subsequent binding to acyl-CoA binding proteins or bound to fatty acid binding proteins 
(FABPs) as non-esterified fatty acids. The FABPs are 14-15 kDa proteins that reversibly 
bind non-esterified saturated and unsaturated long-chain fatty acids, eicosanoids, and 
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other lipids with the purpose of transporting or storing them inside a cell (20). Fatty acids 
esterified to coenzyme A can be bound by FABPs as well. There are nine members of the 
FABP protein family that are expressed differentially in multiple tissues. The most 
abundant isoforms of FABPs expressed in the lactating bovine mammary gland are 
FABP3, FABP4, and FABP5 (6). The expression of FABP3 was detected also at very 
high levels in mouse mammary gland (41). The FABP3 protein, also known as heart 
FABP, is expressed in tissues such as heart, skeletal muscle, mammary gland, brown 
adipose tissue, and others (20). The main function of FABP3 in heart and skeletal 
muscles is to channel fatty acids inside a cell towards mitochondrial β-oxidation. The 
discovery of FABP3 protein in mammary gland was related to the identification of a 
mammary-derived growth inhibitor (MDGI) that turned out to be a mixture of FABP3 
and FABP4 proteins (9, 48). The MDGI inhibited the growth of human breast cancer 
cells (29). The FABP3 protein is highly expressed in the mammary gland during cell 
differentiation and formation of ductal structures at the onset of lactation (5), but the 
requirement of FABP3 for mammary tissue development and function is not well 
established (4, 15). 
 The FABP4, also known as adipocyte FABP, is highly expressed in mature and 
differentiating adipose tissues, and its expression is tightly regulated by fatty acids, 
PPAR-γ agonists, and insulin (20). There is not much information about FABP4 function 
in the mammary gland. The polymorphisms in FABP3 and FABP4 genes were studied in 
Korean native beef cattle in relation to carcass weight and back fat thickness (12). There 
was a significant association between back fat thickness and a few polymorphisms in the 
FABP4 gene. Considering the fact that FABP3, FABP4, and SLC27A6 are highly 
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expressed in bovine mammary gland during lactation with FABP3 being the second most 
abundant transcript among all measured (6, 7), we hypothesize that polymorphisms in 
SLC27A6, FABP3, and FABP4 genes can affect the selectivity of fatty acid uptake from 
the blood and fatty acid transport inside the mammary epithelial cells, resulting in 
differences in milk fatty acid composition.  
   
Materials and methods 
Milk fatty acid analysis 
Milk samples were collected during the morning milking once a month throughout a 305-
d lactation period and stored at -20 °C until further analysis. The extraction of milk fatty 
acids with subsequent esterification into methyl esters for the analysis by gas 
chromatography (GC) was performed according to the procedure published by Chouinard 
et al. (16) with minor modifications. The procedure is based on the original milk lipid 
extraction method with hexane and isopropanol developed by Hara and Radin (25) and 
fatty acid methyl ester production method developed by Christie (13). After thawing, 
milk samples were vortexed for 10 s, and 25 mL aliquots were transferred to 50 mL 
teflon centrifuge tubes pre-rinsed with chloroform/ methanol (2/1 vol.vol). Following the 
centrifugation at 17,800 × g for 30 min at 4 °C, the liquid phase of the milk samples was 
removed and 18 mL of hexane/isopropanol (3/2 vol/vol) were added for every gram of 
lipids with subsequent vortexing for 1 min. To achieve a better separation of hexane 
phase containing lipids from water phase containing proteins, 12 mL of 6.7 % sodium 
sulfate (Na2SO4) solution were added for every gram of lipids and samples were vortexed 
for 1 min. After the centrifugation at 2,500 × g for 5 min at 4 °C, the hexane fraction 
 102
containing lipids was removed into a scintillation vial pre-rinsed with chloroform/ 
methanol (2/1 vol/vol) and an aliquot containing 40 mg of lipids (400 μL) was transferred 
into an esterification vial . After the evaporation of hexane under nitrogen gas, 2 mL of 
hexane were added to the esterification vial followed by 40 μL of methyl acetate and 
vortexing for 30 s. The methylation step was initiated by the addition of 40 μL of sodium 
methoxide (0.4 mL of 5.4 M sodium methoxide in 1.75 mL of methanol) solution. The 
mixture was vortexed for 30 s and allowed to react for 10 min at room temperature. The 
reaction was terminated by the addition of 60 μL of oxalic acid (1 gram of oxalic acid/30 
mL of diethyl ether) solution. The samples were centrifuged at 2,400 × g for 5 min at 
4 °C, and a clear hexane fraction, which contained fatty acid methyl esters, was placed 
into GC vials, purged with nitrogen gas for 3 s, capped, and used for chromatographic 
analysis. In the above steps, capping of the vials that contained hexane lipid extract was 
preceded by purging with nitrogen gas for 3 s.    
A Varian 3900 gas chromatograph (Varian Analytical Instruments, Walnut Creek, 
CA) equipped with CP-8400 auto-sampler, CP-8410 auto-injector, CP-1177 split/splitless 
injector, and flame ionization (FID) detector was used to analyze fatty acid methyl esters 
with helium as a carrier gas. One μL of fatty acid methyl esters in hexane was injected 
(split ratio 50:1) into a fused silica capillary column (SupelcoTM-2560 Capillary Column, 
100 m x 0.25 mm i.d., with 0.2 μm film thickness) with the initial column temperature set 
at 70 °C and held for 4 min. Then, the column temperature was increased to 175 °C at the 
rate of 13 °C/min and held for 27 min with subsequent increase to 215 °C at the rate of 
4 °C/min where it was held for 28 min (46). The injector and detector temperatures were 
set constant at 220 °C. Peak area was measured by integration using Star 
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Chromatography Workstation Version 6, and peaks were identified by comparing the 
retention times with separately run fatty acid methyl ester standards (Matreya LLC, 
Pleasant Gap, PA).  
 
DNA extraction 
Genomic DNA was extracted from 20 mL of blood obtained from the coccygeal vein of 
every dairy cow. The blood was collected into 10 mL EDTA Vacutainer tubes and kept at 
4 °C. After transferring 20 mL of blood into 50 mL centrifuge tubes, the ice-cold 1X red 
blood cell (RBC) lysis buffer was added to fill in the tubes that were inverted and 
incubated on ice for 30 min. The samples were centrifuged at 300 × g for 5 min at 4 °C. 
Supernatant was aspirated and 20 mL of ice-cold 1X RBC lysis buffer were added again 
followed by a light vortexing and 30 min and incubation on ice. After centrifugation and 
aspiration steps performed as mentioned earlier, 20 mL of room temperature PBS buffer 
were added to wash the pellet and the centrifugation step was repeated again. Then, 
supernatant was discarded and pellet was resuspended in PBS, transferred to cryovial, 
and stored at -70 °C until further analysis. The DNA purification from the white blood 
cells was performed with DNeasy® Blood and Tissue Kit (Qiagen Inc., Valencia, CA) 
according to the instructions. The DNA concentration was measured using NanoDrop® 
ND1000, and dilutions were made with DNase-free water to desired concentration.  
 
SNP discovery and genotyping 
The SLC27A6, FABP3, and FABP4 genes (table 3.1), were sequenced in exonic and 
some intronic regions to discover SNPs. A set of 12 DNA samples from cows that were 
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daughters of 12 different sires was used for the SNP discovery. The PCR primers were 
designed with Primer3 (version 0.4.0) software (40). Conventional or “Hot-Start” PCR 
was performed to amplify the DNA regions of interest. For the regular PCR, the reaction 
mixture contained 50 ng of genomic DNA, 13.6 μL of DNA grade water, 2 μL of DMSO, 
1.5 μL of MgCl2 (25 mM), 0.1 μL of forward and reverse primers (100 ng/μL), 0.5 μL of 
dNTP mix (40 mM), 5 μL of 5X buffer, and 0.2 μL of Tag DNA polymerase (5 U/μL) 
with the total volume of the reaction mixture equal to 25 μL. For the HotStarTag® PCR, 
the reaction mixture was almost the same as for the regular PCR with the only difference 
that 5 μL of 10X buffer was used instead of 5X buffer and 0.2 μL of HotStarTag DNA 
polymerase (5 U/μL) was used instead of Tag DNA polymerase. The PCRs were 
performed in a DNA Engine thermal cycler (Bio-Rad) with the separate temperature 
cycle programs for the regular and HotStarTag® PCRs. The regular PCR was performed 
with the following program: 94 °C for 2 min followed by 35 cycles of 94 °C for 15 s, an 
optimal annealing temperature for a particular primer set (table 3.1 ) for 30 s, and 72 °C 
for 30 s with a final extension step at 72 °C for 10 min. The HotStarTag® PCR was 
performed with the following program: 95 °C for 15 min followed by 30 cycles of 94 °C 
for 1 min, an optimal annealing temperature for a particular primer set (table 3.1) for 1 
min, and 72 °C for 1 min with a final extension step at 72 °C for 10 min. The optimal 
annealing temperature for a particular primer set was determined by a PCR temperature 
gradient. Before sequencing, the PCR product was cleaned up from unused primers and 
dNTPs with ExoSAP-IT® (USB Corporation, Cleveland, OH) that contained exonuclease 
1 and shrimp alkaline phosphatase (24). Reverse and forward sequences representing 12 
different samples were aligned using Vector NTI AdvanceTM 10 to identify SNPs. 
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Genotyping of discovered SNPs was performed with Sequenom MassARRAY platform 
using 10 ng of genomic DNA dissolved in DNase-free water (21). Haplotypes and their 
frequencies were estimated using PHASE (version 2.1) program (50, 51). Only samples 
with probability ≥0.9 for the best haplotype pair were used in the analysis. The restriction 
fragment length polymorphism technique was used to genotype animals for DGAT1 
A232K mutation. A set of primers (table 3.2), was used to amplify a 405-bp region of 
DNA containing the mutation site by using a “Hot start” PCR. The resulting PCR product, 
then, was digested with EaeI restriction enzyme and run on a 2% agarose gel. There were 
the 230-bp and 175-bp DNA fragments on a gel when an animal had DGAT1 232K 
genotype and a 405-bp DNA fragment on a gel when an animal had DGAT1 232A 
genotype.    
 
Statistical analysis 
A linear mixed model for longitudinal data was used to analyze the data with PROC 
MIXED procedure of SAS 9.1 (2002). The haplotype substitution model (31) used to test 
the association between intragenic haplotypes and milk fatty acid composition was the 
following: 
Y = µ + dim + dim2 + dim3 + cg + dim*cg + dim2*cg + dim3*cg + ∑bk Hk + sire + ε    
where y is the response variable; µ is the mean response at 0 dim for a cow with no 
copies of the haplotypes; dim, dim2, and dim3 are covariates describing the effects of days 
in milk on milk fatty acid composition; cg is a fixed effect of the contemporary group 
(cg=8 classes); Hk is a haplotype effect fitted as a covariate and coded as 0, 1, or 2 for 0, 
1, or 2 copies of each haplotype present in an animal; bk is the partial regression 
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coefficient, which corresponds to the haplotype substitution effect for the kth haplotype as 
a deviation from the effect of the most frequent haplotype that is set to zero to have a full 
rank model; sire is a sire random effect; and ε is a residual error. The higher order terms 
for days in milk were introduced to account for a non-linear trend of the response 
variables over time. The cubic term of days in milk allows the response variable to have 
different slopes whenever the direction of its trend changes over time. When the higher 
order terms for days in milk were not significant, they were dropped from the model. 
Contemporary groups were created by combining herd (two herds) and season of calving 
(four seasons: December to February, March to May, June to August, and September to 
November) effects. The year of sampling was not included in the model to avoid 
redundancy because the season of calving is already containing some information about 
the year when a particular sample was collected. Haplotypes with a population frequency 
more than 0.05 were used in the analysis, and those with frequency less than 0.05 were 
pooled in the “other” category. The CONTRAST statement in PROC MIXED was used 
to construct the F-tests of the overall haplotype effects, and, when the test was significant 
after applying the Bonferroni adjustment to account for multiple testing, the pairwise 
comparisons between all haplotypes within each gene were performed using the 
ESTIMATE statement and the estimates of the differences between haplotype effects, 
their standard errors, and p-values were reported. The REPEATED statement was used to 
indicate that milk samples were collected repeatedly for the same animal throughout the 
305 d lactation period. Correlations between repeated measures taken on the same animal 
were modeled using a first order autoregressive covariance structure that assumes equal 
variances and correlations that decline exponentially with an increase in the distance 
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between time points (33). The covariance structure was selected on the basis of the 
biology of the experiment and using Akaike’s and Bayesian Information Criteria and 
residual log likelihood (42). 
For the traits that were significantly associated with the overall haplotype effect, 
we performed pairwise comparisons between different haplotypes within the same gene 
to determine which haplotypes had significant effects on differences in milk fatty acid 
composition compared with the effects of other haplotypes. The Bonferroni adjustment 
was used to control type I error rate during multiple comparisons. Bonferroni-adjusted 
significance levels were determined by dividing desired experiment-wide significance 
level (0.05) by the number of pairwise comparisons. The numbers of pairwise 
comparisons for SLC27A6, FABP3, and FABP4 genes were 10, 3, and 3, respectively 
that resulted in Bonferroni-adjusted significance levels of 0.005, 0.0167, and 0.0167, 
respectively. We compared haplotype sequences within each gene based on their effects 
on milk fatty acid composition to determine “tag” SNPs that can be used as genetic 
markers. 
In recent years, a number of studies looked at the effects of SNPs from different 
genes on milk fatty acid composition (38, 43-45). It is difficult, however, to compare the 
size of the effects of different polymorphisms on any particular fatty acid concentration 
in milk because of the different approaches used to analyze the data. To compare the 
results of our study with earlier published data, we genotyped our animals for DGAT1 
K232A and fatty acid synthase g. 17924A>G polymorphisms and analyzed the data the 
same way as earlier with the only difference that allele effects of the SNPs were tested 
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instead of the haplotype effects. All animals on the study were treated in accordance with 
guidelines established by the Iowa State University Committee on Animal Care. 
 
Results 
Mean values, their standard deviations, and 5% and 95% quantiles for milk production, 
milk fat percentage, concentrations of different fatty acids and fatty acid groups, and fatty 
acid indices are reported in table 3.3. There were 39 different milk fatty acids measured 
by GC. All fatty acid data were used to calculate the concentrations of individual fatty 
acids that were expressed as wt %, but the data reported are only for fatty acids present in 
milk at relatively high concentrations. The mean values for the major milk fatty acids in 
our study were similar to those reported by others (30, 52). The major fatty acid in milk 
was palmitic (16:0; 29.33 wt %) followed by oleic (18:1c9; 23.55 wt %), stearic (18:0; 
11.92 wt %), and myristic (14:0; 10.15 wt %) acids. 
 There were 7, 2, and 4 SNPs discovered in SLC27A6, FABP3, and FABP4, 
respectively (table 3.4). The discovered SNPs were validated by using the Sequenom 
MassARRAY system. The number of SNPs discovered was not large because of the 
small number of DNA samples (12 samples), used for sequencing. The majority of SNPs 
were intronic with a few synonymous and nonsynonymous mutations. After genotyping 
animals for discovered SNPs, there were 5, 3, and 3 haplotypes reconstructed for 
SLC27A6, FABP3, and FABP4, respectively, by using the PHASE program (table 3.5). 
The population frequencies of the reconstructed haplotypes were above 5 %.   
 F-tests were used to determine the overall haplotype effect of individual genes on 
milk fatty acid composition (table 3.6). Results with p-value ≤ 0.0167 were considered to 
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be significant, as determined by applying the Bonferroni adjustment to account for testing 
the association of genetic polymorphisms with milk fatty acid composition in each of 
three different genes. The overall haplotype effect of SLC27A6 was associated 
significantly with milk fat percentage, AI, concentrations of SFA, UFA, MUFA, 
SFA/UFA, concentrations of capric (10:0), lauric (12:0), myristic (14:0), and palmitic 
(16:0) acids. The overall haplotype effect of FABP3 was associated significantly with 
only pentadecylic (15:0) acid concentration and the elongation index (table 3.6). The 
FABP4 showed a significant association of its overall haplotype effect with the 
concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, the concentrations of linoleic 
(18:2c9, c12) acid, CLA  (18:2c9, t11) and C18 desaturation index.  
 The pairwise comparisons between the haplotype effects of SLC27A6 on milk fat 
percentage and fatty acid composition (table 3.7) revealed that the haplotype h6 of 
SLC27A6 was the most desirable to select for animals producing healthier milk because 
the haplotype h6 of SLC27A6 was associated with 0.098 lower AI, 1.004 wt % lower 
SFA, 1.004 wt % higher UFA, 0.91 wt % higher MUFA concentrations, 0.072 lower 
SFA/UFA, 0.17 wt % lower capric (10:0) acid, 0.19 wt % lower lauric (12:0) acid, and 
0.32 wt % lower myristic (14:0) acid concentrations compared with the effect of the 
haplotype h5 of SLC27A6. The effect of the haplotype h6 of SLC27A6 also was 
associated with 0.097 wt % lower capric (10:0) acid and 0.11 wt % lower lauric (12:0) 
acid concentrations compared with the effects of the haplotype h1 of SLC27A6. There 
was a tendency for the association of the haplotype h6 of SLC27A6 with 0.052 lower AI, 
0.63 wt % lower SFA, 0.63 wt % higher UFA, 0.54 wt % higher MUFA concentrations, 
and 0.044 lower SFA/UFA compared with the effects of the haplotype h1 of SLC27A6. 
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The haplotype h9 of SLC27A6 was undesirable to select for animals producing 
milk with higher fat percentage because the haplotype h9 of SLC27A6 was associated 
with 0.17 and 0.15 % lower milk fat compared with the effects of the haplotypes h5 and 
h10 of SLC27A6 (table 3.7). On the other hand, the haplotype h9 of SLC27A6 was 
desirable to select for animals producing milk with lower concentration of palmitic (16:0) 
acid because the haplotype h9 of SLC27A6 was associated with 0.50 and 0.63 wt % 
lower palmitic (16:0) acid concentrations compared with the effects of the haplotypes h1 
and h5 of SLC27A6.  
 Pairwise comparisons between the haplotype effects of FABP4 revealed that the 
haplotype h5 of FABP4 was the most desirable to select for animals producing milk with 
0.57 and 0.51 wt % lower SFA, 0.57 and 0.51 wt % higher UFA, 0.48 and 0.40 wt % 
higher MUFA, 0.11 and 0.12 wt % higher PUFA concentrations, 0.04 and 0.037 lower 
SFA/UFA, 0.067 and 0.080 wt % higher linoleic (18:2c9, c12) acid concentration, and 
0.0051 and 0.0053 higher elongation index compared with the effects of the haplotypes 
h1 and h4 of FABP4 (table 3.7). The haplotype h5 of FABP4 also was associated with 
0.035 wt % higher CLA (18:2c9, t11) concentration compared with the effects of the 
haplotype h1 of FABP4. The pairwise comparisons between the haplotypes of FABP3 
showed that the haplotype h1 of FABP3 was associated with 0.050 wt % higher 
concentration of pentadecylic (15:0) acid and 0.008 lower elongation index compared 
with the effect of the haplotype h2 of FABP3. 
 The allele substitution effect of DGAT1 A232K mutation was associated with 
milk fat percentage, AI, concentrations of SFA, UFA, MUFA, and PUFA, SFA/UFA, and 
concentrations of palmitic (16:0), stearic (18:0) and other fatty acids (table 3.8). The 
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significance was declared when p≤0.05. In particular, DGAT1 232K mutation was 
associated with 0.22 % higher milk fat, 0.10 higher AI, 1.05 wt % higher SFA, 1.05 wt % 
lower UFA, 0.88 wt % lower MUFA, 0.16 wt % lower PUFA concentrations, 0.086 
higher SFA/UFA, 0.070 wt % higher lauric (12:0), 0.066 wt % higher myristoleic (14:1c9), 
0.87 wt % higher palmitic (16:0), 0.23 wt % lower stearic (18:0), 0.037 wt % lower oleic 
(18:1c9), 0.038 wt % lower linoleic (18:2c9, c12), 0.042 wt % lower CLA  (18:2c9, t11), 0.041 
wt % higher caproic (6:0), 0.042 wt % higher caprylic (8:0), 0.086 wt % higher capric 
(10:0), 0.013 wt % higher tridecylic (13:0), 0.050 wt % higher pentadecylic (15:0) acid 
concentrations, 0.048 higher C14 desaturation index, and 0.015 lower elongation index 
compared with the effects of DGAT1 232A mutation. In addition, we tested FAS g. 
17924G>A polymorphism for the association with milk fatty acid composition and the 
significance was declared when p≤0.05. Thus, the FAS g. 17924A allele was associated 
with 0.11 wt % higher myristic (14:0) and 0.17 wt % higher palmitic (16:0) acid 
concentrations. 
 
Discussion 
Fatty acid transport proteins, membrane-associated fatty acid binding proteins, and fatty 
acid translocase CD36 participate in fatty acid transport across a cell membrane (10, 11). 
The SLC27A6 corresponds to the group of fatty acid transport proteins. One study looked 
at polymorphisms in SLC27A1 known to be expressed in bovine mammary gland with 
respect to milk fat yield (39), but no significant associations were determined. The 
polymorphisms in fatty acid translocase CD36 that is known to be expressed in both 
murine and bovine mammary glands (7, 41), however, showed some significant 
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associations with fatty acid concentrations. Thus, a few genome-wide association studies 
in humans linked CD36 to some components of metabolic syndrome because of the 
ability of CD36 to affect fatty acid uptake in different tissues (1, 19, 36). It was shown 
that the polymorphisms in CD36 gene were associated with decreased plasma TAG and 
increased plasma  HDL-C concentrations in African-Americans (34). In another human 
study, the plasma TAG lowering effect of fish oil was seen only in the individuals with 
certain polymorphisms in CD36 and the effect of those polymorphisms in the studied 
individuals was attributed to the increased uptake of fatty acids by extrahepatic tissues 
(35). Even though there is limited information about SLC27A6 polymorphisms and fatty 
acid uptake in different tissues, the fact that the polymorphisms in another fatty acid 
transporter CD36 were associated with fatty acid concentrations in human plasma lead us 
to believe in the potential role of SLC27A6 in fatty acid uptake in the mammary tissue.    
The role of FABP1, SLC27A1, and CD36 in the fatty acid uptake into the 
mammary gland of lactating rats was studied using dietary CLA (23). It was determined 
that dietary CLA fed to rats decreased the concentrations of medium-chain SFA and 
palmitic (16:0) acid in milk. The change in milk fatty acid concentrations was 
accompanied by the decrease in the mRNA abundance of FABP1, SLC27A1, and CD36 
in the mammary gland and by the increase in blood nonesterified fatty acid 
concentrations (23). The results of our study clearly indicate the importance of FABP1, 
SLC27A1, and CD36 in fatty acid uptake into mammary gland in rats and the fact that 
the uptake of medium-chain SFA and palmitic (16:0) acid was affected supports the 
results of our study that showed the association between the polymorphisms in SLC27A6 
and the concentrations of capric (10:0), lauric (12:0), myristic (14:0), and palmitic (16:0) 
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acids in milk of dairy cows. The pairwise comparisons between the effects of the 
haplotypes of SLC27A6 revealed that the haplotype h6 always was associated with 
healthier fatty acid composition in milk compared with the effects of the haplotypes h1 
and h5 of SLC27A6 (table 3.7). A “tag” SNP for the haplotype h6 of SLC27A6 was 
identified to be an intronic SNP385 located between exons 1 and 2. The allele C of 
SNP385 was present in the haplotype h6 of SLC27A6. In addition to being associated 
with unhealthy milk fatty acid composition, the haplotype h5 of SLC27A6 also was 
associated with 0.17 % higher milk fat compared with the effect of the haplotype h9 of 
SLC27A6. There were no significant associations between the haplotype h6 of SLC27A6 
and milk fat percentage, meaning that selection for animals with haplotype h6 of 
SLC27A6 will not select for lower percentage of milk fat.  
The FABP3 is one of the most abundant mRNA transcripts among FABPs in 
murine and bovine mammary glands (6, 7, 41). Moreover, the FABP3 expression was 
highly up-regulated during lactation in bovine mammary gland (6, 7). The deletion of 
FABP3 gene in mice, however, did not have any effect on mammary gland development 
or function (14), but the knockout mice had lower concentration of oleic (18:1c9) acid in 
milk compared with the wild type mice. We were able to identify an association between 
the overall haplotype effect of SLC27A6 and the concentration of only pentadecylic 
(15:0) acid and the elongation index. Even though the size of the haplotype effect of 
SLC27A6 on the associated traits was not large, the fact that we had a significant 
association for the elongation index and a tendency for the association with oleic (18:1c9) 
acid concentration (p=0.018, table 3.6) supports the correctness of our data.   
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 Since the discovery of FABP4 in mice (27) and the association of FABP4 genetic 
polymorphisms with the plasma TAG concentrations in humans (53), there have been 
numerous studies that looked at polymorphism in FABP4 gene with regard to different 
lipid associated traits in farm animals. In particular, the polymorphism in FABP4 was 
associated with backfat and intramuscular fat thickness in beef cattle (3, 12), 
intramuscular fat thickness in pigs (22), and the amount of abdominal fat in chickens (54). 
The study that reported the effect of FABP4 genetic polymorphisms on fatty acid 
composition was in beef cattle with the association for palmitoleic (16:1c9) acid 
concentration in adipose tissue (26). The only milk fatty acids that were associated with 
the FABP4 genetic polymorphisms in our study were linoleic (18:2c9, c12) acid and CLA 
(18:2c9, t11). The concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, and C18 
desaturation index were associated with the FABP4 polymorphisms because of the 
association of linoleic (18:2c9, c12) acid and CLA (18:2c9, t11). The pairwise comparisons 
between the haplotype effects of FABP4 revealed that the haplotype h5 of FABP4 always 
was associated with healthier fatty acid composition of milk compared with the effects of 
the haplotypes h1 and h4 of FABP4. After comparing the haplotype sequences of FABP4, 
a “tag” SNP for the haplotype h5 of FABP4 was identified as a nonsynonymous SNP335 
located in exon 3 that leads to the amino acid change from valine to methionine at residue 
112 of FABP4 protein (tables 3.4 and 3.5). The A allele of SNP335 was present in the 
haplotype h5 of FABP4. In addition, three “tag” SNPs were identified for the haplotype 
h1 of FABP4 that was associated with unhealthy fatty acid composition in milk compared 
with the effects of the haplotype h5 of FABP4 (table 3.7). Those SNPs were SNP338 and 
SNP337 located in the intron between exons 3 and 4, and a synonymous SNP336 located 
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in exon 3. The C allele of SNP338, SNP337, and SNP336 was present in the haplotype 
h1 of FABP4. 
A numerical comparison of the size of haplotype effects of SLC27A6, FABP3, 
and FABP4 and the size of allelic effects of DGAT1 A232K, and FAS g. 17924A>G on 
milk fat percentage and fatty acid composition was performed to determine which genetic 
polymorphisms had the largest effect (table 3.9). The size of the largest haplotype effect 
of SLC27A6 on milk fat percentage, AI, the concentrations of SFA and UFA, and 
SFA/UFA were numerically very similar to the size of the allelic effects of DGAT1 
A232K mutation on those traits. Moreover, the size of the largest haplotype effects of 
LSC27A6 on the concentrations of capric (10:0) and lauric (12:0) acids were numerically 
much larger than the size of the allelic effects of DGAT1 A232K mutation on the same 
traits. At the same time, the size of the allelic effect of DGAT1 A232K on the 
concentration of palmitic (16:0) acid was numerically larger than the size of the 
haplotype effects of LSC27A6 on the concentration of the same fatty acid. The size of the 
haplotype effects of FABP4 on the concentrations of SFA, UFA, MUFA, and PUFA, 
SFA/UFA, and the concentration of linoleic (18:2c9, c12) acid numerically was about one 
half of the size of allelic effects of DGAT1 A232K mutation on the same traits. 
Nevertheless, the genetic polymorphisms of FABP4 are still very valuable to select for 
animals producing milk with healthier fatty acid composition.     
 
Conclusions 
The results of our study show that the haplotype effects of SLC27A6 were associated 
significantly with milk fat percentage, AI, the concentrations of SFA, UFA, and MUFA, 
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SFA/UFA, and the concentrations of capric (10:0), lauric (12:0), myristic (14:0), and 
palmitic (16:0) acids. The haplotypes h5 and h6 of SLC27A6 that were the most desirable 
to select for animals producing milk with higher fat percentage and healthier fatty acid 
composition, respectively, did not have any significant associations with studied traits, 
indicating the possibility of selecting for the healthfulness of milk without affecting milk 
fat percentage.   
 The size of the haplotype effects of SLC27A6 on the studied traits was large and 
numerically similar to the size of allelic effects of DGAT1 A232K mutation that makes 
the polymorphisms in SLC27A6 as valuable as the of DGAT1 A232K mutation to select 
for animals producing milk with higher fat percentage and healthier fatty acid 
composition. The haplotype effects of FABP4 were associated significantly with the 
concentrations of SFA, UFA, MUFA, and PUFA, SFA/UFA, and the concentrations of 
linoleic (18:2c9, c12) acid, CLA (18:2c9, t11), and C18 desaturation index. A numerical 
comparison of the size of the haplotype effects of FABP4 with the size of the allelic 
effects of DGAT1 A232K mutation on milk fatty acid composition showed that the 
effects for FABP4 were not as large as those for DGAT1 A232K. The polymorphisms in 
FABP4, however, are still very valuable to select for milk healthfulness.  
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Table 3.1 Gene information 
Gene BTA Chromosomal position, cM 
Gene 
length, bp 
Transcript 
length, bp 
Protein 
length, aa 
Number 
of exons 
Strand 
direction 
SLC27A6 7 79996 24 2297 635 10 Reverse 
FABP3 2 7648 101 724 133 4 Forward 
FABP4 14 4390 42 631 134 4 Reverse 
BTA, Bos taurus autosome; FABP3 and FABP4, fatty acid binding proteins-3 and -4; SLC27A6, solute carrier 
family 27, isoform A6 
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Table 3.2 Primer sequences and annealing temperatures for PCR 
Gene SNP Forward primer Reverse primer PCR type1 Tm, °C
SLC27A6 391 GCATTTCTCATAGGGCTTGC TACAGAGCCTCCCTCAGAGC “Hot start” 60 
SLC27A6 390 TCCTACCAGTGGATGTTACTGC CCAAGTCTGTCTCGCTTTCC Regular 55 
SLC27A6 385, 386, 387 CCAATGTGAAAAGGAAGTTGG GAAGTGGATCTGAGGCTTGG Regular 55 
SLC27A6 383, 384 CCAGCATTCTTTGGAGCAAC ATACTCTACCTGCACCCACCAC Regular 56 
FABP3 332 GCTGACGTAGGCAAACTGG CCCAACCTTGACCAGGAG “Hot start” 58 
FABP3 334 CAGCTCATGCTCATACCCTTC GCTGGAGCTGGTGTAGACG “Hot start” 60 
FABP4 335, 336, 337, 338 AATTGCTAAGAACCTCAAAATAAGC TATTGTCTCCTTCAATGTTGAGC “Hot start” 60 
DGAT1 A232K TGGGCTCCGTGCTGGCCCTGATGGTCTA TTGAGCTCGTAGCACAGGGTGGGGGCGA "Hot start" 63 
1“Hot start” PCR is a procedure that decreases non specific DNA amplification during the initial PCR cycles. 
FABP3 and FABP4, fatty acid binding proteins-3 and -4; SLC27A6, solute carrier family 27, isoform A6 
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Table 3.3 Summary of milk fatty acid composition1, 2 
Trait Mean Standard deviation 5% Quantile 95% Quantile 
Milk production, kg/d 40.24 10.02 24.52 57.43 
Milk fat, % 3.65 0.70 2.50 4.80 
AI 2.07 0.46 1.27 2.80 
SFA, wt % 63.93 4.47 55.57 70.29 
UFA, wt % 36.07 4.47 29.71 44.43 
MUFA, wt % 31.26 4.04 25.66 38.91 
PUFA, wt % 4.81 0.92 3.46 6.42 
SFA/UFA 1.81 0.34 1.25 2.37 
4:0, wt % 2.47 0.76 1.29 3.80 
6:0, wt % 1.55 0.35 0.90 2.05 
8:0, wt % 1.00 0.23 0.57 1.35 
10:0, wt % 2.47 0.63 1.35 3.47 
12:0, wt % 2.94 0.73 1.61 4.10 
13:0, wt % 0.18 0.08 0.07 0.33 
14:0, wt % 10.15 1.60 6.80 12.26 
14:1c9, wt % 0.79 0.30 0.39 1.34 
15:0, wt % 1.08 0.28 0.71 1.63 
16:0, wt % 29.33 2.83 24.91 34.14 
16:1c9, wt % 1.75 0.41 1.16 2.47 
17:0, wt % 0.63 0.09 0.50 0.77 
18:0, wt % 11.92 2.37 8.44 16.14 
18:2c9, c12, wt % 3.24 0.70 2.23 4.47 
18:1c9, wt % 23.55 3.45 18.83 30.05 
18:2c9,t11 (CLA), wt % 0.70 0.24 0.43 1.19 
C14 Index3 0.07 0.02 0.04 0.11 
C16 Index4 0.06 0.01 0.04 0.08 
C18 Index5 0.66 0.05 0.59 0.74 
Elongation index6 0.53 0.05 0.46 0.62 
1Summary statistics were computed from 4397 milk samples collected from 551 cows. 
2The data presented here are for only 16 fatty acids out of 39 fatty acids analyzed because the concentrations of 
the rest of fatty acids in milk were low. 
3C14 Desaturation index = 14:1/ (14:0 + 14:1) 
4C16 Desaturation index = 16:1/ (16:0 + 16:1) 
5C18 Desaturation index = 18:1/ (18:0 + 18:1) 
6Elongation index = (18:0 + 18:1)/ (16:0 + 16:1 + 18:0 + 18:1) 
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Table 3.4 SNPs used for the reconstruction of haplotypes in SLC27A6, FABP3, and 
FABP4 genes 
SNP Gene 
Order in 
haplotype 
sequence 
Nucleotide 
position, 
bp 
Gene area Alleles Mutation type 
A.A. 
Residue 
change 
391 SLC27A6 1 70916 Intron 6-7 T/G Intronic None 
390 SLC27A6 2 67847 Intron 6-7 T/C Intronic None 
387 SLC27A6 3 16048 Intron 2-3 G/C Intronic None 
386 SLC27A6 4 15975 Exon 2 T/C Synonymous None 
385 SLC27A6 5 15740 Intron 1-2 A/C Intronic None 
384 SLC27A6 6 390 Exon 1 C/T Synonymous None 
383 SLC27A6 7 242 Exon 1 A/T Nonsynonymous K81M 
332 FABP3 1 80 Exon 1 T/C Synonymous None 
334 FABP3 2 3876 Intron 2-3 G/T Intronic None 
338 FABP4 1 3767 Intron 3-4 T/C Intronic None 
337 FABP4 2 3745 Intron 3-4 T/C Intronic None 
336 FABP4 3 3711 Exon 3 G/C Synonymous None 
335 FABP4 4 3691 Exon 3 G/A Nonsynonymous V112M 
FABP3 and FABP4, fatty acid binding proteins-3 and -4; SLC27A6, solute carrier family 27, isoform A6 
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Table 3.5 Intragenic haplotypes and their frequencies   
Gene Haplotype Sequence1, 2 Frequency3 
SLC27A6 h1 G1C2C3C4A5C6A7 0.44 
SLC27A6 h5 G1C2G3T4A5C6T7 0.14 
SLC27A6 h6 G1C2G3T4C5C6T7 0.11 
SLC27A6 h9 T1T2C3C4A5C6A7 0.07 
SLC27A6 h10 T1T2G3T4A5C6A7 0.18 
FABP3 h1 T1G2 0.74 
FABP3 h2 T1T2 0.07 
FABP3 h3 C1G2 0.20 
FABP4 h1 C1C2C3G4 0.50 
FABP4 h4 T1T2G3G4 0.27 
FABP4 h5 T1T2G3A4 0.24 
1Subsripts indicate the order of SNPs in a particular haplotype for a particular gene  
2The “tag” SNPs in the haplotypes of interest are highlighted in bold and underlined 
3Only haplotypes with the population frequencies ≥ 5% were considered in the analysis 
FABP3 and FABP4, fatty acid binding proteins-3 and -4; SLC27A6, solute carrier family 27, isoform A6 
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Table 3.6 Results of F-tests for the overall haplotype effect on milk fatty acid 
composition 
SLC27A6 FABP3 FABP4  
Trait 
 F-value p-value F-value p-value F-value p-value 
Milk fat 3.29 0.0059* 0.04 0.96 2.16 0.12 
AI 3.38 0.005* 2.20 0.11 3.34 0.036 
SFA 3.21 0.0071* 1.71 0.18 5.36 0.0048* 
UFA 3.21 0.0071* 1.71 0.18 5.36 0.0048* 
MUFA 2.96 0.012* 1.87 0.15 4.39 0.013* 
PUFA 2.49 0.03 0.33 0.72 6.35 0.0018* 
SFA/UFA 3.13 0.0082* 2.38 0.093 4.80 0.0084* 
4:0 1.07 0.37 1.94 0.14 0.51 0.60 
6:0 1.77 0.12 1.83 0.16 3.83 0.022 
8:0 2.42 0.034 0.59 0.55 4.06 0.018 
10:0 3.26 0.0063* 0.70 0.50 3.20 0.041 
12:0 3.37 0.0051* 0.73 0.48 2.50 0.082 
13:0 0.99 0.42 3.57 0.029 0.51 0.60 
14:0 2.81 0.016* 0.70 0.50 1.71 0.18 
14:1c9 0.95 0.45 0.01 0.99 1.58 0.21 
15:0 1.48 0.19 5.91 0.0028* 0.68 0.51 
16:0 2.88 0.014* 2.96 0.052 0.42 0.66 
16:1c9 0.96 0.44 0.92 0.40 1.66 0.19 
17:0 1.31 0.26 2.36 0.095 1.64 0.20 
18:0 0.59 0.71 2.48 0.085 1.34 0.26 
18:1c9 1.77 0.12 4.03 0.018 1.31 0.27 
18:2c9, c12 2.31 0.042 1.13 0.32 5.20 0.0057* 
18:2c9, t11 (CLA) 0.83 0.53 0.52 0.60 4.91 0.0076* 
Index 14 1.23 0.29 0.00 1.00 2.46 0.086 
Index 16 1.3 0.26 0.67 0.51 2.98 0.051 
Index 18 0.84 0.52 2.15 0.12 4.15 0.016* 
Elongation index 1.81 0.11 5.09 0.0063* 0.13 0.88 
*The Bonferroni adjustment was used to account for multiple testing on four different genes. The significance 
of haplotype effects was declared if p≤0.0167 (0.05 divided by the number of genes that was 3) 
FABP3 and FABP4, fatty acid binding proteins-3 and -4; SLC27A6, solute carrier family 27, isoform A6 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 4084 and 512; 4192 and 526; and 4133 and 518 for SLC27A6, FABP3, and FABP4, 
respectively.
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Table 3.7 Pairwise comparisons of SLC27A6, FABP3, and FABP4 haplotype effects on 
milk fatty acid composition 
SLC27A6 
H-Hb AI SFA UFA MUFA SFA/UFA 10:0 12:0 14:0 
H1-H6 0.052 0.63 -0.63 -0.54 0.044 0.097 0.11  
 (0.022) (0.23) (0.23) (0.21) (0.017) (0.034) (0.038) NS 
 0.017‡ 0.0058‡ 0.0058‡ 0.01‡ 0.01‡ 0.0042 0.0048  
H5-H6 0.098 1.004 -1.004 -0.91 0.072 0.17 0.19 0.32 
 (0.026) (0.28) (0.28) (0.25) (0.021) (0.041) (0.046) (0.091) 
 0.0002 0.0003 0.0003 0.0003 0.0006 <.0001 <.0001 0.0004 
SLC27A6 FABP3 
H-Hb Milk fat 16:0 H-Hb 15:0 Elongation index 
H1-H9  0.50 H2-H1 -0.050 0.008 
 NS (0.18)  (0.016) (0.003) 
  0.0047  0.0027 0.0051 
H5-H9 0.17 0.63    
 (0.051) (0.19)    
 0.001 0.0009    
H10-H9 0.15     
 (0.049) NS    
 0.0021     
FABP4 
H-Hb SFA UFA MUFA PUFA SFA/UFA 18:2c9, c12 
18:2c9, t11 
(CLA) 
C18 
Index 
H1-H5 0.57 -0.57 -0.48 -0.11 0.04 -0.067 -0.035 -0.0051 
 (0.18) (0.18) (0.16) (0.034) (0.014) (0.025) (0.012) (0.002) 
 0.0018 0.0018 0.0039 0.0022 0.0034 0.0068 0.0022 0.0088 
H4-H5 0.51 -0.51 -0.40 -0.12 0.037 -0.080  -0.0053 
 (0.20) (0.20) (0.18) (0.038) (0.015) (0.027) NS (0.0021) 
 0.0101 0.0101 0.029‡ 0.0012 0.013 0.0029  0.013 
1The first number out of three numbers in a cell is an estimate of the haplotype substitution effect expressed in 
wt % for all individual fatty acids and fatty acid groups excluding indices. The second number in the 
parenthesis is a standard error of an estimate of the haplotype substitution effect expressed in the same units as 
the estimate. The third number is a p-value.  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value were 
≤ 0.005, 0.0167, and 0.0167 for SLC27A6, FABP3, and FABP4, respectively (0.05 divided by the number of 
comparisons that were 10, 3, and 3 for SLC27A6, FABP3, and FABP4, respectively). 
‡Tended to be significant (p-value ≤ 0.05). 
H-Hb, indicates a pair of haplotypes for which the haplotype effects on milk fatty acid composition were 
compared with Hb, indicating the position of a haplotype used as a baseline.  
FABP3 and FABP4, fatty acid binding proteins-3 and -4; NS, not significant; SLC27A6, solute carrier family 
27, isoform A6 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 4084 and 512; 4192 and 526; and 4133 and 518 for SLC27A6, FABP3, and FABP4, 
respectively. 
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Table 3.8 Allele substitution effects of DGAT1 A2232K and FAS g. 17924G>A 
polymorphisms on milk fatty acid composition 
DGAT1 (A232K) FAS (g. 17924G>A) 
Trait 
Estimate Standard error p-value Estimate 
Standard 
error p-value 
Milk fat, % 0.22 0.030 <.0001 0.0080 0.023 0.72 
AI 0.10 0.019 <.0001 0.008 0.014 0.58 
SFA, wt % 1.05 0.20 <.0001 -0.099 0.14 0.50 
UFA, wt % -1.05 0.20 <.0001 0.099 0.14 0.50 
MUFA, wt % -0.88 0.19 <.0001 0.11 0.13 0.41 
PUFA, wt % -0.16 0.037 <.0001 -0.011 0.028 0.70 
SFA/ UFA 0.086 0.015 <.0001 -0.004 0.011 0.69 
4:0, wt % 0.0046 0.025 0.86 -0.024 0.020 0.22 
6:0, wt % 0.060 0.015 0.0001 -0.015 0.011 0.17 
8:0, wt % 0.042 0.011 <.0001 -0.009 0.008 0.25 
10:0, wt % 0.086 0.030 0.0042 -0.013 0.022 0.57 
12:0, wt % 0.070 0.033 0.035 -0.003 0.024 0.90 
13:0, wt % 0.013 0.003 <.0001 0.000 0.002 0.85 
14:0, wt % 0.11 0.061 0.081 0.11 0.047 0.018 
14:1c9, wt % 0.042 0.015 0.0037 0.0012 0.0098 0.90 
15:0, wt % 0.056 0.012 <.0001 -0.0042 0.0086 0.63 
16:0, wt % 0.87 0.11 <.0001 -0.17 0.085 0.042 
16:1c9, wt % 0.087 0.022 <.0001 -0.0038 0.016 0.81 
17:0, wt % -0.0035 0.0032 0.27 0.0016 0.0023 0.49 
18:0, wt % -0.23 0.11 0.032 0.040 0.078 0.61 
18:1c9, wt % -0.88 0.14 <.0001 0.036 0.10 0.73 
18:2c9, c12, wt % -0.12 0.026 <.0001 -0.0077 0.020 0.70 
18:2c9, t11 (CLA), wt % -0.028 0.013 0.028 0.0061 0.0093 0.51 
C14 Index 0.0030 0.0013 0.016 -0.00022 0.00083 0.79 
C16 Index 0.00099 0.00068 0.14 0.00024 0.00049 0.63 
C18 Index -0.004 0.002 0.062 0.000 0.002 0.83 
Elongation index -0.015 0.002 <.0001 0.002 0.001 0.23 
DGAT1, diacylglycerol acyltransferase-1; FAS, fatty acid synthase 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 2587 and 325; and 4003 and 500 for DGAT1 and FAS, respectively. 
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Table 3.9 Summary of the largest effects of polymorphisms in SLC27A6, FABP3, 
FABP4, and DGAT1 genes on milk fat percentage and milk fatty acid composition 
Gene Trait 
SLC27A6 FABP3 FABP4 DGAT1 FAS 
Milk fat, % 0.17 NS NS 0.22 NS 
AI 0.098 NS NS 0.10 NS 
SFA, wt % 1.004 NS 0.57 1.05 NS 
UFA, wt % 1.004 NS 0.57 1.05 NS 
MUFA, wt % 0.91 NS 0.48 0.88 NS 
PUFA, wt % NS NS 0.12 0.16 NS 
SFA/ UFA 0.072 NS 0.04 0.086 NS 
4:0, wt % NS NS NS NS NS 
6:0, wt % NS NS NS 0.060 NS 
8:0, wt % NS NS NS 0.042 NS 
10:0, wt % 0.17 NS NS 0.086 NS 
12:0, wt % 0.19 NS NS 0.070 NS 
13:0, wt % NS NS NS 0.013 NS 
14:0, wt % 0.32 NS NS NS 0.11 
14:1c9, wt % NS NS NS 0.042 NS 
15:0, wt % NS 0.050 NS 0.056 NS 
16:0, wt % 0.63 NS NS 0.87 0.17 
16:1c9, wt % NS NS NS 0.087 NS 
17:0, wt % NS NS NS NS NS 
18:0, wt % NS NS NS 0.23 NS 
18:1c9, wt % NS NS NS 0.88 NS 
18:2c9, c12, wt % NS NS 0.080 0.12 NS 
18:2c9, t11 (CLA), wt % NS NS 0.035 0.028 NS 
C14 Index NS NS NS 0.0030 NS 
C16 Index NS NS NS NS NS 
C18 Index NS NS 0.0053 NS NS 
Elongation index NS 0.008 NS 0.015 NS 
FABP3 and FABP4, fatty acid binding proteins-3 and -4; FAS, fatty acid synthase; DGAT1, diacylglycerol 
acyltransferase-1; SLC27A6, solute carrier family 27, isoform A6 
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Abstract 
Dietary saturated fatty acids (SFA) are known to increase plasma cholesterol 
concentrations in humans leading to the higher risk of developing cardiovascular diseases. 
In particular, individual SFA such as palmitic (16:0), myristic (14:0), and lauric (12:0) 
acids can raise plasma cholesterol concentrations much higher compared with the other 
SFA and their presence in milk at high concentrations is undesirable. The main objective 
of our study was to develop genetic markers that can be used to improve the healthfulness 
of bovine milk, that is known to contain high concentrations of SFA and palmitic (16:0) 
and myristic (14:0) acids. The sterol regulatory element binding protein-1c (SREBP-1c) 
is involved in the transcriptional regulation of lipogenesis, and its proteolytic activation is 
controlled by SREBP cleavage-activating protein (SCAP) and insulin-induced genes 
(Insig) that are all part of the SREBP pathway. We sequenced genes from the SREBP 
pathway to discover single nucleotide polymorphisms (SNPs) and reconstructed 
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haplotypes within each gene after genotyping cows for the discovered SNPs. The results 
of our study showed significant association of the overall haplotype effect of SREBP1 
with the concentrations of myristic (14:0) and myristoleic (14:1c9) acids, and C14 
desaturation index. The overall haplotype effect of Insig1 was associated with the 
concentrations of polyunsaturated fatty acids (PUFA) and linoleic (18:2c9, c12) acid. We 
did not detect any significant associations of SCAP genetic polymorphisms with milk 
fatty acid composition. In conclusion, the information about genetic polymorphisms in 
SREBP1 and Insig1 can be used to select animals producing milk with healthier fatty acid 
composition.  
 
Introduction 
Dietary saturated fatty acids (SFA) are known to raise plasma total cholesterol and low-
density lipoprotein cholesterol concentrations in humans leading to the increased risk of 
developing cardiovascular diseases [1, 2]. Not all SFA, however, have the same effect on 
plasma cholesterol concentrations. Palmitic (16:0) and myristic (14:0) acids, for example, 
can raise plasma cholesterol concentrations much higher compared with the other SFA, 
and because of that their presence at high concentrations in human diets is undesirable [1]. 
The monounsaturated fatty acids (MUFA), however, are considered neutral with regard 
to plasma cholesterol concentrations, and their presence in human diets can be increased 
at the expense of SFA [1, 3, 4]. In recent years, a number of studies researched the 
possibilities of decreasing the concentration of atherogenic fatty acids in bovine milk by 
dietary and genetic means to improve the healthfulness of milk [5-10]. The genetic 
approach, however, is more plausible than the dietary approach because the conversion of 
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dietary unsaturated fatty acids (UFA) into milk UFA in ruminants is hampered by 
ruminal biohydrogenation [11]. The advantage of genetic improvement of milk 
healthfulness also is supported by the moderate to high heritabilities of milk fatty acids [7, 
12-15]. To provide tools for the selection of animals with healthier milk fatty acid 
composition, we designed a study to discover genetic polymorphisms associated with 
milk fatty acid composition. The sterol regulatory element binding protein-1c (SREBP-
1c) known to activate the expression of lipogenic genes such as acetyl-CoA carboxylase, 
fatty acid synthase, long chain fatty acid elongase, and stearoyl-CoA desaturase [16], and 
other genes from the SREBP pathway involved in the SREBP-1c activation were the 
focus of our study. 
The SREBPs (SREBP-1a, SREBP-1c, and SREBP-2) are encoded by two 
different genes (SREBP1 and SREBP2), with SREBP-1a and SREBP-1c being produced 
from SREBP1 gene by alternative transcription [16]. The pathway of proteolytic 
activation of SREBPs was elucidated by studying SREBP-2 activation. It was established 
that in sterol-depleted cells SREBP cleavage activating protein (SCAP) transports 
SREBPs in the coat protein complex II (COPII)-coated vesicles from ER to Golgi, where 
N-terminal domain of SREBPs is released into the cytosol after a sequence of proteolytic 
cleavages catalyzed by site-1 and site-2 proteases [17, 18]. The cleaved SREBPs then 
enter the nucleus where they activate the transcription of genes from the fatty acid and 
cholesterol biosynthetic pathways. When ER cholesterol concentration rises above 5%, 
SCAP binds cholesterol and undergoes a conformational change that prevents SCAP-
SREBP transport in COPII-coated vesicles to Golgi. As a result, N-terminal domain of 
SREBPs cannot be released and no transcriptional activation of sterol regulatory element 
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containing genes can occur. Another protein known as insulin-induced gene (Insig) was 
found to reside in ER membrane and to bind to SCAP in the presence of oxysterols 
leading to the inhibition of SCAP-SREBP transport to Golgi even in the sterol-depleted 
cells [17, 18]. There are two known genes (Insig-1 and Insig-2) that code for three 
different forms of Insig proteins (Insig-1, Insig-2a, and Insig-2b). In the presence of 
oxysterols, Insig-1 prevents SCAP-SREBP transport to Golgi. The Insig-1 also is 
transcriptionally activated by SREBPs, thus providing a feed-back mechanism by which 
nuclear SREBPs trigger buildup of their own inhibitor. 
In contrast to SREBP-1a and SREBP-2, expression and nuclear abundance of 
SREBP-1c does not depend on cellular cholesterol concentration [19]. Moreover, 
overexpression of the nuclear form of SREBP-1c protein in the liver of transgenic mice 
caused TAG accumulation without any change in cholesterol concentration [20]. The 
activity of SREBP-1c is controlled by transcriptional regulation of its gene expression 
and by the proteolytic cleavage of SREBP-1c protein in Golgi. Transcriptional regulation 
of SREBP-1c is accomplished by liver X-activated receptors (LXRs), insulin, and 
glucagon [16]. The main role of LXRs is to activate oleate (18:1) production for the 
synthesis of cholesteryl esters. This increased oleate synthesis could be potentially 
achieved by up-regulating fatty acid elongase and the stearoyl-CoA desaturase activities 
as observed in transgenic mice overexpressing the nuclear form of SREBP-1a in their 
livers [21, 22]. LXRs are also a part of regulatory mechanism by which UFA can 
suppress fatty acid biosynthesis [16]. Insulin up-regulates SREBP-1c expression, leading 
to an increase in the rates of fatty acid biosynthesis as was demonstrated in rodents using 
cultures of isolated hepatocytes and adipocytes [23] whereas glucagon opposes the action 
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of insulin on lipogenesis by raising intracellular cAMP concentration [16]. It was shown 
that in liver insulin can increase SREBP-1c proteolytic activation by decreasing the 
mRNA abundance of Insig-2a protein that otherwise would be able to block SCAP-
SREBP-1c transport from ER to Golgi and subsequently inhibit SREBP-1c activation 
[24]. Insulin did not change the transcription of Insig-1. 
 Mutations in the sterol-sensing domain of SCAP prevented sterol-induced binding 
of SCAP to Insig proteins and abolished feedback regulation of the SREBP processing by 
sterols in Chinese hamster ovary cell lines [25]. Considering this fact, the expression of 
genes of the SREBP pathway in bovine mammary gland [26], the importance of SREBP-
1c activation for the induction of lipogenesis, and the necessity of interaction among 
SREBP-1c, SCAP, and Insig proteins for SREBP-1c proteolytic activation, we 
hypothesized that polymorphisms in SREBP-1, SCAP, and Insig-1 genes can be 
associated with differences in milk fatty acid composition in dairy cattle. The SREBP-1, 
Insig-1, and SCAP genes were sequenced to identify single nucleotide polymorphisms 
(SNPs). After genotyping animals for the discovered SNPs, the intragenic haplotypes 
were reconstructed and the associations between the haplotypes and milk fatty acid 
composition were tested for each gene separately. The results of the association tests are 
presented in this paper. 
 
Materials and methods 
Milk fatty acid analysis 
Milk samples were collected during morning milking once a month throughout a 305-d 
lactation period and stored at -20 °C until further analysis. The extraction of milk fatty 
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acids with subsequent esterification into methyl esters for the analysis by gas 
chromatography (GC) was performed according to the procedure published by Chouinard 
et al. [27] with minor modifications. The procedure is based on the original milk lipid 
extraction method with hexane and isopropanol developed by Hara and Radin [28] and 
fatty acid methyl ester production method developed by Christie [29]. After thawing, 
milk samples were vortexed for 10 s and 25 mL aliquots were transferred to 50 mL teflon 
centrifuge tubes pre-rinsed with chloroform/ methanol (2/1 vol.vol). Following the 
centrifugation at 17,800 × g for 30 min at 4 °C, the liquid phase of the milk samples was 
removed and 18 mL of hexane/isopropanol (3/2 vol/vol) were added for every gram of 
lipids with subsequent vortexing for 1 min. To achieve a better separation of hexane 
phase containing lipids from water phase containing proteins, 12 mL of 6.7 % sodium 
sulfate (Na2SO4) solution were added for every gram of lipids and samples were vortexed 
for 1 min. After the centrifugation at 2,500 × g for 5 min at 4 °C, the hexane fraction 
containing lipids was removed into a scintillation vial pre-rinsed with chloroform/ 
methanol (2/1 vol/vol) and an aliquot containing 40 mg of lipids (400 μL) was transferred 
into an esterification vial. After the evaporation of hexane under nitrogen gas, 2 mL of 
hexane were added to the esterification vial followed by 40 μL of methyl acetate and 
vortexing for 30 s. The methylation step was initiated by the addition of 40 μL of sodium 
methoxide (0.4 mL of 5.4 M sodium methoxide in 1.75 mL of methanol) solution. The 
mixture was vortexed for 30 s and allowed to react for 10 min at room temperature. The 
reaction was terminated by the addition of 60 μL of oxalic acid (1 gram of oxalic acid/30 
mL of diethyl ether) solution. The samples were centrifuged at 2,400 × g for 5 min at 
4 °C and a clear hexane fraction that contained fatty acid methyl esters was placed into 
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GC vials, purged with nitrogen gas for 3 s, capped, and used for chromatographic 
analysis. In the above steps, capping of the vials that contained hexane lipid extract was 
preceded by purging with nitrogen gas for 3 s.    
A Varian 3900 gas chromatograph (Varian Analytical Instruments, Walnut Creek, 
CA) equipped with CP-8400 auto-sampler, CP-8410 auto-injector, CP-1177 split/splitless 
injector, and flame ionization (FID) detector was used to analyze fatty acid methyl esters 
with helium as a carrier gas. One μL of fatty acid methyl esters in hexane was injected 
(split ratio 50:1) into a fused silica capillary column (SupelcoTM-2560 Capillary Column, 
100 m x 0.25 mm i.d., with 0.2 μm film thickness) with the initial column temperature set 
at 70 °C and held for 4 min. Then, the column temperature was increased to 175 °C at the 
rate of 13 °C/min and held for 27 min with subsequent increase to 215 °C at the rate of 
4 °C/min where it was held for 28 min [30]. The injector and detector temperatures were 
set constant at 220 °C. Peak area was measured by integration using Star 
Chromatography Workstation Version 6, and peaks were identified by comparing the 
retention times with separately run fatty acid methyl ester standards (Matreya LLC, 
Pleasant Gap, PA).  
 
DNA extraction 
Genomic DNA was extracted from 20 mL of blood obtained from the coccygeal vein of 
every dairy cow. The blood was collected into 10 mL EDTA Vacutainer tubes and kept at 
4 °C. After transferring 20 mL of blood into 50 mL centrifuge tubes, the ice-cold 1X red 
blood cell (RBC) lysis buffer was added to fill in the tubes that were inverted and 
incubated on ice for 30 min. The samples were centrifuged at 300 × g for 5 min at 4 °C. 
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Supernatant was aspirated and 20 mL of ice-cold 1X RBC lysis buffer were added again 
followed by a light vortexing and 30 min and incubation on ice. After centrifugation and 
aspiration steps performed as mentioned earlier, 20 mL of room temperature PBS buffer 
were added to wash the pellet and the centrifugation step was repeated again. Supernatant 
was discarded and pellet was resuspended in PBS, transferred to cryovial, and store at -
70 °C until further analysis. The DNA purification from the white blood cells was 
performed with DNeasy® Blood and Tissue Kit (Qiagen Inc., Valencia, CA) according to 
the instructions. The DNA concentration was measured using NanoDrop® ND1000 and 
dilutions were made with DNase free water to desired concentration.  
 
SNP discovery and genotyping 
The SREBP1, Insig1, and SCAP (table 4.1), were sequenced in exonic and some intronic 
regions to discover SNPs. A set of 12 DNA samples from cows that were daughters of 12 
different sires was used for the SNP discovery. The PCR primers were designed with 
Primer3 (version 0.4.0) software [31]. Conventional or “Hot-Start” PCR was performed 
to amplify the DNA regions of interest. For the regular PCR, the reaction mixture 
contained 50 ng of genomic DNA, 13.6 μL of DNA grade water, 2 μL of DMSO, 1.5 μL 
of MgCl2 (25 mM), 0.1 μL of forward and reverse primers (100 ng/μL), 0.5 μL of dNTP 
mix (40 mM), 5 μL of 5X buffer, and 0.2 μL of Tag DNA polymerase (5 U/μL) with the 
total volume of the reaction mixture equal to 25 μL. For the HotStarTag® PCR, the 
reaction mixture was almost the same as for the regular PCR with the only difference that 
5 μL of 10X buffer was used instead of 5X buffer and 0.2 μL of HotStarTag DNA 
polymerase (5 U/μL) was used instead of Tag DNA polymerase. The PCRs were 
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performed in a DNA Engine thermal cycler (Bio-Rad) with the separate temperature 
cycle programs for the regular and HotStarTag® PCRs. The regular PCR was performed 
with the following program: 94 °C for 2 min followed by 35 cycles of 94 °C for 15 s, an 
optimal annealing temperature for a particular primer set (table 4.1 ) for 30 s, and 72 °C 
for 30 s with a final extension step at 72 °C for 10 min. The HotStarTag® PCR was 
performed with the following program: 95 °C for 15 min followed by 30 cycles of 94 °C 
for 1 min, an optimal annealing temperature for a particular primer set (table 4.2) for 1 
min, and 72 °C for 1 min with a final extension step at 72 °C for 10 min. The optimal 
annealing temperature for a particular primer set was determined by a PCR temperature 
gradient. Before sequencing, the PCR product was cleaned up from unused primers and 
dNTPs with ExoSAP-IT® (USB Corporation, Cleveland, OH) that contained exonuclease 
1 and shrimp alkaline phosphatase [32]. To identify SNPs, reverse and forward sequences 
representing 12 different samples were aligned using Vector NTI AdvanceTM 10. 
Genotyping of discovered SNPs was performed with Sequenom MassARRAY platform 
using 10 ng of genomic DNA dissolved in DNase-free water [33]. Haplotypes and their 
frequencies were estimated by using PHASE (version 2.1) program [34, 35]. Only 
samples with probability ≥0.9 for the best haplotype pair were used in the analysis.   
 
Statistical analysis 
A linear mixed model for longitudinal data was used to analyze the data with PROC 
MIXED procedure of SAS 9.1 (2002). The haplotype substitution model [36] used to test 
the association between intragenic haplotypes and milk fatty acid composition was the 
following: 
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Y = µ + dim + dim2 + dim3 + cg + dim*cg + dim2*cg + dim3*cg + ∑bk Hk + sire + ε    
where y is the response variable; µ is the mean response at 0 dim for a cow with no 
copies of the haplotypes; dim, dim2, and dim3 are covariates describing the effects of days 
in milk on milk fatty acid composition; cg is a fixed effect of the contemporary group 
(cg=8 classes); Hk is a haplotype effect fitted as a covariate and coded as 0, 1, or 2 for 0, 
1, or 2 copies of each haplotype present in an animal; bk is the partial regression 
coefficient which corresponds to the haplotype substitution effect for the kth haplotype as 
a deviation from the effect of the most frequent haplotype that is set to zero to have a full 
rank model; sire is a sire random effect; and ε is a residual error. The higher order terms 
for days in milk were introduced to account for a non-linear trend of the response 
variables over time. The cubic term of days in milk allows the response variable to have 
different slopes whenever the direction of its trend changes over time. When the higher 
order terms for days in milk were not significant, they were dropped from the model. 
Contemporary groups were created by combining herd (two herds) and season of calving 
(four seasons: December to February, March to May, June to August, and September to 
November) effects. The year of sampling was not included in the model to avoid 
redundancy because the season of calving is already containing some information about 
the year when a particular sample was collected. Haplotypes with a population frequency 
more than 0.05 were used in the analysis and those with frequency less than 0.05 were 
pooled in the “other” category. The CONTRAST statement in PROC MIXED was used 
to construct the F-tests of the overall haplotype effects and when the test was significant 
after applying a Bonferroni adjustment to account for multiple testing, pairwise 
comparisons between all haplotypes within each gene were performed by using 
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ESTIMATE statement and the estimates of the differences between haplotype effects, 
their standard errors, and p-values were reported. The REPEATED statement was used to 
indicate that milk samples were collected repeatedly for the same animal throughout the 
305 d lactation period. Correlations between repeated measures taken on the same animal 
were modeled using a first order autoregressive covariance structure that assumes equal 
variances and correlations that decline exponentially with an increase in the distance 
between time points [37]. The covariance structure was selected based on the biology of 
the experiment and using Akaike’s and Bayesian Information Criteria and residual log 
likelihood [38]. 
For the traits that were significantly associated with the overall haplotype effect, 
we performed pairwise comparisons between different haplotypes within the same gene 
to determine which haplotypes had significant effects on differences in milk fatty acid 
composition compared with the effects of other haplotypes. A Bonferroni adjustment was 
used to control the type I error rates for multiple comparisons, Bonferroni-adjusted 
significance levels were determined by dividing desired experiment-wide significance 
level (0.05) by the number of pairwise comparisons. The numbers of pairwise 
comparisons for SREBP1 and Insig1 genes were 3 and 3, respectively that resulted in 
Bonferroni-adjusted significance levels of 0.0167 each. We compared haplotype 
sequences within each gene based on their effects on milk fatty acid composition to 
determine “tag” SNPs that can be used as genetic markers. All animals on the study were 
treated in accordance with guidelines established by the Iowa State University Committee 
on Animal Care. 
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Results 
There were 39 different milk fatty acids measured by GC and used to calculate the 
concentrations of individual fatty acids that were expressed as wt %. The data reported, 
however, are only for fatty acids present in milk at relatively high concentrations (table 
4.3). Mean values, their standard deviations, and 5% and 95% quantiles for milk 
production, milk fat percentage, concentrations of different fatty acids and fatty acid 
groups, and fatty acid indices are reported. The mean values for the major milk fatty 
acids in our study were similar to those reported by others [6, 15], with palmitic (16:0; 
29.33 wt %) acid being the major milk fatty acid followed by oleic (18:1c9; 23.55 wt %), 
stearic (18:0; 11.92 wt %), and myristic (14:0; 10.15 wt %) acids. 
 The number of SNPs identified for SREBP1, Insig1, and SCAP was 5, 20, and 19, 
respectively (table 4.4). Those SNPs were validated using by Sequenom MassARRAY 
system. The number of SNPs for SREBP1 was not large because of the small number of 
animals (12 animals) used to discover SNPs. The majority of SNPs were intronic with 
two synonymous and one non-synonymous mutations. After genotyping animals for the 
discovered SNPs, the PHASE program was used to reconstruct intragenic haplotypes. 
There were 3, 3, and 2 haplotypes determined for SREBP-1, Insig-1, and SCAP genes, 
respectively, and their population frequencies were above 5 % (table 4.5).  
 F-tests were used to determine the overall haplotype effects on milk fatty acid 
composition for each gene separately (table 4.6). Results with p-value ≤ 0.0167 were 
considered to be significant, as determined by applying the Bonferroni adjustment to 
account for testing the association of genetic polymorphisms with milk fatty acid 
composition in each of three different genes. The overall haplotype effect of SREBP1 
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was associated significantly with the concentrations of myristic (14:0) and myristoleic 
(14:1c9) acids and C14 desaturation index. The overall haplotype effect of Insig1 was 
associated significantly with the concentrations of MUFA, PUFA, and palmitic (16:0) 
and linoleic (18:2c9, c12) acids. There was not any single trait that was associated 
significantly with the overall haplotype effect of SCAP. 
 The pairwise comparisons between the haplotype effects of SREBP1 revealed that 
the haplotype h1 of SREBP1 was the most desirable to select for animals producing 
healthier milk with lower concentration of myristic (14:0) acid, higher concentration of 
myristoleic (14:1c9) acid, and higher C14 desaturation index. In particular, the haplotype 
h1 of SREBP1 was associated significantly with 0.23 wt % lower myristic (14:0) acid 
concentration compared with the effect of the haplotype h5 of SRABP1. Moreover, the 
haplotype h1 of SREBP1 was associated significantly with 0.036 wt % higher myristoleic 
(14:1c9) acid concentration and 0.0033 higher C14 desaturation index compared with the 
effect of the haplotype h4 of SREBP1. At the same time, the haplotype h4 of SREBP1 
was associated significantly with 0.043 wt % lower myristoleic (14:1c9) acid 
concentration compared with the effect of the haplotype h5 of SREBP1.  
 The pairwise comparisons between the haplotypes of Insig1 revealed that the 
haplotype h23 of SREBP1 was the most desirable to select for animals producing 
healthier milk because it was associated significantly with 0.099 wt % higher PUFA and 
0.083 wt % higher linoleic (18:2c9, c12) acid concentrations compared with the effect of 
the haplotype h3 of Insig1. The pairwise comparisons between the haplotypes of Insig1 
revealed no significant associations with MUFA and palmitic (16:0) acid concentrations 
because the significance of the overall haplotype effect for those traits was caused by the 
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haplotypes with the population frequencies less than 5 % that were not considered in 
pairwise comparisons. There were no pairwise comparisons performed between the 
haplotypes of SCAP because the overall haplotype effect of SCAP was not associated 
significantly with any of the traits. 
 
Discussion 
The fact that the transcriptional activity of stearoyl-CoA desaturase-1 (SCD-1) gene is 
regulated by the SREBP-1c transcription factor [16] sparked much interest into 
investigating the possible association between genetic polymorphisms in the SREBP1 
and fatty acid composition in beef and milk. An 84 bp indel was discovered in intron 5 of 
the SREBP1 in Japanese Black cattle [39]. The indel presence resulted in the long and 
short forms of the SREBP1 being present in the cattle genome. The absence of the 
SREBP1 indel was associated with the higher percentage of MUFA and lower melting 
point in intramuscular adipose tissue of beef cattle [39]. The MUFA included only 
myristoleic (14:1), palmitoleic (16:1), and oleic (18:1) acids. The indel effect on fatty 
acid composition was explained by its possible role in micro-RNA production that could 
regulate the expression of some downstream genes involved in lipid metabolism. In a 
subsequent study, however, the effects of the indel present in SREBP1 gene on fatty acid 
composition of intramuscular adipose tissue in beef were not consistent with the earlier 
findings [40]. Moreover, the authors of the second study were able to determine the 
association of the 84 bp indel in the SREBP1 with lower concentrations of myristic (14:0) 
and palmitic (16:0) acids and higher C14 desaturation and elongation indices in only one 
group of animals. The association of the SREBP1 genetic polymorphism characterized by 
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the presence of the 84 bp indel in intron 5 also was studied in Italian Brown cattle with 
respect to variations in milk fatty acid composition, but no significant associations were 
found [41]. The chicken SREBP-1 genetic polymorphisms were tested for the association 
with the degree of fatness between lean and fat chicken lines, but no significant 
associations were found [42]. In a human study, polymorphisms in the SREBP-1 gene 
were associated with diabetes risk and plasma cholesterol concentrations [43]. In our 
study, the only fatty acids significantly associated with polymorphisms in the SREBP-1 
gene were myristic (14:0) and myristoleic (14:1) acids and the C14 desaturation index. 
The pairwise comparisons between the SREBP1 haplotypes revealed two tag SNPs that 
allow distinguishing the most desirable haplotype h1 of SREBP1 from the rest of 
SREBP1 haplotypes. The tag SNPs were intronic SNP43 and nonsynonymous SNP46 
with T alleles present in the h1 haplotype of SREBP1 for both SNPs. The 
nonsynonymous SNP43 was causing the amino acid change from leucine for T allele to 
proline for C allele at 852 residue of SREBP-1c protein. It is possible that the presence of 
leucine instead of proline at 852 residue of SREBP-1c protein leads to the increased 
ability of SREBP-1c transcription factor to activate the delta-9 desaturase transcription 
and as a result, leads to the increased concentration of myristoleic (14:1) acid, decreased 
concentration of myristic (14:0) acid, and increased C14 desaturation index. The delta-9 
desaturases catalyze the desaturation of fatty acids with 12 to 19 carbon atoms [44]. The 
results of our study can be supported partially by what was reported for the association of 
the SREBP-1 genetic polymorphisms with beef fatty acid composition, but there are 
definitely many inconsistencies with respect to the SREBP1 genetic effect.  
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 There were just a few studies that looked at polymorphisms in Insig2 gene with 
regard to obesity-related phenotypes and plasma cholesterol concentrations in humans 
[45, 46]. The significant association of Insig2 genetic polymorphisms was established 
only with plasma cholesterol concentrations [46]. There are no association studies that 
looked at polymorphisms in Insig1 gene to the best of our knowledge. In our study, the 
haplotype h23 of Insig1 was the most desirable to select for animals producing healthier 
milk because it was associated with the higher concentrations of PUFA and linoleic 
(18:2c9, c12) acids. We were able to identify a group of “tag” SNPs for the h23 haplotype 
of Insig1 that included all SNPS from which the haplotype was reconstructed except for 
SNP81, SNP120, SNP121, and SNP133. All the “tag” SNPs for the haplotype h23 of 
Insig1 were intronic except for SNP96 that was a synonymous mutation located in exon 4. 
We also were able to identify a “tag” SNP for the haplotype h3 of Insig1 that was an 
intronic SNP133. The effects of Insig1 genetic polymorphisms on fatty acid composition 
can be attributed to the Insig1 altered maturation of SREBP-1c and consequently, 
changes in the expression of SREBP-1c target genes that lead to the observed phenotypes. 
 A study on a diet-induced milk fat depression in dairy cows highlighted a 
potential role of SREBP1 in the regulation of lipid biosynthesis in lactating mammary 
gland by showing a decrease in SREBP1, SCAP, Insig1, and Insig2 gene expressions 
after feeding a diet rich in vegetable oil [47]. Based on the results of this study, it is 
difficult to see, however, whether Insig1 or Insig2 played any role in the regulation of 
SREBP1 protein activation, because, if it was the case, the expression of either Insig1 or 
Insig2 or both isoforms should had been increased. It could be also possible that the low 
expression levels for Insig1 and Insig2 were seen as a result of decreased SCAP 
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expression. In another study, there was an up-regulation in the expression of SREBP1, 
SREBP2, SCAP, Insig1, and Insig2 during the lactation, but the information is still 
incomplete to make any conclusions about potential involvement of any of the above 
proteins from the SREBP pathway in the regulation of lipid biosynthesis in bovine 
mammary gland [26]. The importance of Insig-1 in the regulation of SREBP processing 
was demonstrated first in vitro with regard to cholesterol biosynthesis [48]. Later, the 
importance of both Ising1 and Insig2 proteins in the suppression of hepatic lipogenesis 
was demonstrated in vivo [49]. The information about functionality of the SREBP 
pathway in the mammary gland and its importance in the regulation of lipid biosynthesis 
is lacking. In mice, it was shown that SREBP-1a and SREBP-1c are expressed in the 
mammary tissue and their expression is increased during lactation [50]. In addition to 
earlier described regulatory mechanisms for lipid biosynthesis involving SREBP-1c that 
are assumed to be true in lactating mammary gland, some studies suggested a potential 
role for insulin in the regulation of lipid biosynthesis via PI3 kinase  pathway with 
protein kinase B (Akt1) being a possible downstream effector. Overexpression of a 
constitutively active form of Akt1 in mice during lactation results in precocious lipid 
droplet formation in mammary epithelial cells with a significant increase in milk lipid 
concentration that reaches 60-70% on a wet weight bases as compared to only 25-30% in 
wild type mice [51]. Based on the recent discoveries of Akt  role in the regulation of 
SREBP activation [52-54], it was proposed [50] that insulin-mediated up-regulation of 
lipid biosynthesis via Akt is achieved by either Akt stimulated proteolytic activation of 
SREBP-1c or Akt-stimulated decrease in the degradation of a nuclear form of SREBP-1c 
in the nucleus or both. 
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 There were a few studies that looked at the associations of SCAP genetic 
polymorphisms with obesity- and atherosclerosis-related phenotypes in humans, but no 
significant associations were found [55-57]. In a study with mutant Chinese hamster 
ovary cell lines, a few mutations identified in SCAP gene were related to abolished 
interaction between SCAP and SREBP proteins and failed inhibition of cholesterol 
biosynthesis even in the presence of sterols in the culture media [25]. In our study, we 
were not able to find any significant associations between SCAP genetic polymorphisms 
and milk fatty acid composition. Moreover, we used 19 SNPs to reconstruct haplotypes 
within SCAP gene and identified only two haplotypes that differ by alleles of SNP52. 
Our results show that the genetic polymorphisms in SCAP are not abundant because of 
the importance of maintaining the integrity of SCAP protein for its function.  
 
Conclusions 
The results of our study showed that the haplotype h1 of SREBP1 was the most desirable 
to select for animals producing healthier milk because the haplotype h1 of SREBP1was 
associated significantly with lower concentration of myristic (14:0) acid, higher 
concentration of myristoleic (14:1c9) acid, and larger C14 desaturation index. Two “tag” 
SNPs for the haplotype h1 of SREBP1 were identified, with one being a nonsynonymous 
mutation that might be responsible for the effects attributed to the haplotype h1 of 
SREBP1 on milk fatty acid composition. The haplotype h23 of Insig1 was the most 
desirable to select for milk healthfulness because it was associated significantly with 
higher concentrations of PUFA and linoleic (18:2c9, c12) acid in milk. There were 15 “tag” 
SNPs identified for the haplotype h23 of Insig1. There were no significant associations 
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with milk fatty acid composition determined for SCAP. In conclusion, the information 
about the genetic polymorphisms in the SREBP pathway can be used to develop genetic 
markers to select for animals producing healthier milk. 
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Table 4.1 Gene information 
Gene BTA Chromosomal position, cM 
Gene 
length, bp 
Transcript 
length, bp 
Protein 
length, aa 
Numbe
r of 
exons 
Strand 
direction 
SREBP1 19 50 15922 3871 1146 19 Forward 
Insig1 4 101 12710 2762 276 6 Forward 
SCAP 22 64 27746 3880/ 3991 1244/ 1281 21/ 22 Reverse 
BTA, Bos taurus autosome; Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein 
cleavage-activating protein; SREBP1, sterol regulatory element binding protein-1 
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Table 4.2 Primer sequences and annealing temperatures for PCR 
Gene SNP Forward primer Reverse primer Tm, °C 
SREBP1 42, 43 CAGGTGCTTTTGGTAGAGGAG GCAGGACCTAAGGACAGGAG 58 
SREBP1 44 GCTGGTGCTCTTCTCCTTG AGAGACGTTGCAGCAGGTG 60 
SREBP1 46 CATCACCATGCAGTGAGGAG CATGCTGGAGCTGATGGAG 58 
SREBP1 47 GCAGCTTCTCCATCAGCTC CCCTTACCTTGTCAATGGAG 56 
Insig1 79 GGTGGTGAACCAGAGCAGAG GAGAAGATGGTGGCGATGAC 56 
Insig1 81, 85 TGCACTTCCGTCTTCATTCTC TGGAGTCAGCCAGGTACTGAG 56 
Insig1 93 TCCAGAAGGCAGAGCAGAAG GGATTCATTTCAACCACGAAAC 56 
Insig1 94, 95, 96, 99, 100 AGTTGTTTCGTGGTTGAAATG TGTGAATCAACAATAAGAAGTGC 56 
Insig1 103 TACCCATGAAGCTGAGATGC CAGGCAAACCAAGCTGAC 58 
Insig1 109, 110, 111, 112 CTGGGTCAGCTTGGTTTGC ATGTTGCACGCTCCTTCATC 60 
Insig1 113 GGGTGGTTGCTGTCATAGG CACCAGCCTCTTCCAGTTTC 58 
Insig1 120, 121 TTTGGATGTTACTGTTGTGTCTTG GGCTCCTCACTACTGCACG 56 
Insig1 127 CCCTCCTTCAGTCTGTCCTG TGCTCCTGCAACAACAGC 58 
Insig1 129 CACCTTGCTAGACTCCCTTG GCAGACAACAGACACGAACTC 56 
Insig1 132, 133 AGCAGTACCACCTCCTGTCC CAACTTGGCATTTAATAACACGAG 56 
SCAP 51, 52 TAGTGTAAACCATACCCTCAATGTG GGAGTGGTGAATTCCACAGG 58 
SCAP 54 CCTTGCCAGGAACAGGAC CTGCACGCTTTACCTGACTG 56 
SCAP 56 TGCTGTTTTATCCTCACAGTGC TTAGAGCAAAGCTGACATCAAGTTAC 56 
SCAP 57 CTTCTCCACCCTCTCTGTGC CACTCACAAACGCAGACTACC 56 
SCAP 58, 59 GGAGTTGATGGTTCCTGCTC ATGAAGCCAACCAGCAAAG 58 
SCAP 60 CTGCATGGGATTACCTACCTG CCTCTCCACTTGGCACTCTC 56 
SCAP 61 TGACTTCCTTCCAGAGAGTGC AGAATGACACCTGACCTCTGC 58 
SCAP 63, 64 GCAGAGGTCAGGTGTCATTC CACTTCACAAAGGAAGATGTGC 58 
SCAP 65 AACGCTAGCACTTTCTCTAACAAAC ATGGCTGATTCATGCTGATG 56 
SCAP 67, 68 TTTTCTCCACATCCTCTCCAG GATCAGTGACTCCAACACACG 58 
SCAP 72 GGTGCTGGAGAATTCACATCC CATCTGCTCCCACTCCTCAG 56 
SCAP 73, 75 ACCTCCTGACATCGTCTGC GGGAGTAATGGAAATCACAGG 23 
SCAP 393 GTCCTTAGGGTTGGAGCATTTG AGCTGGGAGGCTCAGTAATGG 60‡ 
SCAP 395 CTAACCACCTCCTCCTCAGC CAGACTCCTCTCCCTGATGAC 56 
Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein cleavage-activating protein; SREBP1, sterol regulatory element binding 
protein-1 
  
162
Table 4.3 Summary of milk fatty acid composition1, 2 
Trait Mean Standard deviation 5% Quantile 95% Quantile 
Milk production, kg/d 40.24 10.02 24.52 57.43 
Milk fat, % 3.65 0.70 2.50 4.80 
AI 2.07 0.46 1.27 2.80 
SFA, wt % 63.93 4.47 55.57 70.29 
UFA, wt % 36.07 4.47 29.71 44.43 
MUFA, wt % 31.26 4.04 25.66 38.91 
PUFA, wt % 4.81 0.92 3.46 6.42 
SFA/UFA 1.81 0.34 1.25 2.37 
4:0, wt % 2.47 0.76 1.29 3.80 
6:0, wt % 1.55 0.35 0.90 2.05 
8:0, wt % 1.00 0.23 0.57 1.35 
10:0, wt % 2.47 0.63 1.35 3.47 
12:0, wt % 2.94 0.73 1.61 4.10 
13:0, wt % 0.18 0.08 0.07 0.33 
14:0, wt % 10.15 1.60 6.80 12.26 
14:1c9, wt % 0.79 0.30 0.39 1.34 
15:0, wt % 1.08 0.28 0.71 1.63 
16:0, wt % 29.33 2.83 24.91 34.14 
16:1c9, wt % 1.75 0.41 1.16 2.47 
17:0, wt % 0.63 0.09 0.50 0.77 
18:0, wt % 11.92 2.37 8.44 16.14 
18:2c9, c12, wt % 3.24 0.70 2.23 4.47 
18:1c9, wt % 23.55 3.45 18.83 30.05 
18:2c9,t11 (CLA), wt % 0.70 0.24 0.43 1.19 
C14 Index3 0.07 0.02 0.04 0.11 
C16 Index4 0.06 0.01 0.04 0.08 
C18 Index5 0.66 0.05 0.59 0.74 
Elongation index6 0.53 0.05 0.46 0.62 
1Summary statistics were computed from 4397 milk samples collected from 551 cows. 
2The data presented here are for only 16 fatty acids out of 39 fatty acids analyzed because the concentrations of 
the rest of fatty acids in milk were low. 
3C14 Desaturation index = 14:1/ (14:0 + 14:1) 
4C16 Desaturation index = 16:1/ (16:0 + 16:1) 
5C18 Desaturation index = 18:1/ (18:0 + 18:1) 
6Elongation index = (18:0 + 18:1)/ (16:0 + 16:1 + 18:0 + 18:1) 
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Table 4.4 SNPs used for the reconstruction of haplotypes in SREBP1, Insig1, and SCAP 
genes 
SNP Gene 
Order in 
haplotype 
sequence 
Nucleotide 
position, 
bp 
Gene area Alleles Mutation type 
A.A. 
Residue 
change 
43 SREBP1 1 8729 Intron 2-3 C/T Intronic None 
42 SREBP1 2 8837 Intron 2-3 A/G Intronic None 
44 SREBP1 3 11598 Intron 9-10 C/G Intronic None 
46 SREBP1 4 13495 Exon 14 T/C Nonsynonymous L852P 
47 SREBP1 5 13801 Intron 15-16 T/C Intronic None 
79 Insig1 1 631 Intron 1-2 T/A Intronic None 
85 Insig1 2 2681 Intron 2-3 A/C Intronic None 
81 Insig1 3 2797 Intron 2-3 C/A Intronic None 
93 Insig1 4 4280 Intron 3-4 G/A Intronic None 
99 Insig1 5 4487 Intron 3-4 G/T Intronic None 
96 Insig1 6 4683 Exon 4 C/T Synonymous None 
95 Insig1 7 4772 Intron 4-5 C/G Intronic None 
94 Insig1 8 4796 Intron 4-5 T/C Intronic None 
103 Insig1 9 5157 Intron 4-5 C/T Intronic None 
112 Insig1 10 5454 Intron 5-6 T/C Intronic None 
111 Insig1 11 5501 Intron 5-6 G/A Intronic None 
110 Insig1 12 5727 Intron 5-6 A/G Intronic None 
109 Insig1 13 5790 Intron 5-6 A/G Intronic None 
113 Insig1 14 6757 Intron 5-6 A/G Intronic None 
120 Insig1 15 7413 Intron 5-6 G/A Intronic None 
121 Insig1 16 7580 Intron 5-6 A/C Intronic None 
127 Insig1 17 8900 Intron 5-6 A/G Intronic None 
129 Insig1 18 9952 Intron 5-6 G/A Intronic None 
133 Insig1 19 10782 Intron 5-6 T/C Intronic None 
132 Insig1 20 10825 Intron 5-6 G/C Intronic None 
52 SCAP 19 51 5' UTR/ Exon 1 T/G Synonymous None 
51 SCAP 18 256 5' UTR/ Intron 1-2 T/C Intronic None 
54 SCAP 17 747 Intron 2-3 C/G Intronic None 
56 SCAP 16 1526 Intron 2-3 T/C Intronic None 
57 SCAP 15 2043 Intron 2-3 A/T Intronic None 
59 SCAP 14 2147 Intron 2-3 G/A Intronic None 
58 SCAP 13 2357 Intron 2-3 A/G Intronic None 
60 SCAP 12 2976 Intron 2-3 C/T Intronic None 
61 SCAP 11 3634 Intron 2-3 A/C Intronic None 
63 SCAP 10 4011 Intron 2-3 A/G Intronic None 
64 SCAP 9 4020 Intron 2-3 G/A Intronic None 
65 SCAP 8 5138 Intron 2-3 A/G Intronic None 
67 SCAP 7 8259 Intron 2-3 T/C Intronic None 
Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein cleavage-activating protein; 
SREBP1, sterol regulatory element binding protein-1 
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Table 4.4 (continued) 
SNP Gene 
Order in 
haplotype 
sequence 
Nucleotide 
position, 
bp 
Gene area Alleles Mutation type 
A.A. 
Residue 
change 
68 SCAP 6 8296 Intron 2-3 G/A Intronic None 
72 SCAP 5 11504 Intron 2-3 G/A Intronic None 
73 SCAP 4 12615 Intron 2-3 A/G Intronic None 
75 SCAP 3 12747 Intron 2-3 G/T Intronic None 
393 SCAP 2 19727 Intron 9-10 G/A Intronic None 
395 SCAP 1 21468 Intron 11-12 G/A Intronic None 
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Table 4.5 Intragenic haplotypes and their frequencies   
Gene Haplotype Sequence1, 2 Frequency3 
SREBP1 h1 T1G2C3T4C5 0.61 
SREBP1 h4 C1G2G3C4C5 0.19 
SREBP1 h5 C1A2C3C4T5 0.20 
Insig-1 h3 A1C2C3A4T5T6G7C8T9C10A11G12G13G14G15A16G17A18C19C20 0.35 
Insig-1 h7 A1C2A3A4T5T6G7C8T9C10A11G12G13G14A15C16G17A18T19C20 0.28 
Insig-1 h23 T1A2C3G4G5C6C7T8C9T10G11A12A13A14G15A16A17G18T19G20 0.33 
SCAP h1 G1G2G3A4G5G6T7A8G9A10A11C12A13G14A15T16C17T18G19 0.11 
SCAP h2 G1G2G3A4G5G6T7A8G9A10A11C12A13G14A15T16C17T18T19 0.75 
1Subsripts indicate the order of SNPs in a particular haplotype for a particular gene  
2The “tag” SNPs in the haplotypes of interest are highlighted in bold and underlined 
3Only haplotypes with the population frequencies ≥ 5% were considered in the analysis 
Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein cleavage-activating protein; 
SREBP1, sterol regulatory element binding protein-1 
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Table 4.6 Results of F-test for the overall haplotype effect on milk fatty acid 
composition 
SREBP-1 Insig-1 SCAP  
Trait 
 F-value p-value F-value p-value F-value p-value 
Milk fat 2.00 0.14 2.06 0.10 0.45 0.64 
AI 2.36 0.09 2.25 2.25 0.49 0.61 
SFA 0.83 0.44 2.95 0.032 1.00 0.37 
UFA 0.83 0.44 2.95 0.032 1.00 0.37 
MUFA 1.11 0.33 3.64 0.013* 0.90 0.41 
PUFA 0.86 0.43 3.65 0.012* 0.53 0.59 
SFA/UFA 0.74 0.48 2.73 0.043 0.81 0.44 
4:0 0.45 0.64 0.33 0.81 1.57 0.21 
6:0 0.59 0.56 0.58 0.63 0.74 0.48 
8:0 0.94 0.39 1.18 0.32 0.42 0.66 
10:0 2.61 0.07 1.05 0.37 0.58 0.56 
12:0 2.93 0.05 1.17 0.32 0.84 0.40 
13:0 1.19 0.30 1.69 0.17 0.31 0.73 
14:0 7.87 0.0004* 0.44 0.73 0.15 0.86 
14:1c9 4.87 0.0079* 3.05 0.028 1.93 0.15 
15:0 1.28 0.28 2.25 0.081 0.27 0.76 
16:0 0.81 0.45 3.47 0.016* 1.24 0.29 
16:1c9 2.47 0.086 2.52 0.057 2.11 0.12 
17:0 1.47 0.22 1.77 0.15 0.31 0.73 
18:0 1.07 0.34 1.03 0.38 0.38 0.68 
18:1c9 1.89 0.15 1.42 0.24 0.34 0.71 
18:2c9, c12 2.06 0.13 4.45 0.0041* 0.12 0.89 
18:2c9, t11 (CLA) 0.48 0.62 2.35 0.072 1.70 0.18 
Index 14 4.41 0.012* 2.66 0.047 2.31 0.10 
Index 16 1.67 0.19 3.24 0.022 3.14 0.044 
Index 18 0.20 0.82 1.04 0.38 1.22 0.30 
Elongation index 0.90 0.41 1.92 0.13 0.13 0.88 
*The Bonferroni adjustment was used to account for multiple testing on four different genes. The significance 
of haplotype effects was declared if p≤0.0167 (0.05 divided by the number of genes that was 3) 
Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein cleavage-activating protein; 
SREBP1, sterol regulatory element binding protein-1 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 3804 and 474; 3993 and 500; and 4074 and 511 for SREBP1, Insig1, and SCAP, 
respectively.
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Table 4.7 Pairwise comparisons of SREBP1 and Insig1 haplotype effects on milk fatty 
acid composition 
SREBP1 Insig1 
H-Hb 14:0 14:1c9 
C14 
Index H-Hb PUFA 18:2
c9, c12 
H5-H1 0.23   H23-H3 0.099 0.083 
 (0.057) NS NS  (0.032) (0.023) 
 <.0001    0.0024 0.0003 
H1-H4  0.036 0.0033    
 NS (0.013) (0.0011)    
  0.0055 0.0031    
H5-H4  0.043     
 NS (0.015) NS    
  0.0046     
1The first number out of three numbers in a cell is an estimate of the haplotype substitution effect expressed in 
wt % for all individual fatty acids and fatty acid groups excluding indices. The second number in the 
parenthesis is a standard error of an estimate of the haplotype substitution effect expressed in the same units as 
the estimate. The third number is a p-value.  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0167 and 0.0167 for SREBP1 and Insig1, respectively (0.05 divided by the number of comparisons that were 
3 and 3 for SREBP1 and Insig1, respectively). 
H-Hb, indicates a pair of haplotypes for which the haplotype effects on milk fatty acid composition were 
compared with Hb, indicating the position of a haplotype used as a baseline.  
Insig1, insulin-induced gene-1; SCAP, sterol regulatory element binding protein cleavage-activating protein; 
SREBP1, sterol regulatory element binding protein-1 
The numbers for the milk samples used in the analysis and the cows from which the samples were collected 
were the following: 3804 and 474; and 3993 and 500 for SREBP1 and Insig1, respectively. 
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CHAPTER 5. GENERAL CONCLUSIONS 
 
General Discussion 
The main objective of my dissertation research project was to identify single nucleotide 
polymorphisms (SNPs) that are associated with bovine milk fatty acid composition. The 
information about those SNPs can be used by animal breeders to select for animals 
producing milk with a healthier fatty acid profile. In recent years, much attention has 
been devoted to controlling fatty acid composition of human diets because of the 
association of high concentrations of dietary saturated fatty acids (SFA) with the 
increased incidence of cardiovascular diseases (CVD), the number one cause of death 
worldwide. Bovine milk and other dairy products are one of the major sources of SFA in 
human diets. This fact underlies the importance of controlling fatty acid composition in 
milk and other dairy products to decrease the risk of developing CVD.  
The number of studies that researched association between genetic 
polymorphisms and bovine milk fatty acid composition is limited [1-7]. One of the earlier 
studies that looked at the effects of genetics on milk fatty acid composition was 
conducted only for Bos taurus autosome 19 (BTA19) [6]. Another study used the whole-
genome approach to find QTL for milk fatty acid composition [8, 9]. In our study, we 
used a candidate gene approach to find SNPs significantly associated with milk fatty acid 
composition. The glycerol-3-phosphate acyltransferases-1 and -4 (GPAT1 and GPAT4), 
1-acylglycerol-3-phosphate acyltransferase-1 (AGPAT1), and phosphatidate phosphatase 
(LPIN1) genes from the triacylglycerol biosynthetic pathway were studied to test 
association of the polymorphisms in those genes with milk fatty acid composition. The 
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overall haplotype effect of GPAT4 was significantly associated with the concentrations 
of capric (10:0), lauric (12:0), palmitic (16:0), and oleic (18:1c9) acids and as a 
consequence with the concentrations of SFA, unsaturated fatty acids (UFA), 
monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), SFA/UFA, 
C16 and C18 desaturation indices, and the atherogenic index (AI). The overall haplotype 
effect of GPAT1 was significantly associated with milk fat percentage, the concentrations 
of caproic (6:0), caprylic (8:0), capric (10:0), tridecylic (13:0), margaric (17:0), and 
myristoleic (14:1c9) acids and C14 desaturation index. The overall haplotype effect of 
AGPAT1 showed significant associations with the concentrations of PUFA, caproic (6:0), 
margaric (17:0), and linoleic (18:2c9, c12) acids, conjugated linoleic acid (CLA, 18:2c9, t11), 
and myristoleic (14:1c9) acid. The overall haplotype effects of LPIN1 were associated 
only with myristoleic (14:1c9) acid concentration and C14 desaturation index. 
After numerical comparison of the size of haplotype effects of GPAT4 and 
GPAT1 and the size of allelic effects of DGAT1 A232K on milk fat percentage and fatty 
acid composition, we determined the haplotype effect of GPAT4 was associated with at 
least the same or larger differences in AI (0.13), concentrations of SFA (1.48 wt %), UFA 
(1.48 wt %), MUFA (1.34 wt %), PUFA (0.23 wt %), SFA/UFA (0.12), and lauric (12:0; 
0.23 wt %) acid concentration compared with the effects of DGAT1 A232K mutation. 
The haplotype effect of GPAT4 also was associated with at least the same or larger 
difference in capric (10:0; 0.21 wt %) acid concentration compared with the GPAT1 
haplotype effects. 
The solute carrier family 27 (SLC27), isoform A6 and fatty acid binding proteins-
3 and -4 (FABP3 and FABP4) involved in fatty acid uptake into mammary gland and 
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fatty acid transport inside the mammary epithelial cells were studied to test the 
association of the polymorphisms in those genes with milk fatty acid composition. The 
results of our study showed that the overall haplotype effect of SLC27A6 was associated 
significantly with the percentage of milk fat, the concentrations of SFA, UFA, MUFA, 
SFA/UFA, the concentrations of capric (10:0), lauric (12:0), myristic (14:0), and palmitic 
(16:0) acids in milk. The overall haplotype effect of FABP4 was associated significantly 
with the concentrations of SFA, UFA, MUFA, PUFA, SFA/UFA, the concentrations of 
linoleic (18:2c9, c12) acid, conjugated linoleic (18:2c9, t11) acid, and C18 desaturation index. 
The overall haplotype effect of FABP3 was associated significantly with the 
concentrations of only pentadecylic (15:0) acid and elongation index. 
Numerical comparison of the size of the haplotype effects of SLC27A6 and the 
size of allelic effects of DGAT1 A232K on milk fat percentage and fatty acid 
composition, we determined that the size of the largest haplotype effect of SLC27A6 on 
milk fat percentage, AI, the concentrations of SFA and UFA, and SFA/UFA were 
numerically very similar to the size of the allelic effects of DGAT1 A232K mutation on 
those traits. Moreover, the size of the largest haplotype effects of LSC27A6 on the 
concentrations of capric (10:0) and lauric (12:0) acids were numerically much larger than 
the size of the allelic effects of DGAT1 A232K mutation on the same traits. 
The sterol regulatory element binding protein-1c (SREBP-1c) is involved in the 
transcriptional regulation of lipogenesis, and its proteolytic activation is controlled by 
SREBP cleavage-activating protein (SCAP) and insulin-induced genes (Insig) that are all 
part of the SREBP pathway. The results of our study showed the significant association 
of the overall haplotype effect of SREBP1 with the concentrations of myristic (14:0) and 
  
171
myristoleic (14:1c9) acids, and C14 desaturation index. The overall haplotype effect of 
Insig1 was associated with the concentrations of PUFA and linoleic (18:2c9, c12) acid. We 
did not detect any significant associations of SCAP genetic polymorphisms with milk 
fatty acid composition.  
In conclusion, we were able to identify genetic polymorphisms in GPAT4, 
GPAT1, and SLC27A6 genes that were associated with the differences in milk fatty acid 
composition and the size of those differences for certain fatty acids was very large when 
numerically compared with the effects of DGAT1 A232K mutation. The associations of 
the polymorphisms for the other genes were valuable as well. The results of this study 
provide the information about genetic polymorphisms that can be used to develop genetic 
markers for the selection of animals producing milk with the healthier fatty acid profile. 
 
Future Research 
In our study, we used a candidate gene approach to discover genetic polymorphisms that 
are associated significantly with bovine milk fatty acid composition. Even though it is a 
good approach for the discovery of the associations of interest [10], the whole-genome 
studies could provide a better view of the whole picture. One of the first studies that 
searched for the QTLs associated with milk fatty acid composition focused only on 
BTA19 [6]. At that time, the QTL located in the same region of the chromosome as fatty 
acid synthase gene was identified. Later, the first whole-genome study that used SNPs as 
genetic markers was conducted to search for QTLs associated with bovine milk fatty acid 
composition [8, 9]. One of the main disadvantages of both studies was a small number of 
DNA markers used to cover each chromosome. In the future, it is desirable to do studies 
  
172
with 50K or 100K SNP chips to genotype each animal for those numbers of SNPs and 
improve the accuracy of detecting and positioning QTLs for milk fatty acid composition. 
Ideally, studies that use chips with more than a million SNPs would be desirable to get 
better results.  
 As for the candidate gene approach, it is necessary to use a DNA sample set from 
more than 12 animals to increase chances of discovering more SNPs. Then, choosing 
between 10 and 20 equally spaced SNPs throughout a gene and genotyping animals for 
those SNPs with subsequent haplotype reconstruction within each gene and association 
analysis is a good approach to evaluate the effects of genetic polymorphisms for a 
particular gene on milk fatty acid composition. In the event of significant associations, 
further gene sequencing to detect nonsynonymous and possibly causative SNPs should be 
continued.  
 It is known that a quantitative trait such as milk fatty acid composition is 
determined by a large number of genes and by the interactions between those genes. So, 
it is important to test the associations between the phenotype and SNP interactions in the 
whole-genome studies or haplotype interactions within certain biosynthetic pathways 
when a candidate gene approach is used. Inexpensive and efficient ways to genotype 
animals for the SNPs of interest is an issue when the candidate gene approach is used. 
Even though the Sequenom MassARRAY system is a very efficient way to do 
genotyping, the fact that amplifying DNA in the areas of the genome rich in GC base 
pairs could reduce the PCR yield and consequently decrease the quality of genotypic data 
that would encourage researchers to look for the alternative ways to genotype their 
animals.  
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 The phenotypic data set should be larger. In our study, number of daughters per 
sire was relatively small that did not allow good estimation of sire effects. In the future, 
the number of animals from which the whole-lactation monthly milk samples are 
collected should be at least doubled to 1,000. Another issue that comes with the increased 
number of milk samples to be analyzed for fatty acid composition is the high cost of 
using gas chromatography for this type of analysis. The alternative approach would be to 
use infrared spectroscopy after developing the prediction equations based on the milk 
fatty acid data obtained from GC or to use high performance liquid chromatography and 
mass spectrometry to obtain much broader information about composition of milk 
samples.   
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APPENDIX A. SUPPLIMENTARY INFORMATION FOR CHAPTER 2 
 
Table A1 Pairwise comparisons of GPAT4 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.024 0.031 
-0.024 
0.021 
0.047 
0.025 
-0.085 
0.033 
-0.025 
0.024 
h2 0.4509  -0.047 0.029 
0.023 
0.034 
-0.109 
0.041 
-0.049 
0.032 
h3 0.2487 0.1079  0.070 0.024 
-0.062 
0.033 
-0.002 
0.020 
h6 0.0655 0.4995 0.0035  -0.132* 0.036 
-0.072 
0.026 
h8 0.0101 0.0078 0.0605 0.0002*  0.060 0.034 
AI 
h10 0.2909 0.1286 0.9363 0.005 0.0803  
 
Trait Haplotype h1 h2 h3 h6 h8 H10 
h1  0.095 0.331 
-0.262 
0.216 
0.640 
0.267 
-0.842 
0.347 
-0.255 
0.253 
h2 0.7729  -0.357 0.309 
0.545 
0.358 
-0.937 
0.430 
-0.350 
0.339 
h3 0.2269 0.2487  0.902* 0.253 
-0.580 
0.345 
0.007 
0.215 
h6 0.0166 0.1285 0.0004*  -1.482* 0.375 
-0.895* 
0.269 
h8 0.0156 0.0295 0.0926 <.0001*  0.587 0.360 
SFA 
h10 0.3137 0.3026 0.9736 0.0009* 0.1034  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0033 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table A1 (continued) 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  -0.095 0.331 
0.262 
0.216 
-0.640 
0.267 
0.842 
0.347 
0.255 
0.253 
h2 0.7729  0.357 0.309 
-0.545 
0.358 
0.937 
0.430 
0.350 
0.339 
h3 0.2269 0.2487  -0.902* 0.253 
0.580 
0.345 
-0.007 
0.215 
h6 0.0166 0.1285 0.0004*  1.482* 0.375 
0.895* 
0.269 
h8 0.0156 0.0295 0.0926 <.0001*  -0.587 0.360 
UFA 
h10 0.3137 0.3026 0.9736 0.0009* 0.1034  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  -0.270 0.301 
0.116 
0.196 
-0.741* 
0.243 
0.597 
0.316 
0.116 
0.229 
h2 0.37  0.387 0.282 
-0.471 
0.326 
0.867 
0.391 
0.386 
0.309 
h3 0.5535 0.1708  -0.858* 0.231 
0.481 
0.314 
0.000 
0.195 
h6 0.0023* 0.149 0.0002*  1.339* 0.341 
0.858* 
0.245 
h8 0.0595 0.027 0.1256 <.0001*  -0.481 0.328 
MUFA 
h10 0.6123 0.2111 0.9993 0.0005* 0.1427  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.176 0.148” 0.101 0.227* 0.147* 
  0.060 0.039 0.048 0.063 0.046 
h2 0.0034  -0.028 -0.075 0.051 -0.029 
   0.056 0.065 0.078 0.062 
h3 0.0002* 0.614  -0.047 0.079 -0.001 
    0.046 0.062 0.039 
h6 0.0368 0.2471 0.309  0.126 0.046 
     0.068 0.049 
h8 0.0003* 0.517 0.2075 0.065  -0.080 
      0.065 
PUFA 
h10 0.0014* 0.6354 0.9807 0.3486 0.2224  
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Table A1 (continued) 
Trait Haplotype h1 H2 h3 h6 h8 h10 
h1  0.006 -0.022 0.047 -0.067 -0.014 
  0.025 0.016 0.020 0.026 0.019 
h2 0.8226  -0.028 0.042 -0.073 -0.019 
   0.023 0.027 0.032 0.026 
h3 0.178 0.2367  0.069* -0.045 0.008 
    0.019 0.026 0.016 
h6 0.0188 0.1224 0.0003*  -0.115* -0.061* 
     0.028 0.020 
h8 0.0101 0.0244 0.0804 <.0001*  0.054 
      0.027 
SFA/UFA 
h10 0.4681 0.448 0.6137 0.0027* 0.0485  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.017 0.011 0.029 -0.026 -0.005 
  0.018 0.012 0.014 0.019 0.014 
h2 0.3447  -0.006 0.012 -0.043 -0.022 
   0.017 0.019 0.023 0.018 
h3 0.357 0.7108  0.018 -0.037 -0.016 
    0.014 0.019 0.012 
h6 0.0432 0.5278 0.1772  -0.056 -0.034 
     0.020 0.015 
h8 0.1612 0.0629 0.0468 0.0063  0.021 
      0.019 
8:0 
h10 0.7062 0.2291 0.1704 0.0185 0.2745  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.126 0.051 0.069 -0.083 -0.012 
  0.048 0.031 0.039 0.050 0.037 
h2 0.009  -0.075 -0.057 -0.209* -0.138 
   0.045 0.052 0.062 0.049 
h3 0.1043 0.0967  0.018 -0.134 -0.064 
    0.037 0.050 0.031 
h6 0.0755 0.2742 0.6279  -0.152 -0.081 
     0.055 0.039 
h8 0.1 0.0009* 0.0075 0.0054  0.071 
      0.052 
10:0 
h10 0.7348 0.0052 0.0419 0.0379 0.1771  
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Table A1 (continued) 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.159 0.049 0.060 -0.068 -0.016 
  0.054 0.035 0.044 0.057 0.041 
h2 0.0034  -0.110 -0.099 -0.227* -0.175* 
   0.051 0.059 0.070 0.055 
h3 0.1683 0.0295  0.011 -0.117 -0.064 
    0.041 0.056 0.035 
h6 0.1681 0.0917 0.7818  -0.129 -0.076 
     0.061 0.044 
h8 0.229 0.0013* 0.0379 0.0363  0.053 
      0.059 
12:0 
h10 0.7039 0.0017* 0.0666 0.0853 0.3706  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.129 -0.018 0.019 -0.175 -0.170 
  0.107 0.069 0.086 0.113 0.081 
h2 0.2286  -0.147 -0.110 -0.305 -0.299 
   0.101 0.116 0.139 0.110 
h3 0.8005 0.1451  0.037 -0.158 -0.152 
    0.082 0.112 0.069 
h6 0.8232 0.345 0.6535  -0.195 -0.189 
     0.122 0.087 
h8 0.1209 0.0292 0.1577 0.1098  0.005 
      0.117 
14:0 
h10 0.0362 0.0065 0.0271 0.0299 0.9633  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  -0.042 -0.312 0.228 -0.428 0.027 
  0.195 0.128 0.157 0.204 0.149 
h2 0.8288  -0.270 0.270 -0.386 0.069 
   0.182 0.211 0.253 0.200 
h3 0.0149 0.1383  0.540* -0.116 0.339 
    0.149 0.203 0.127 
h6 0.1466 0.1997 0.0003*  -0.656* -0.201 
     0.221 0.159 
h8 0.0367 0.128 0.5689 0.0031*  0.455 
      0.212 
16:0 
h10 0.8564 0.7298 0.0078 0.2059 0.0324  
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Table A1 (continued) 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  -0.27 0.01 -0.61* 0.19 -0.09 
  0.24 0.15 0.19 0.25 0.18 
h2 0.2583  0.28 -0.35 0.46 0.18 
   0.22 0.26 0.31 0.24 
h3 0.9263 0.2039  -0.63* 0.18 -0.11 
    0.18 0.25 0.15 
h6 0.0014* 0.179 0.0006*  0.80* 0.52 
     0.27 0.19 
h8 0.4477 0.138 0.4781 0.0029*  -0.28 
      0.26 
18:1c9 
h10 0.6064 0.4698 0.4843 0.0069 0.2745  
 
Traits Haplotype h1 h2 h3 h6 h8 h10 
h1  0.03 0.03 -0.01 0.05 0.03 
  0.02 0.01 0.02 0.02 0.02 
h2 0.1105  0.001 -0.04 0.02 -0.01 
   0.02 0.02 0.03 0.02 
h3 0.0105 0.9442  -0.04 0.02 -0.01 
    0.02 0.02 0.01 
h6 0.6096 0.0641 0.0068  0.06 0.03 
     0.02 0.02 
h8 0.0134 0.4397 0.3668 0.0079  -0.03 
      0.02 
CLA 
h10 0.097 0.7391 0.5274 0.0399 0.2159  
 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  -0.0009 0.0007 -0.0019 0.0008 0.0013 
  0.0011 0.0007 0.0009 0.0011 0.0008 
h2 0.4261  0.0016 -0.0010 0.0017 0.0022 
   0.0010 0.0012 0.0014 0.0011 
h3 0.3353 0.1272  -0.0026* 0.0001 0.0006 
    0.0008 0.0011 0.0007 
h6 0.0299 0.3763 0.0019*  0.0027 0.0032* 
     0.0012 0.0009 
h8 0.4708 0.2323 0.9044 0.027  0.0005 
      0.0012 
C16 
Index 
h10 0.1077 0.0487 0.357 0.0003* 0.6632  
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Table A1 (continued) 
Trait Haplotype h1 h2 h3 h6 h8 h10 
h1  0.004 0.001 -0.009* 0.002 0.001 
  0.004 0.002 0.003 0.004 0.003 
h2 0.2354  -0.003 -0.013* -0.003 -0.004 
   0.003 0.004 0.005 0.004 
h3 0.6871 0.324  -0.010* 0.001 0.000 
    0.003 0.004 0.002 
h6 0.0022* 0.0007* 0.0004*  0.010 0.010* 
     0.004 0.003 
h8 0.6849 0.5588 0.8762 0.0106  -0.001 
      0.004 
C18 
Index 
h10 0.8208 0.3235 0.889 0.0012* 0.8163  
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Table A2 Pairwise comparisons of GPAT1 haplotype effects on milk fatty acid 
composition 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  -0.108 -0.065 0.014 0.040 -0.061 
  0.057 0.049 0.050 0.045 0.048 
h2 0.0591  0.043 0.122 0.148* 0.047 
   0.052 0.054 0.047 0.053 
h7 0.1824 0.4103  0.079 0.105* 0.004 
    0.039 0.033 0.040 
h8 0.7793 0.023 0.0414  0.026 -0.075 
     0.037 0.044 
h9 0.3794 0.0019* 0.0015* 0.4852  -0.100 
      0.037 
Milk fat 
h12 0.2053 0.3745 0.9119 0.0922 0.0064  
 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  -0.046 -0.013 0.040 0.011 0.022 
  0.027 0.023 0.024 0.021 0.023 
h2 0.0881  0.033 0.086* 0.057 0.068 
   0.024 0.025 0.022 0.025 
h7 0.5571 0.1842  0.053 0.025 0.036 
    0.018 0.016 0.019 
h8 0.0944 0.0007* 0.0038  -0.028 -0.017 
     0.017 0.021 
h9 0.5911 0.0101 0.1089 0.109  0.011 
      0.017 
6:0 
h12 0.3253 0.0068 0.0589 0.4073 0.5369  
 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  -0.048 -0.020 0.009 0.002 0.008 
  0.019 0.016 0.017 0.015 0.016 
h2 0.0114  0.029 0.057* 0.051* 0.056* 
   0.017 0.018 0.016 0.018 
h7 0.2267 0.0997  0.029 0.022 0.028 
    0.013 0.011 0.013 
h8 0.5999 0.0014* 0.028  -0.006 -0.001 
     0.012 0.015 
h9 0.8789 0.0014* 0.0465 0.601  0.006 
      0.012 
8:0 
h12 0.6249 0.0017* 0.0401 0.9476 0.6542  
*The Bonferroni adjustment for multiple comparisons was, used and significance was declared if p-value was ≤ 
0.0033 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table A2 (continued) 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  -0.151 -0.077 -0.013 -0.003 -0.022 
  0.053 0.045 0.046 0.042 0.044 
h2 0.0044  0.074 0.138 0.148* 0.129 
   0.048 0.049 0.044 0.049 
h7 0.086 0.1277  0.064 0.074 0.056 
    0.036 0.031 0.037 
h8 0.7808 0.0054 0.0722  0.010 -0.009 
     0.034 0.041 
h9 0.9432 0.0008* 0.0151 0.7726  -0.019 
      0.034 
10:0 
h12 0.6241 0.0091 0.1325 0.8306 0.583  
 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  -0.015* -0.005 -0.005 -0.007 0.001 
  0.005 0.004 0.004 0.004 0.004 
h2 0.0024*  0.009 0.009 0.007 0.016* 
   0.004 0.004 0.004 0.004 
h7 0.211 0.0318  -0.000 -0.002 0.006 
    0.003 0.003 0.003 
h8 0.2079 0.0394 0.9578  -0.002 0.006 
     0.003 0.004 
h9 0.0544 0.0682 0.4276 0.5129  0.009 
      0.003 
13:0 
h12 0.7587 0.0004* 0.059 0.0787 0.0055  
 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  0.006 0.043 0.035 -0.030 0.072* 
  0.024 0.021 0.021 0.019 0.020 
h2 0.8169  0.037 0.030 -0.035 0.066* 
   0.022 0.023 0.020 0.023 
h7 0.038 0.0904  -0.007 -0.073* 0.029 
    0.016 0.014 0.017 
h8 0.0959 0.1872 0.6524  -0.065* 0.037 
     0.016 0.019 
h9 0.1213 0.077 <.0001* <.0001*  0.102* 
      0.016 
14:1 
h12 0.0004* 0.0033* 0.0837 0.0513 <.0001*  
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Table A2 (continued) 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  0.0029 0.0031 -0.0048 -0.0099 0.0057 
  0.0056 0.0047 0.0049 0.0044 0.0047 
h2 0.5985  0.0002 -0.0077 -0.0128 0.0028 
   0.0051 0.0052 0.0046 0.0052 
h7 0.5108 0.9705  -0.0079 -0.0130* 0.0026 
    0.0038 0.0032 0.0039 
h8 0.3281 0.1401 0.0365  -0.0051 0.0105 
     0.0036 0.0043 
h9 0.0252 0.0056 <.0001* 0.1549  0.0156* 
      0.0036 
17:0 
h12 0.2183 0.5893 0.5018 0.0149 <.0001*  
 
Trait Haplotypes h1 h2 h7 h8 h9 h12 
h1  0.0020 0.0046 0.0032 -0.0025 0.0057 
  0.0021 0.0017 0.0018 0.0016 0.0017 
h2 0.3366  0.0026 0.0013 -0.0045 0.0037 
   0.0019 0.0019 0.0017 0.0019 
h7 0.0094 0.1691  -0.0013 -0.0071 0.0012 
    0.0014 0.0012 0.0014 
h8 0.0725 0.5123 0.3435  -0.0058 0.0025 
     0.0013 0.0016 
h9 0.1215 0.0085 <.0001* <.0001*  0.0082 
      0.0013 
C14 
Index 
h12 0.0009* 0.0518 0.4194 0.1197 <.0001*  
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Table A3 Pairwise comparisons of AGPAT1 haplotype effects on milk fatty acid 
composition 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.018 0.035 -0.098 -0.123* 
  0.060 0.041 0.053 0.036 
h4 0.76  0.016 -0.116 -0.141 
   0.067 0.076 0.065 
h6 0.4007 0.8056  -0.133 -0.157* 
    0.063 0.049 
h9 0.0681 0.1276 0.0362  -0.025 
     0.062 
PUFA 
h10 0.0008* 0.0295 0.0013* 0.689  
 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.018 0.006 0.057 0.045* 
  0.024 0.017 0.021 0.015 
h4 0.4629  -0.011 0.039 0.027 
   0.027 0.031 0.026 
h6 0.7055 0.6689  0.050 0.038 
    0.025 0.019 
h9 0.008 0.2023 0.0452  -0.012 
     0.025 
6:0 
h10 0.0023* 0.3021 0.0487 0.6272  
 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.009 0.005 0.031 0.027 
  0.017 0.012 0.015 0.010 
h4 0.5882  -0.004 0.022 0.017 
   0.019 0.022 0.019 
h6 0.6541 0.8337  0.026 0.021 
    0.018 0.014 
h9 0.0408 0.3136 0.1496  -0.005 
     0.018 
8:0 
h10 0.0112 0.3549 0.1283 0.7869  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.005 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table A3 (continued) 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.017 0.005 -0.067* 0.019 
  0.022 0.015 0.020 0.014 
h4 0.4455  -0.012 -0.084* 0.001 
   0.025 0.028 0.024 
h6 0.7273 0.6383  -0.073* 0.013 
    0.023 0.018 
h9 0.0007* 0.0029* 0.002*  0.086* 
     0.023 
14:1 
h10 0.1727 0.9533 0.4689 0.0002*  
 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.031 -0.010 -0.012 -0.020 
  0.018 0.012 0.016 0.011 
h4 0.0812  -0.041 -0.043 -0.051 
   0.020 0.023 0.019 
h6 0.4262 0.0398  -0.002 -0.010 
    0.019 0.015 
h9 0.4629 0.0591 0.9181  -0.008 
     0.019 
15:0 
h10 0.0742 0.0085 0.511 0.6831  
 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.0090 -0.0002 0.0038 -0.0072 
  0.0049 0.0034 0.0044 0.0030 
h4 0.0676  -0.0092 -0.0052 -0.016* 
   0.0055 0.0063 0.0053 
h6 0.9552 0.0942  0.0040 -0.0070 
    0.0052 0.0040 
h9 0.3881 0.4055 0.4424  -0.0111 
     0.0051 
17:0 
h10 0.016 0.0023* 0.0795 0.0316  
 
 
 
 
 
 
 
 
 
 
  
186
Table A3 (continued) 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  -0.029 0.035 -0.038 -0.082* 
  0.043 0.030 0.038 0.026 
h4 0.4942  0.064 -0.009 -0.053 
   0.048 0.054 0.046 
h6 0.2407 0.1803  -0.073 -0.117* 
    0.045 0.035 
h9 0.316 0.8701 0.1054  -0.044 
     0.044 
18:2 
h10 0.0017* 0.2544 0.0008* 0.3229  
 
Trait Haplotypes h2 h4 h6 h9 h10 
h2  0.020 0.003 -0.044 -0.035* 
  0.020 0.014 0.018 0.012 
h4 0.3374  -0.016 -0.064 -0.055 
   0.023 0.026 0.022 
h6 0.8098 0.4745  -0.047 -0.039 
    0.021 0.016 
h9 0.0147 0.0137 0.0259  0.009 
     0.021 
CLA 
h10 0.0044* 0.0129 0.0192 0.6753  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
187
Table A4 Pairwise comparisons of LPIN1 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h1 h4 h13 h18 h22 h24 h26 
h1  -0.025 -0.036 -0.037 -0.085* -0.004 -0.007 
  0.019 0.021 0.019 0.023 0.020 0.018 
h4 0.1795  -0.011 -0.012 -0.060 0.021 0.018 
   0.022 0.019 0.023 0.021 0.018 
h13 0.084 0.6162  -0.001 -0.049 0.032 0.029 
    0.022 0.024 0.022 0.021 
h18 0.0556 0.5309 0.978  -0.048 0.033 0.030 
     0.023 0.021 0.018 
h22 0.0002* 0.01 0.041 0.0332  0.081* 0.078* 
      0.024 0.022 
h24 0.8355 0.3165 0.152 0.121 0.001*  -0.003 
       0.020 
14:1 
h26 0.6989 0.3086 0.1574 0.0939 0.0003* 0.8891  
 
Trait Haplotype h1 h4 h13 h18 h22 h24 h26 
h1  -0.0020 -0.0027 -0.0032 -0.0073* -0.0000 -0.0005 
  0.0016 0.0018 0.0016 0.0020 0.0017 0.0015 
h4 0.2202  -0.0008 -0.0012 -0.0053 0.0020 0.0014 
   0.0019 0.0016 0.0020 0.0018 0.0015 
h13 0.1263 0.6822  -0.0005 -0.0045 0.0028 0.0022 
    0.0019 0.0020 0.0019 0.0018 
h18 0.0527 0.4396 0.8091  -0.0041 0.0032 0.0027 
     0.0019 0.0018 0.0015 
h22 0.0002* 0.0074 0.0256 0.0343  0.0073* 0.0067* 
      0.0021 0.0018 
h24 0.9866 0.2647 0.1468 0.0735 0.0005*  -0.0006 
       0.0017 
C14 
Index 
h26 0.73 0.3452 0.2115 0.0804 0.0003* 0.7392  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.005 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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APPENDIX B. SUPPLIMENTARY INFORMATION FOR CHAPTER 3 
 
Table B1 Pairwise comparisons of SLC27A6 haplotype effects on milk fatty acid 
composition 
Trait Haplotypes h1 h5 h6 h9 h10 
h1  0.048 -0.052 -0.119 0.032 
  0.033 0.036 0.046 0.028 
h5 0.1445  -0.100 -0.167* -0.016 
   0.043 0.051 0.038 
h6 0.1473 0.0215  -0.067 0.083 
    0.056 0.040 
h9 0.0109 0.001* 0.2292  0.151* 
     0.049 
Milk fat 
h10 0.2569 0.6651 0.0381 0.0021*  
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.046 -0.052 -0.029 -0.004 
  0.020 0.022 0.028 0.017 
h5 0.0221  -0.098* -0.075 -0.050 
   0.026 0.031 0.023 
h6 0.0168 0.0002*  0.022 0.047 
    0.034 0.025 
h9 0.2949 0.0138 0.5101  0.025 
     0.030 
AI 
h10 0.7929 0.0284 0.0538 0.4002  
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.371 0.213 
-0.633 
0.229 
-0.375 
0.299 
-0.087 
0.181 
h5 0.0813  -1.004* 0.279 
-0.746 
0.325 
-0.458 
0.244 
h6 0.0058 0.0003*  0.258 0.359 
0.546 
0.259 
h9 0.2103 0.0221 0.4726  0.288 0.315 
 
 
 
 
 
SFA 
h10 0.63 0.0602 0.0355 0.3615  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.005 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table B1 (continued) 
Trait Haplotype h1 h5 h6 h9 h10 
h1  -0.371 0.213 
0.633 
0.229 
0.375 
0.299 
0.087 
0.181 
h5 0.0813  1.004* 0.279 
0.746 
0.325 
0.458 
0.244 
h6 0.0058 0.0003*  -0.258 0.359 
-0.546 
0.259 
h9 0.2103 0.0221 0.4726  -0.288 0.315 
 
UFA 
 
 
 
 
h10 0.63 0.0602 0.0355 0.3615  
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  -0.376 0.193 
0.536 
0.208 
0.228 
0.271 
0.042 
0.164 
h5 0.051  0.912* 0.253 
0.604 
0.294 
0.418 
0.221 
h6 0.01 0.0003*  -0.308 0.326 
-0.494 
0.235 
h9 0.4005 0.0404 0.3438  -0.186 0.285 
 
MUFA 
 
 
 
 
h10 0.799 0.0584 0.0359 0.5152  
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.027 0.016 
-0.044 
0.017 
-0.033 
0.022 
-0.007 
0.014 
h5 0.086  -0.072* 0.021 
-0.060 
0.024 
-0.034 
0.018 
h6 0.0101 0.0006*  0.011 0.027 
0.037 
0.019 
h9 0.1433 0.0137 0.6726  0.026 0.024 
 
SFA/UFA 
 
 
 
 
h10 0.6122 0.0607 0.0547 0.2718  
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Table B1 (continued) 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.068 0.031 
-0.097* 
0.034 
0.026 
0.044 
0.009 
0.027 
h5 0.0314  -0.165* 0.041 
-0.042 
0.048 
-0.059 
0.036 
h6 0.0042* <.0001*  0.123 0.053 
0.106 
0.038 
h9 0.5602 0.3814 0.0209  -0.017 0.047 
10:0 
h10 0.7424 0.1023 0.0059 0.7167  
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.079 0.035 
-0.108* 
0.038 
0.050 
0.050 
0.000 
0.030 
h5 0.0261  -0.187* 0.046 
-0.029 
0.054 
-0.079 
0.041 
h6 0.0048* <.0001*  0.158 0.060 
0.108 
0.043 
h9 0.317 0.5882 0.0085  -0.050 0.052 
 
 
12:0 
 
 
 
h10 0.9883 0.0511 0.0132 0.3396   
 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.180 0.069 
-0.145 
0.075 
0.099 
0.097 
-0.004 
0.059 
h5 0.0096  -0.324* 0.091 
-0.081 
0.105 
-0.184 
0.079 
h6 0.0539 0.0004*  0.243 0.117 
0.141 
0.085 
h9 0.3068 0.4413 0.0375  -0.103 0.102 
14:0 
h10 0.9456 0.021 0.0987 0.3154  
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Table B1 (continued) 
Trait Haplotype h1 h5 h6 h9 h10 
h1  0.137 0.124 
-0.120 
0.134 
-0.496* 
0.175 
-0.085 
0.106 
h5 0.2699  -0.257 0.163 
-0.633* 
0.190 
-0.223 
0.142 
h6 0.3706 0.1151  -0.376 0.210 
0.034 
0.151 
h9 0.0047* 0.0009* 0.0736  0.410 0.184 
16:0 
h10 0.4189 0.1178 0.8203 0.026  
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Table B2 Pairwise comparisons of FABP3 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h1 h2 h3 
h1  -0.050* -0.021 
  0.016 0.011 
h2 0.0027*  0.028 
   0.019 
 
15:0 
h3 0.0464 0.1271  
 
Trait Haplotype h1 h2 h3 
h1  0.008* 0.003 
  0.003 0.002 
h2 0.0051*  -0.004 
   0.003 
Elongation 
index 
 
h3 0.0634 0.1492  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0167 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table B3 Pairwise comparisons of FABP4 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h1 h4 h5 
h1  -0.057 0.176 
-0.569* 
0.182 
h4 0.7447  -0.512* 0.199 
 
SFA 
 
 
h5 0.0018* 0.0101*  
 
Trait Haplotype h1 h4 h5 
h1  0.057 0.176 
0.569* 
0.182 
h4 0.7447  0.512* 0.199 
 
UFA 
h5 0.0018* 0.0101*  
 
Trait Haplotype h1 h4 h5 
h1  0.081 0.159 
0.475* 
0.164 
h4 0.6107  0.394 0.180 
 
MUFA 
 
 
h5 0.0039* 0.0285  
 
Trait Haplotype h1 h4 h5 
h1  -0.016 0.033 
0.105* 
0.034 
h4 0.6297  0.122* 0.038 
 
PUFA 
 
 
h5 0.0022* 0.0012*  
 
Trait Haplotype h1 h4 h5 
h1  -0.003 0.013 
-0.040* 
0.014 
h4 0.8244  -0.037* 0.015 
 
SFA/UFA 
 
 
h5 0.0034* 0.0129*  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0167 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table B3 (continued) 
Trait Haplotype h1 h4 h5 
h1  -0.014 0.067* 
  0.024 0.025 
h4 0.5692  0.080* 
   0.027 
 
 
18:2 
h5 0.0068* 0.0029*  
 
Trait Haplotype h1 h4 h5 
h1  0.0067 0.0353* 
  0.0111 0.0115 
h4 0.544  0.0285 
   0.0126 
CLA 
h5 0.0022* 0.0234  
 
Trait Haplotype h1 h4 h5 
h1  -0.0002 0.0019 
0.0051* 
0.0020 
h4 0.9325  0.0053* 0.0021 
 
Index 18 
 
h5 0.0088* 0.0134*  
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APPENDIX C. SUPPLIMENTARY INFORMATION FOR CHAPTER 4 
 
Table C1 Pairwise comparisons of SREBP1 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h1 h4 h5 
h1  0.076 0.226* 
  0.059 0.057 
h4 0.2013  0.150 
   0.070 14:0 
h5 <.0001* 0.0314  
 
Trait Haplotype h1 h4 h5 
h1  -0.0360* 0.0069 
  0.0129 0.0123 
h4 0.0055*  0.0429* 
   0.0151 
14:1 
h5 0.5743 0.0046*  
 
Trait Haplotype h1 h4 h5 
h1  -0.0033* -0.0010 
  0.0011 0.0011 
h4 0.0031*  0.0023 
   0.0013 
Index 
14 
h5 0.351 0.0757  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value was ≤ 
0.0167 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
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Table C2 Pairwise comparisons of Insig1 haplotype effects on milk fatty acid 
composition 
Trait Haplotype h3 h7 h23 
h3  -0.015 -0.263 
  0.165 0.154 
h7 0.9269  -0.248 
   0.160 
MUFA 
h23 0.089 0.1213  
 
Trait Haplotype h3 h7 h23 
h3  0.071 0.099* 
  0.035 0.032 
h7 0.0413  0.028 
   0.034 
PUFA 
h23 0.0024* 0.4054  
 
Trait Haplotype h3 h7 h23 
h3  0.028 0.040 
  0.108 0.101 
h7 0.7921  0.011 
   0.105 
16:0 
h23 0.6946 0.9141  
 
Trait Haplotype h3 h7 h23 
h3  0.047 0.083* 
  0.024 0.023 
h7 0.0571  0.036 
   0.024 
18:2 
h23 0.0003* 0.1263  
*The Bonferroni adjustment for multiple comparisons was used, and significance was declared if p-value 
was ≤ 0.0167 
The p-values for pairwise comparisons are below diagonal, and estimates with standard errors are above 
diagonal. 
 
 
 
